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S U M M A R Y
The introduction to this thesis examines examples and character­
istics of two-stage chemical carcinogenesis, with particular reference 
to the promotion of mouse skin tumours by 12-0-tetradecanoylphorbol- 
13-acetate (TPA). The effects of TPA, TPA analogues and other tumour 
promoters on mammalian cells in culture are also reviewed.
The experimental section is in five parts. Chapter 2 lists 
materials and methods basic to the cell culture procedures used in 
the succeeding chapters. Chapter 3 is concerned with the established 
Chinese hamster ovary cell line, CHO-Kl. Procedures for the maintenance, 
manipulation and storage of CHO-Kl cells are detailed. Investigations, 
including karyological studies, certifying cells as CHO-Kl are reported, 
along with experiments to determine the lethal effects of three mutagens/ 
carcinogens and TPA towards these cells.
In Chapter 4 the design and validation of a CHO-Kl/ouabain-resis- 
tance mutation assay system is described. Subsequently, the effect of 
TPA on the frequency of both spontaneous and mutagen-induced ouabain- 
resistant mutants is determined, the promoter being added to cultures 
for various intervals during mutation expression and selection. In simi­
lar experiments the effect of TPA on spontaneous and ethyl methanesul- 
phonate-induced mutation to thioguanine-resistance is also determined.
The hypothesis that tumour promoters act by inducing mitotic re­
combination is examined in Chapter 5 by ascertaining if TPA is capable 
of inducing or enhancing sister chromatid exchanges, or of inducing 
metaphase quadriradial chromosome structures.
Chapter 6 initially confirms that TPA induces blast transformation 
of human lymphocytes. The possibility of utilising a microculture
assay of lymphocyte stimulation as a short term screening test for 
environmental tumour promoters is then studied by investigating an 
apparent correlation between lymphocyte mitogenicity and tumour- 
promoting potency.
Chapter 7 summarises the findings of the experimental sections 
and relates them to recent data reported by other workers and to 
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1.1 Two-Stage Caro ino gene sis
In 1941 Berenblnm discovered that a regimen of oroton oil, the non- 
oarcinogenic seed oil of Croton tiglinm L. (family Saphorhiaoeae) , 
applied alternately with the carcinogen 3,4f"benzpyrene to mouse 
skin caused a remarkable increase in tumour yield over that induced 
by benzpyrene alone. Mottraa (1944) later found that benapyrene 
need be applied only once in a sub-oeurcinogenic dose for subsequent 
repeated applications of oroton oil to elicit large numbers of 
tumours. The latter experiment demonstrated that tuaour induction, 
in mouse skin at least, can be divided into two distinct treatment 
stages and lead to the proposal of the two—stage theory of chemical 
carcinogenesis (Berenblum and Shubik 1947) # Within this theory, 
exposure to a sub-threshold dose of carcinogen such as benzpyrene 
(termed initiation), is envisaged to induce changes resulting in 
the formation of latent tumour cells. Subsequent repeated treat­
ment with a twour-enhancing agent such as oroton oil (termed 
pixweotion) enables these 'initiated* cells to express a neoplastic 
phenotype and proliferate to form tumours. Agents such as oroton 
oil, which exhibit tumour-promoting activity, are a unique class 
of co-carcinogens that are not themsleves mutagenic or carcinogenic 
but which cause the formation of tumours when applied repeatedly 
after initiation with a sub-threshold dose of carcinogen (Boutwe 11 
1964) • Co-carcinogenesis is a general term for all forms of ang^ 
mentation of tumour induction (Evans and Soper 1978) *
In the absence, until recently, of any other satisfactory 
experimental models, two—stage tmsour induction has primarily been 
studied and characterised using the mouse skin system. Such studies
were greatly facilitated by the isolation, identification and 
characterisation of the active tumour-promoting principles within 
oroton oil (Becker 1966, 1971; Van Duuren 1969)# These are a 
series of 12,13-diesters of the polyfunctional, tetracyclic 
diterpene alcohol, phorbol. The most abundant and most active 
of these diesters, 12-0-tetradecanoylphorbol-13-ecetate (TPA), 
has now superseded oroton oil as the promoter of choice in two- 
stage tumour induction experiments.
In mouse skin the initiation-promotion protocol has been 
shown to induce tumours — benign papillomas, from which squamous 
carcinomas develop some weeks later (Bums et al, 1976) - earlier 
and in greater numbers than any other carcinogenic stimulus for 
the skin (Van Duuren 1969, Boutwell 1974) • However, though there 
are a number of exceptions, most notably urethane (Van Duuren 1969) t 
the majority of initiators of skin tumours are also complete car­
cinogens, that is, at sufficiently hi^ single or cumulative doses 
they elicit tumours. This fact is incorporated into the two-stage 
theory of carcinogenesis by assuming that these compounds possess 
tumour-promoting as well as tumour initiating activity (Boutwell 
1964, 1976)• The efficiency of the initiation-promotion protocol 
is then attributed to oroton oil and TPA being much more potent 
promoters than complete carcinogens, which only act as promoters 
at levels far above those required to accomplish initiation (Bout­
well 1976).
The initiation stage of ttmour induction in mouse skin is 
not necessarily accompanied by morphological alterations in either 
the^idemis or dermis (Boutwell 1974, Diamond et al. I960). As 
initiation requires only a single application of carcinogen, it is 
presumed to be a rapid process (Diamond et al. i960) . In addition.
it has been repeatedly shown to be irreversible even when the time 
betvfeen initiation and promotion is greatly extended (in some cases 
to over a year) (Boutwell I964, Van Duuren I969) • This is despite 
the fact that the epidermal cells fYom which tumours develop are 
continually dividing (Boutwell 1974) * An important characteristic 
of agents capable of accomplishing initiation is that their action 
is additive, even at dose levels so low that they are not even 
detectable as a single dose when followed by promoter (Boutwell 
1964). Given the characteristics of initiation and initiators, the 
body of opinion is that initiation results in the formation of 
permanent, heritable changes in the genetic material of target 
epidermal cells (Boutwell 1974, Trosko et al. 1977, Slaga et al. 
1976a, Xlnsella and Radman 1973, Weinstein et al. 1979, Diamond et 
al. 1980, Blumberg I98O, I98I).
In contrast to initiation, promotion is a slow process re­
quiring repeated exposure to the promoting agent over several weeks 
(Nottram 1944, Boutwell I964, Van Duuren I969)• In mouse skin it 
is accompanied by morphological alterations, particularly in the 
epidermis %diere chronic exposure to a promoter causes persistent 
diffuse hyperplasia (Van Duuren 1966, Diamond et al. I980) . There 
is also good evidence that promotion is a reversible stage in car­
cinogenesis. Increasing the interval between promoter applications 
beyond the optimal time, while keeping the individual and cumulative 
dose of promoter constant, greatly reduces or eliminates the pro­
moting effect in initiated mouse skin (Boutwell I964). Tumour 
promotion itself has been further divided into conversion and prop­
agation steps. Boutwell (I964) made this sub-division on finding 
that after prolonged promotion of initiated skin a point is reached, 
short of observable tumours, %diere a non-specific proliferative
stiiBulus can be eubetituted for promoter to elicit tumoure.
PromoterB may elicit an occasional tumour %dien applied repet­
itively without prior topical treatment with an initiator (Boutwell 
1974) # This is probably due to the occurence of 'background* 
initiated cells resulting from the action of ubiquitous environ­
mental carcinogens. Nevertheless, that tumour promoters are not 
just weak carcinogens, differing only quantitatively from initiators, 
is established by the different characteristics of initiation and 
promotion and the finding that if order of application is reversed 
(promoter then initiator) no tumours develop (Berenblum and Ear an 
1955)* Further, certain factors capable of inhibiting promotion 
have no influence on initiation (Boutwell 1964)* Thus the action 
of a tumour promoter is qualitatively different from that of an 
initiator and probably results fjrom interaction at a different 
molecular target.
The foregoing characterisat ion of two-staige carcinogenesis 
and its components was wholely derived from results in the mouse 
skin system. Recently, models of two-stage carcinogenesis have 
been developed in other species and tissues and with promoting 
c Ml pounds distinct from oroton oil and its tumour—promoting con­
stituents. Dietary phenobarbitone, for example, has been shown to 
promote hepatocarcinogenesis in rats initiated by prior feeding with 
2-ace tyl am inof luorene (AAF) and other he patoc arc ino gens (Peraino 
et al. 1971, 1978). Phenobarbitone is a clear-out promoter in 
this system, being non-carcinogenic per ee and only enhancing tumour 
formation Wien given after initiator. Furthermore, initiation by 
AAF is irreversible and the promoting effect of phenobarbitone is 
most pronounced at low initiator doses (Peraino et al. 1978) ; anal­
ogous to two-stage carcinogenesis in mouse skin (Boutwell 1974) •
TABLE 1.1. ANIMAL MODELS OP TWO-STAGE CARCINOG^SIS IN TISSUES 
OTHER THAN MOUSE SKIM.
Tissue Initiator Method of 
Application






IBCBA Topical Phorbol Ip injection 1
Mouse lung 
and liver
DKN So injection Phorbol Ip injection 2
Mouse
Fore stomach
DMBA Intragas trio TPA Intragastric 3





M AAF Diet BET or DDT Diet 5
Rat Colon MNNG Intrarectal Various bile 
acids
Intrarectal 6







IBIBA Intragastric Hi^ fat diet 6
ft ft Progesterone Db injection 8
Abbreviat ion s s
Ipy intraperitoneal; So, Bubcutsneous; Im, intramuBOular;
DMBA, 7,12-dimetbyIbenzanthracene ; DKN, dimeihylnitrosaaine;
AAF, 2-aoetylaminof luorene ; DAB, p-dimethy laminoazobenzene ;
DENA, diethy Inltroeamine ; MNNG, NMmethyl-N-nitro-N-nitroeoguanidine ; 
MNU, methylnitroBourea.
References;
(l) Berenblum and Lena! (1970); (2) Armuth and Berenblm(l972) ;
(3) Goeritler et al. (1979); (4) Peraino et al. (1971);
(5) Peraino et al. (1978); (6) Wynder et al. (1978);
(7) Hicks et al. (1978); (8) Toshida et al. (1980).
This and some of the other experimental cancers which can demonstrate 
two—stage tumour induction; with initiation by a low molecular weight 
electrophile followed by chronic exposure to a promoter; are pre­
sented in Table 1#1. The examples given are presented because tum­
ours at these organ sites represent the major mortality burden of 
cancer in man (Sivak 1976) • It must be pointed out that compounds 
that are prcsnoters in one system may be inactive in another; phorbol 
(Hecker 1971) and phenobarbitone (Grube et al. 1975)* for example, 
are inactive as promoters in mouse skin althou^ they are promoters 
in other tissues (Table 1*1). This suggests that either different 
mechanisms of promotion are operative in different tissues and/or 
that some tissues are incapable of metabolising certain promoters to 
an active form.
The large number of experimental cancers subject to prMiotion 
suggests that environmentally induced human cancer may involve a sim­
ilar stage in its development. This is of great importance because 
at least 80-90^ of all human cancers are thou^t to be environment­
ally induced (Wynder 1978). The alarming possibility that certain 
environmental factors may be capable of promoting cancer in man long 
after a low level carcinogenic insult is supported by several lines 
of epidemiological evidence. Unfortunately, most studies cannot un­
equivocally distinguish promoting activity from other forms of co­
carcinogenesis. There is, however, one unambiguous example of tum­
our promotion in man. The h i ^  incidence of oesophageal cancer in 
Curacao has been shown to be almost certainly due to natives habitu­
ally chewing roots of the Euphorbiacea Croton flavens, extracts of 
Wiich, though non-carcinogenic, have been shown to contain mouse skin 
tumour—promoting factors closely related to the phorbol diesters in 
oroton oil (Hecker 1976).
Other studies provide circumstantial evidence that modifying
factors including tumour promoters enhance low dose or low potency 
carcinogens in man. One of the most striking examples is the find­
ing of a 10-fold hitler lung cancer mortality among asbestos workers 
who were smokers than among workers who were non-smokers (Selikoff 
and Hammond 1975)# Though this may have been due to simple oo-car- 
c ino genesis, it has been found that cigarette smoke condensate con­
tains tumour-promoting as well as oo-c arc ino genic and carcinogenic 
(initiating) components (Van Duuren 1969# Van Duuren 1973)# Further, 
the decline of lung cancer in ex-smokers suggests that a reversible 
tumour-promoting activity of cigarette smoke dominates its tumour- 
inducing potential (Diamond et al. I980). The cause of the rela­
tively high incidence of mammary cancer in U.S. women is presumed 
to be the result of a high fat (HF) diet, (Wynder et al. 1978).
Given the known tumour-promoting effect of a HF diet on mammary 
cancer in rats (Table l.l), this is an indication of a promotion 
component in human breast cancer. Similarly, increased secretion 
of bile acids (probably also related to HF diet), is implicated as 
a tumour—promot ing factor in cancer of the colon in man (Wynder et 
al. 1978). Again, there is an analogy with one of the animal models 
of two—stage carcinogenesis in Table 1.1.
As it is likely that tumour pixwotion is a stage in the pro­
gression of at least some human cancers, the phenomenon wsurants 
intensive investigation. Firstly, so that tumour promoters of aetio- 
logical significance may be identified and screened from man's envir­
onment. Secondly, because elucidation of the mechanism(s) of pro­
motion may suggest ways of interrupting the carcinogenic process and 
more rational basés for cancer therapy than those currently employed.
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1.2 Chemistry of Skin Tumour Promoters
Tumour—promot ing action can now be demonstrated in a variety of 
tissues and species by a considerable number of compounds (Table 
l.l). However, the phorbo 1-12,13-diesters (exemplified by TPA) 
which operate in the classical mouse skin syst«n, remain the most 
potent and unequivocal promoters and consequently the most approp­
riate for use in studies of tumour promotion. In addition, these 
compounds constitute a unique series, with a full range of promoting 
activity, suitable for establishing structure-activity relationships 
(see below). The existence of this series has also encoursiged stu­
dies aimed at identifying which of the many biological and biochem­
ical effects of the phorbol diesters (see 1*5 and 1.7), are crucial 
to their tumour-promoting action.
The general structure of the phorbo 1-12,13-diesters as des­
cribed by Hecker (1978), is given in Pig 1.1a. They are a group of 
diterpene derivatives based on the hypothetical parent hydrocarbon 
tigliane (Evans and Soper 1978), (Pig 1.1b). There are two main 
regions within the phorbol diester molecule:
(1) the hydrophilic phorbol moiety, and
(2) the hydrophobic, saturated fatty acid chains
at C—12 and C—13.
Absence of the ester chains, as in the parent alcohol phorbol, 
results in total lack of promoting activity in skin (Hecker 1971), 
except in a skin-tumour—sensitive (STS) strain of mice (Baird and 
Boutwell 1971) • Thus the hydrophobic portion of the molecule is 
required for promoting activity in this target tissue, possibly be­
cause it allows passage of the molecule through a lipid environment 
to its site of action (Hecker 1978) . It has also been demonstrated 
















Pig 1.1. Structures of phorbo 1-12,l^-diesters (a) and 4^-phorbol-
12,13-diester8 (o) with tigliane (b), daphnane (d) and ingsnane (e) 
hydrocarbon skeletons. Structures a and o from Heoker (1978); b, d 
and e Arom Evans and So per ( 1978) #
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hydrophobic portion is crucial# The activity of such die sters in­
creases with increasing chain length up to 8 carbons, but then, 
beginning with the 12 carbon ohain length decreases markedly %Thiel- 
mann and Heoker 1969) #
Alteration of the overall configuration of the phorbol moiety 
can profoundly affect ttanour-promoting activity# If the configura­
tion of the C-4 hydroxyl is inverted# the result is a 4<^*Phorbol 
(Pig l#lo), in which the $- and 7- membered rings of the molecule 
are cie-interlinked rather than trane-interlinked as in Pig l#la 
(Hecker 1978) # Simultaneously, the formerly rigid ring system ac­
quires considerable conformational flexibility# The result is ab­
lation of promoting activity, as evidenced by the fact that phorbol-
12,13-didecanoate (PDD) is a strong tumour promoter whereas 4 -FDD 
is completely inactive (Thielmann and Hecker 1969)* Another import­
ant feature of the C-4, 0-10 ring junction is that méthylation at the 
4-position leads to very greatly reduced promoting activity# Thus 
TPA's analogue 4^-0-methyl-TPA (MeTPA) , is only very weakly active 
as a promoter (Hecker 1978) * Because it is the non-promoting entity 
of the closest possible chemical structure to TPA, MeTPA is the most 
appropriate negative control compound available for inclusion in 
tumour promotion experiments# It is also well established that the 
presence of the free allylic hydroxyl group at C—20 is essential for 
h i ^  promoting activity, estérification at this position leads to 
greatly reduced activity in TPA and other phorbol—12,13-diesters 
(Hecker 1968, 197l)* The effect of deletion or modification of 
other functional groups within the phorbol moiety is less certain# 
However, it appears that the C-1, C-2 double bond, thou^ not the 
C-6, C-7 double bond is a prerequisite for biological activity and 
that the cyclopropane ring system can be opened without total loss 
of activity (Hecker 1978) #
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As stated above (l.l), diterpenoid phorbo1-12,l>-diesters were 
isolated from oroton oil, the seed oil of Croton tiglium L. and iden­
tified as the tumour-promoting principles of that material. Plants 
other than C. tiglium, from the families Euphorbiaoeae and Thymale- 
aceae, contain different types of diterpene esters with tumour- 
promoting activity in mouse skin. Evans and Soper (1978) and Hecker 
(1978), have classified these compounds by the nature of their ceirbon 
skeleton into three classes:
(1) esters of tigliane, including the phorbol diesters 
of C. tiglium and esters obtained from other plants 
exhibiting different degrees of oxygenation of the 
parent tigliane alcohol, e.g. 4^eoxy-phorbol esters;
(2) esters of daphnane (see Fig l.ld), including esters 
of the parent alcohol resiniferonol such as resinif- 
eratoxin and esters of modified resiniferonol mole­
cules such as meserein, and
(3) esters of ingenane (see Fig l.le), including those 
of the parent alcohol ingenol.
All these diterpene esters show structure-act ivity relationships gen­
erally similar to those described for the phorbol diesters, and all 
certainly show the need for both a hydrophilic and a hydrophobic 
portion within the molecule for tumour-promoting activity in mouse 
skin (Evans and Soper 1978, Hecker 1978)#
In addition to diterpene esters, other topically applied chemi­
cals have tumour-promoting activity in mouse skin. The most potent 
of these is the phenolic compound anthralin, which is frequently 
used experimentally as a non-diterpene ester-type skin tumour pro­
moter. However, on a molar basis, this compound is much less potent 
than TPA, requiring an approximately 1,000-fold higher dose to elicit
1 2
a comparable timour yield when applied repeatedly to identically 
initiated mouse skin (Boutwell 1974)• Certain other phenolic com­
pounds exhibit weak promoting activity in mouse skin (Van Duuren 
1969) and this may, in part, account for the promoting activity of 
certain fractions of cigarette anoke condensate, idiich are known 
to contain phenolic components (Wynder et al. 1978) . A number of 
chemicals possessing hydrophilic/hydrophobic (amphiphilic) struc­
tures exhibit mouse skin tumour—promot ing activity. Some long 
chain unsaturated fatty acids, including oleic and 1 auric acid, are 
weakly active at high doses (Holsti 1959)1 emd potency is increased 
in methyl esters of the free acids (Arffmann and Glavind 1971).
Setala (I960) has also established the tumour-promoting properties 
of several non-ionic surface—active agents from amongst the Spans 
and Tweens. Promoting activity has, in addition, been reported 
for several linear alkanes of 10-16 carbon chain length (Sice I966) 
and for iodoacetic acid (Gvynn and Salaman 1953) t molecules which 
are neither phenolic or amphi^ilic. The above compounds show a 
diversity of chemical structure and within this disparate group the 
frequency of application to initiated skin required to promote tum­
our formation varies greatly. Coupled with the extrwiely low potency 
of these compounds, compared with phorbol esters such as TPA, this 
has lead to the suggestion that the mechanism of action of the phor­
bol esters and related diterpenes may be unique among mouse skin tum­
our promoters (Blumberg I98I).
1 3
1*3 Physical Properties of the Phorhol Esters.
The physical properties of the phorbol diesters are mainly a 
reflection of the amphiphilic nature of these molecules. The 
surface tension of aqueous TPA solutions at decreases with 
increasing TPA concentration up to 2 z 10“^,  above which no 
further decrease is observed (Jacobson et al.l973)» As well as 
illustrating that TPA is surface—active, this result gives an 
estimate of the ester'd aqueous solubility limit which agrees 
reasonably well with the value of 3*7 % 10“^ ,  determined by a 
spectrophotometric method (Van Duuren et al.1976). Like many 
other surface—active agents TPA forms micelles; these have been 
detected in aqueous solution at 10""4( (Edelman and Wang 1978) . 
Furthermore, it has been demonstrated by Jacobson et al. (l975) 
that TPA and other phorbol esters can interact with lipid struc­
tures in vitro. TPA, FDD, and PDD*s inactive stereoisomer 4^- 
FDD, each inserted into a phosphatidylcholine monolayer at the 
air-water interface idien introduced into the aqueous subphase, as 
evidenced by an increase in the surface pressure of the mono­
layer. In the same study it was found that both TPA and 4<-FDD 
interacted with dipalmitoylphosphatidylcholine liposomal bilayers 
to reduce the enthalpy of the minor transition associated with a 
change in the tilt of the acyl side chains of the phospholipid 
molecules.
The above findings raise questions about measurements per­
formed with TPA and other phorbol esters above the solubility 
limits of these compounds. In addition they emphasise the parti­
ally lipophilic nature of the diesters and their capacity to 
interact with phospholipid bilayers analogous to cell and intra­
cellular membranes.
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1*4 NetabolisB of Phorbol Esters
Before considering the biological and biochemical effects of the 
phorbol diesters, an important issue to be considered is whether 
these compounds are the actual promoting species or whether they 
first require conversion to active metabolites. Hecker (l970) 
found that up to 72hr after administration of &-TPA to mouse 
skin, recoverable radioactivity remained largely associated with 
unchanged promoter molecules. Only two metabolites, as opposed 
to autozidation products (Schmidt and Hecker 1975), appeared to 
be generated truly enzymatically and then only in minor amounts.
As promoters, the two metabolites and all autozidation breakdown 
products were much less active than TPA. In vitro, a number of 
cell types metabolise TPA and other {diorbol diesters quite rapidly 
(Diamond et al.19^0). However, the products of such metabolism are 
again of much lower biological activity than the original molecules. 
Thus the information currently available indicates that metabolism 
of TPA is not required for biological activity and that such meta­
bolites as do arise should be considered the result of metabolic 
inactivation.
Though more data are needed before it can be determined 
idiether this is a general rule for all phorbol diester tumour 
promoters, the few relevant results available do not contradict 
this ELS sumption (Blumberg 19dO). This overall conclusion is further 
supported by the fact that the phorbol diesters produce rapid effects 
in mouse skin and a multitude of other biological systems (see below), 
strongly suggesting that the parent compounds are the ultimate tumour 
promoters.
1 5
1«3 Effects of Phorbol Esters in Mouse Skin
KazBDalian skin is composed of two distinct structures, the inner 
dermis and the outer epidermis. The dermis is responsible for 
the tensile strength of the skin. It is relatively acellular and 
consists largely of connective tissue with occasional blood and 
lymph vessels. The overlying epidermis, which is avascular and 
alymphatio, serves to exclude harmful substances and micro-organisms. 
It stems from a basal layer of nucleated cells, 1 - 2  cells thick, 
immediately above the dermis. These cells divide regularly and 
half their dau^ter cells differentiate into keratin producing 
cells (kératinocytes) that go on to die and continually renew 
the tough keratin covering provided by the epidermis. Skin tumours 
are known to develop from epidermal cells (Boutwell 1974), and so 
research into the mechanism of two—stage tumour induction has con­
centrated on the epidermis as the target tissue of both initiating 
and promoting agents. It is, however, conceivable that the dermis 
plays a role in promotion, as promoter induced changes in this 
structure may well indirectly effect initiated epidermal cells.
The sequence of biological changes following promoter treat­
ment of mouse skin is well established. An important overall ob­
servation is that the histological changes that follow acute treat­
ment appear to be the same whether or not the skin has previously 
been exposed to an initiating agent (Diamond et al. I980). Within 
a very few hours (^4hr) after application of a single effective 
(promoting) dose of TPA (l7nmol), oedema and erythema are evident 
at the site of exposure (Van Duuren I969, Evans and Soper 1978) . 
These are local tissue reactions characteristic of the inflamma­
tory response to an irritant. At about the same time, enlargement 
of the basal cells of the epidermis (hypertrophy) and dilation of
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the intercellular spaces is observed at the microscopic level (Raick 
1973a) • By 24hr, leucocytes have infiltrated the dermis (Prei and 
Stephens 1968) . Again, like oedema and erythema, this is charact­
eristic of a classic inflammatory response# A sustained stimula­
tion of mitotic activity in the basal cell layer of the epidermis 
starts after about 24brs and continues for several days, resulting 
in an increase in the number of nucleated cell layers from the nor­
mal 1 — 2, to 3 - 4 or more (Raick 1973a)• Cell proliferation is 
soon followed by a phase of increased kératinisation of the upper 
layers of the epidermis (Raick 1973a) . All these responses to the 
promoter, including the marked increase in cell number (hyperplasia) , 
gradually subside and after about two weeks the epidermis regains 
its normal appearance (Raick 1973b)# However, repeated promoter 
treatment, as in the two-stage procedure for tumour induction, pre­
vents this 'reversion* and maintains the skin in a constant state 
of mild, diffuse epidermal hyperplasia (Van Duuren I969).
A response, similar to that produced by TPA, can be evoked in 
mouse skin by many irritants which lack tumour-promoting ability 
(Diamond et al. 198O) , establishing that irritation is not suffic­
ient in itself for tumour promotion. Interestingly, skin treated 
with such an agent differs histologically from that treated with 
TPA. After TPA treatment, the hyperplasia in the nucleated cell 
layer of the epidermis occurs before an increase in mitotic index, 
probably as a result of secondment (by dedifferentiation) of kéra­
tinocytes back into the stem cell population (Raick 1973a)» Treat­
ment with the irritant but weakly promoting compound ethylphenyl- 
propiolate (EPP), conversely, first produces an increase in mitotic 
activity and then an increase in the number of nucleated cells 
(Raick 1974)» At the electron-microscopic level, TPA-treated
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epidermis acquires an ultrastructure resembling that at a rather 
early stage of embryonic development (Raick 1973a). Such dediffer­
entiation is not, however, seen after exposure to EPP (Raick 1974) # 
Another important observation is that for TPA the dose threshold 
for the inflammatory/hyperplastic response is at least 1,000-fold 
lower than that for tumour promotion (Boutwell 1974) # Furthermore, 
though structure-activity relationships for tumour-promoting activ­
ity and irritancy generally correspond within the diterpene esters, 
there are a number of exceptions, most notably phorbol dibutyrate 
(Thielmann and Hecker 19&9) and certain esters of 12-deojyphorbol 
(Edwards et al. 1981), which are strong irritants but only very weak 
or non-promoters.
Although all irritants are not skin tumour promoters, all such 
promoters are irritants. This was recognised as early as 1950 
(Shubik 1950) and up to the present time no exceptions to this rule 
have been identified. Thus irritancy is established as a prerequis­
ite property of all skin tumour promoters (Diamond et al. I98O, 
Blumberg 198I) . It may be that irritation is required to evoke 
hyperplasia, which has been shown to be necessary to complete tum­
our promotion (Boutwell I964) • It is obviously crucial in invest­
igations into the mechanism of tumour promotion to elucidate the 
critical changes that promoters induce that distinguish them from 
irritants. Evans and Schmidt (1979) have stressed the importance 
of including appropriate controls for irritancy in experiments using 
TPA and other diterpene esters, ideally non-promoting congeners of 
closely similar structure which possess potent inflammatory activity.
In view of the profound biological effect of phorbol diester 
treatment in mouse skin, it is not surprising that numerous con­
current biochemical changes have been reported. It is probable
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that only a very few of the observed ohanges are essential for tum­
our promotion and much effort is directed at identifying these cruc­
ial alterations. It must be stressed that the effects observed in 
mouse skin are essentially the response of normal cells. It may be 
that the biochemical responses to promoters of initiated epidermal 
cells are quantitatively and/or qualitatively different but because 
of the overwhelming number of normal cells, these differences cannot 
be detected.
A single application of l?nmol TPA was found to sequentially 
stimulate tritiated precursor uptake into RNA, protein and finally, 
after an initial depression below control,DKA in both epidermis 
(Baird et al. 1971) and whole skin (Raick 1973a). This series of 
events probably relates to preparation for epidermal cell division. 
When phorbol and 4 of its diesters were tested at equimolar doses 
it was found that tumour-promoting activity correlated with ability 
to sustain stimulation of macromolecular synthesis (Bsdrd et al. 
1971).
As well as increasing total protein synthesis, there is evid­
ence suggesting that TPA changes the pattern of such synthesis. Two 
'new' protein bands were found on polyacrylamide gel electrophoret- 
ograms of the soluble protein from mouse skin 3.$hr after TPA treat­
ment (Boutwell 1974)« These were absent or barely detectable in the 
soluble protein from normal skin, or skin treated with sioetic acid, 
a hyperplastic agent with extremely weak promoting activity (Blum­
berg 1980). TPA also induces a dose-related increase in histone 
phosphorylation, the extent of which, when phorbol and phorbol dib­
enzoate were tested at equimolar concentration, was found to correl­
ate with tumour-promoting activity (Raineri et al. 1973) •
Phorbol ester treated epidermis shows changes in a number of
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enzyme activities. Some of these alterations may well be relevant 
to tumour promotion, given the long history of altered enzyme lev­
els associated with cancer (Boutwell 1974)• Of considerable signif­
icance is the induction of ornithine decarboxylase (ODC); the first 
and rate-limiting enzyme in poly amine biosynthesis, the products of 
which — putreseine, spermidine and spermine - are associated with 
rapid growth (Boutwell 1974) and may influence cell differentiation 
(O'Brien I980). O'Brien et al. (1975a) found that a single applic­
ation of 17nmol TPA induces a more than 200-fold increase in ODC ac­
tivity in mouse epidermis. A very sharp peak in activity is observed 
at 5"6hrs, followed by a return to the normal, very low basal level 
by 24hr. Subsequent to increased ODC activity the levels of putre- 
Bcine and spermidine, but not spermine, are elevated (O'Brien I980). 
Induction of ODC by TPA is dose-dependent over practically the same 
dose range as tumour promotion and the response to equimolar concen­
trations of other phorbol diesters correlates with their tumour—pro­
moting activity (O’Brien et al. 1975b)• Hon-phorbol diester promot­
ers also induce ODC but non-promoting hyperplastic agents do not 
(O'Brien et al. 1975b), suggesting that the induction of this enzyme 
is relevant to the mechanism of promotion. O'Brien (I980) has, in 
addition, reported that skin tumours induced by the two-stage proto­
col exhibit permanently elevated ODC activity and poly amine levels. 
Another enzyme involved in polyamine biosynthesis, S-adenosyl- 
methionine decarboxylase (SAMD) is also induced by TPA. However, 
the response is considerably less than with ODC and can also be 
evoked by certain non-promoting hyperplastic agents (O'Brien 1975b) , 
thus its relevance is questioned.
Several investigators have studied the effects of promoters on 
cyclic nucleotide metabolism. Thou^ their effects on cyclic aden—
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osine monophosphate (c-ANP) levels are in dispute, it is established 
that promoters render the skin unresponsive to B-adrenergio agonists 
(Diamond et al# I98O) # Catecholamines usually induce a rapid rise 
in epidermal c—AMP that is mediated by membrane—bound B-adrenergic 
receptors (Grimm and Marks 1974); this effect is blocked by prior 
treatment of the skin with TPA or other timour promoters (Grimm and 
Marks 1974), but not by non-promoting hyperplastic treatments (Marks 
1978) • In much the same way and possibly by a related mechanism, 
proliferating epidermal cells are rendered unresponsive to epidermal 
G^ chalone (an endogenous inhibitor of epidermal cell proliferation) 
for the first two days following TPA treatment (Marks 1978) • However, 
in this case, inhibition can also be achieved by non—promoting hyper­
plastic agents#
These findings, allied to the kno%m affinity of phorbol diesters 
for phospholipid monolayers and bilayers (l#3)i suggest that the 
primary and possibly predominant effect of tumour promoters may be 
mediated at the cell and/or intracellular membrane(s). Such a view 
stems from the early work of Van Duuren (1969) i who reported that 
phorbol esters, albeit at very hi^ concentrations, labillse rabbit 
liver lysosomes. Other evidence of the interaction of tumour promot­
ing phorbol esters with membranes comes from in vitro studies using 
isolated membrane fractions# Kubinski et al# (1973), found that 
^B-FDD cosedimented with liver microsomal membranes in CsCl gradients 
and, further, that microsomal membranes exposed to phorbol diesters 
showed a change in buoyant density and an altered affinity for DNA# 
Van Duuren et al. (1976) have reported that exposure to TPA decreases 
the intrinsic fluorescence of rat liver plasma membranes, suggesting 
an altered conformation of proteins in the lipid bilayer. The non­
promoter 4(X-PDD and the weak promoter 3-hydro2y-TPA caused markedly
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less quenching than TPA. In mouse skin itself Eelmes et al (1974) 
found that following application of ^H-PDD the radioactivity in sub- 
cellular fractions paralleled their membrane content. As well as 
demonstrating that phorbol diesters are predominantly sequestered 
into the membranous fractions of cells, this result illustrates the 
difficulties in determining specific interactions of these compounds 
with receptor sites or membrane components, given their generalised 
uptake into membranes. An early consequence of TPA treatment of 
mouse skin, which is very likely a result of induced membrane 
changes, is increased phospholipid metabolism. Following a single 
application of 17umol TPA, the synthesis of phosphatidylcholine and 
phosphatidylethanolamine (in whole skin) rise within 3hr to a level 
markedly above control, a response which cannot be evoked by non- 
promoting hyperplastic agents or an initiating carcinogen (Rohr- 
schneider and Boutwell 1973) • The possible importance of this res­
ponse with respect to tumour promotion is strongly implied by the 
finding that mouse skin papillomas contain hi^er levels of phos­
phatidylcholine than their tissue of origin (Rohrschneider and 
Boutwell 1973).
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1.6 Inhibitors of Tumour Promotion in Mouse Skin 
Inhibition of a biological process can lead to increased under­
standing of the basic mechanisms involved in that process. The 
most potent inhibitors of tumour promotion are the anti-inflamma­
tory glucocorticosteroids; when administered (topically) simultan­
eously with repeated doses of TPA they greatly or completely supj^ 
ress tumour formation in initiated mouse skin (Slaga et al. 1978b). 
The anti-promoting activity of these compounds is probably a conse­
quence of their inhibitory effect on cell proliferation - necessary 
for the concluding propagation substep of tumour promotion (l.l) — 
rather than direct pharmacological antagonism at a crucial molec­
ular target. The effects of non-steroidal anti-inflammatory agents 
such as indomethacin (an inhibitor of prostaglandin biosynthesis 
(Blumberg I980) ) , are generally less impressive (Viaje et al.
1977)• Indomethacin*8 inhibitory activity nevertheless suggests a 
role for prostaglandins in tumour promotion.
Tumour promotion can also be suppressed by various pro tease in­
hibitors, including the chloromethyl ketones TLCK and TPCK, anti­
pain, and leupeptin (Troll et al. 1978). However, these agents 
probably do not specifically inhibit pro tease enzymes and clear 
evidence that tumour promoters stimulate pro tease activity in mouse 
skin is lacking (Diamond et al. I980) .
Insists gained into the nature of tumour promotion by the use 
of the above anti-promoters has thus been limited. However, the 
final major class of known anti-promoters, the retinoids (the family 
of molecules cwsprised of vitamin A and its synthetic analogues), 
are likely to be much more useful. Verma and Boutwell (1977) dis­
covered that retinoic acid applied concurrently with TPA inhibits 
tumour promotion in a dose-dependent manner. When applied to
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mouse skin in close time relation to TPA, retinoic acid also 
dramatically inhibits TPA—induced epidermal ODC activity (Verma 
and Boutwell 1977). In addition,for a range of natural and syn­
thetic retinoids, there is a good correlation between the ability 
to inhibit ODC-induction by TPA in mouse skin and an inhibitory 
effect on promotion, as measured by the formation of skin pap­
illomas (Verma et al. 1978, 1979) • Vitamin A is known to be 
required for the maintenance of normal epithelial cell differ­
entiation in man and other mammals (Spom 1978) . Therefore it is 
possible that the retinoids exert their anti-promoting activity 
by countering abnormal cell differentiation, which is character­
istically exhibited by cancer cells (Spom 1978) .
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1*7 Effects of Tumour Promoters on Cells in Culture 
Cell and organ culture systems offer to the study of chemical car­
cinogenesis and tumour promotion the advantages of being better 
defined and more flexible than in vivo systems and, because they 
are far simpler, experimental results are also more easily inter­
preted, In vitro studies with tumour promoters have almost ex­
clusively employed the phorbol diesters, in particular TPA. They 
have investigated the effects of promoters on:
(1) primary cultures — cultures initiated from cells, 
tissues or organs taken directly frcwn an organism;
(2) primary cell lines - cell populations, derived at 
first and subsequent subcultures from primary cul­
tures, which characteristically can only be sub­
cultured a finite number of times; and
(3} established cell lines - cell lines, often derived 
from primary lines, >hich demonstrate an ability 
to be subcultured indefinitely.
All these types of cells, especially the established cell lines, 
are someidiat altered from the original cells in vivo and extra­
polation of results to the in vivo situation must, consequently, 
be undertaken with caution. However, the findings of in vitro 
studies are undoubtedly useful because they reflect and extend ob­
servations made in mouse skin. They have also lesul to the realiz­
ation that the phorbol diesters are powerful tools for investiga­
ting not only tumour promotion, but also cell proliferation and 
differentiation. A general observation is that when a series of 
phorbol diesters has been tested for a specific effect in vitro, a 
correlation has usually been found between promoting activity in 
mouse skin and the ability to induce that effect.
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The aim of many workers has been to mimic two-stage carcin­
ogenesis in vitro. Individual cells of several established rodent 
cell lines undergo malignant transformation following exposure to 
oncogenic viruses or chemicals, with the result that they lose the 
contact-or density-dependent inhibition of cell division which nor­
mally limits their saturation density in monolayer culture and form 
piled-up, criss-crossed foci (Paul 1975, Heidelberger 1976)• Con­
currently they undergo morphological changes and acquire the capa­
bility to grow in soft agar or agarose and to give rise to tumours 
when injected into appropriate animal hosts (Heidelberger 1976)•
Sivak and Van Duuren (196?) showed that in a mixed population of 
contact-inhibited Swiss 3T3 mouse fibroblasts and SV40 virus-trans­
formed cells, the yield of transformed foci was enhanced by a puri­
fied phorbol ester fraction from croton oil. However, with contact- 
inhibited 3T3 cells,in which a few transformed foci appear spontan­
eously, the number of foci was not increased by exposure to 
7,12-dime thy Ibenz anthracene (DKBA) alone, or DMBA followed by pro­
moter; therefore, this was not a true in vitro initiation-promotion 
transformation system.
A similar system, again employing established mouse fibroblasts, 
represents the most convincing example of two—stage carcinogenesis 
in vitro so far demonstrated. In cultures of C3^/lOTl/2 cells (a 
clone derived from the C3H cell line) treated with subtransforming 
doses of methyIcholanthrene, benzpyrene or DMBA, subsequent continu­
ous exposure to a non—toxic, non-transforming concentration of TPA 
(l.6xlO"^) produces substantial numbers of transformed foci (Mondai 
et al. 1976). The hydrocarbon must be given before the promoter in 
order for transformation to oocur, and the potencies of a series of 
phorbol derivatives in this system parallel their in vivo promoting
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activities* Furthermore, in these cells ultraviolet (UV) li^t 
acts as a pure initiator, transformation only occuring when UV ex­
posure is followed by TPA treatment (Mondai and Heidelberger 1976) • 
Although this system is analogous with respect to timing and dosage 
to two—stage carcinogenesis in mouse skin, a major objection to its 
use in the study of tumour promotion is that the target cells are 
fibroblastic, \diereas the epidermal cells of the skin are epithe­
lial. Several groups are therefore attempting to develop two- 
stage carcinogenesis models in epithelial cell systems, but as yet 
without success (Blumberg I98I)#
TPA can have striking, reversible effects on the morphology 
and size of cells in monolayer culture. These effects are most 
apparent in sparse, growing cultures, although similar ohanges 
occur in confluent cultures (Diamond et al. I980) . Procedures for 
the preparation of primary cultures of newborn mouse epidermis have 
been developed by two groups (Yuspa et al. 1976a, Fusenig and 8am- 
sel 1978). The epidermal cells differentiate in vitro and produce 
keratin proteins that are identical to those of the outer horny 
layer of the skin. TPA (lO"— lO"^) alters the morphology of these 
cells, shifting them to a clearly less differentiated state with 
wider intercellular spaces (Yuspa et al. 1976a, Fusenig and Samsel
1978); changes similar to those seen in mouse skin treated with 
TPA (Raick 1973a) .
Cells of fibroblastic primary cell lines also exhibit changes 
in appearance following exposure to TPA. Within a few hours after 
exposure of growing cultures of WI-38 diploid him an fibroblasts 
(Diamond et al. 1974) or chick embryo fibroblasts (CEF) (Driedger 
and Blumberg 1977) to low concentrations of TPA (l.6xlO*’*̂M and 
5xlO"^ respectively) the cells become elongated, the number of
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narrow oytoplasmic processes increases, and the nuclear and cyto­
plasmic membranes show more distinctly than in control cultures. 
While the human cells retain a normal well-orientated growth patt­
ern (Diamond et al. 1974), TPA-treated CEF assume a criss-crossed, 
disorientated arrangement similar to, but distinguishable from, 
that induced by transformation with Rous sarcoma virus (RSV) (Dried­
ger and Blumberg 1977, Wilson and Reich 1979) • Indeed in CEP in­
fected with RSV, treatment with TPA accentuates morphological alt­
erations induced by virus transformation, such as spherical cell 
shape, multi layer ing and disorganisation of the monolayer (Wilson 
and Reich 1979) • The mean cell volumes of both the human and chick 
fibroblasts are also significantly reduced, to 70—75?̂  (Diamond et 
al. 1974) and 62^̂ (Driedger and Blumberg 1977) of control cells 
respectively. Driedger and Blumberg (1977) ascertained that for 
CEF the protein per cell falls in parallel with cell voluse, there­
fore the volume decrease is due to changes in the overall composit­
ion of the cell. Further, they determined that the growth rate of 
CEF in TPA-containing medium is no different from that in control 
medium, indicating that the effects of TPA are not the result of 
generalised toxicity.
The changes in cellular morphology, refract ility and volume 
seen in established Swiss 3T3 mouse fibroblasts treated with 8x10 ^  
TPA are very similar to those seen in WI—38 human fibroblasts 
(above) (Diamond et al. 1974)• Sparse cultures of WI-38, 3T3 and 
CE fibroblasts continually exposed to TPA all eventually achieve 
hi^ier cell densities than control cultures (Diamond et al. 1974, 
Driedger and Blumberg 1977) # Diamond et al. (1980) suggest that 
the TPA-induced decrease in cell size may increeise final monolayer 
densities by delaying the onset of contact-dependent growth inhib-
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ition, which operates in these three cell types (Paul 1975)#
Increased epidermal macromolecular synthesis and cell prolif­
eration are characteristic of the response of mouse skin to tumour 
promoter treatment (l»5)« TPA is capable of stimulating these 
associated events in many cell culture systems in which cells have 
become growth-inhibited. This effect of TPA (and other active 
phorbol diesters) may be due to direct stimulation of cell replic­
ation mechanisms, a consec^uence of interruption of growth controls 
(such as contact—inhibition of growth) , or a combination of these 
mechanisms. In any event, the likely target for promoter action 
is the cell membrane, given the probable role of this cell organ­
elle as the transducer of many endogenous and exogenous growth- 
modifying signals (Jazwinski et al. 1978, Tsien et al. 1982).
Sivak and Van Duuren (1970) added 8xl0"**̂ M TPA to monolayer 
cultures of resting Swiss 3T3 mouse fibroblasts 3 days after the 
cells had reached confluence and become contact—inhibited. TPA 
exposure evoked a sequential stimulation of RNA and DRA synthesis, 
and after 4 days the amount of protein per culture had also in­
creased 2.07-fold. Similar observations were made by Estensen et 
al. (1974) using confluent, contact-inhibited Balb/c 3T3 mouse 
fibroblasts and by O'Brien (1980) using human fibroblasts. In 
all these cases, cells were exposed to TPA in the presence of serum- 
containing nutrient medium. It was found that when presented in 
completely serum-free medium, TPA (1.6x10 M̂) is incapable of in­
ducing DNA synthesis in quiescent cultures of Swiss 3T3 fibroblasts, 
thus demonstrating that for this cell type at least TPA's growth- 
stimulating activity is dependent on the presence of certain serum 
factors (Dicker and Rosengurt 1978) . In this same study it was 
shown that serum can be substituted by polypeptide hormones such
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as epidermal growth factor (BCT*) (Savage et al. 1972), insulin, or 
fibroblast-derived growth factor (PDGP) (Bourne and Rozengurt 1976). 
TPA (l.6ilo"̂ M and 3»2xlO~*̂ M) strongly potentiated stimulation of 
DNA synthesis and cell division by these polypeptides in serum- 
free medium. The interaction between the tumour-promoter and BGF 
or insulin was particularly striking, because neither of these sub­
stances produced a substantial stimulation of DRA synthesis by it­
self. A synergistic interaction between insulin and TPA was also 
found in quiescent serum—free cultures of Swiss 3T6 and human em­
bryonic lung fibroblasts. Insulin enhanced the mild stimulatory 
effect of 1.6xlO"^ TPA on the percentage of cells in DNA ^mthesis, 
as determined by the fraction of cells pulse-labs lied with H- 
thymidine. At higher concentrations (1.6-4.8x10* M) TPA was a 
strong growth—stimulator per se in both these cell types, showing 
that TPA induction of cell proliferation does not always require 
the presence of other growth factors. TPA and other diterpene 
esters also stimulate many normally non-proliferating lymphocyte 
populations; this is discussed separately in Chapter 6. Rot all 
cell types in stationary phase respond to TPA by proceeding towards 
cell division. For example, 3 day old quiescent cultures of hamster 
embryo fibroblasts (HBF) showed no stimulation of low level DNA 
synthesis following addition of 1.6xlO*^M TPA (O'Brien I980). 
Neither did this concentration of phorbol ester enhance the eleva­
tion of DNA synthesis in response to fresh medium containing 10^ 
serum.
TPA can elevate DNA synthesis and cell proliferation above 
control levels in several growing cell culture systems. Although, 
in many cases, it appears that the observed elevation of growth 
parameters is a rebound phenomenon, due to synchronization of cells
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during an initial inhibition of DNA Efynthesis by TPA (Paterson et 
al. 1977), certain results represent much more than this. Partic­
ularly important are findings in primary cultures of newborn mouse 
epidermal cells. In these cells, as in mouse skin, TPA, after an 
initial depression below control, causes a pronounced and sustained 
stimulation of DNA synthesis, which is succeeded by a wave of cell 
proliferation and marked hyperplasia (Fusenig and Samsel 1978).
That this response is not merely an overshoot phenomenon is estab­
lished by the fact that the stimulation of cell proliferation is 
very great and actually involves an increase in the proliferative 
compartment of the cell population. The similarity of results in 
this in vitro model of mouse epidermis with those in vivo suggests 
that the enhancement by TPA and other phorbol esters of epidermal 
cell growth in adult mouse skin is mainly caused by direct inter­
action with the target cells, and is not simply part of a non­
specific inflammatory response. The stimulation of DNA synthesis 
by TPA in this system is dose-dependent over the range 10*^10*^, 
and for a series of phorbol esters there is a good correlation 
between the ability to stimulate DNA synthesis and tumour—promoting 
potency (Yuspa et al. 1976b). Growing C3I^OTl/2 mouse fibroblasts 
show a response to TPA somewhat similar to that of mouse epidermal 
cells (Weinstein et al. 1978). In both minimal and enriched media 
TPA (4*8x10* M) causes a transient inhibition of exponential growth. 
Though this is followed by a return to the original growth rate, not 
a stimulation of growth, TPA treated cultures go on to achieve a 
much higher saturation density (approximately 4% controls), anal­
ogous to the TPA-induced hyperplasia in mouse skin.
A large number of studies have examined specific biochemical 
effects of phorbol esters, in a variety of cell culture systems.
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In primary newborn epidermal cell cultures as in adult mouse epi­
dermis in vivo, TPA increases ODC activity. Treatment of 24hr old 
cultures with 1.6x10**̂ ! TPA induces a 3-10-fold increase in ODC 
activity, with peak induction at about 9hr (Yuspa et al. 1976b). 
Rou^ rank-order correlation of ODC stimulation with promoting 
activity was demonstrated for TPA, five other phorbol diesters and 
phorbol by Yuspa et al. (1976b). Phorbol diester tumour promoters 
also induce ODC in hamster embryo fibroblast (HEP) cell cultures 
with the extent of induction being greater in cells which have 
undergone malignant transformation than in normal HEP (O'Brien 
1980). In these cells the induction of ODC by TPA is not followed 
by an increase in DNA synthesis, as occurs following ODC induction 
in mouse epidermal cells in vivo and in vitro. This is interpreted 
as indicating that enhanced ODC activity is not simply an event 
preceeding promoter—induced cell proliferation. An interpretation 
supported by the finding that TPA does not induce ODC in confluent 
cultures of human fibroblaats, but does stimulate a large percent­
age (309̂  or more) of these cells to enter S phase (O'Brien I980). 
TPA also induces SAMD activity in cpiiescent cultures of HEP (O'Brien 
1980) . However, whereas TPA potentiates the induction of ODC in 
response to the addition of fresh serum-contedning medium in such 
cultures, it does not potentiate the induction of SAMD following 
this same stimulus. This suggests that the induction of SAMD is 
different in character to the induction of ODC.
An effect of tumour promoters of probably great importance is 
the production of reversible changes in specific cellular proteins 
normally characteristic of cells which have undergone malignant 
transformation. The alterations most thoroughly studied are the 
loss of the major cell surface protein LETS (large-external-trans-
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formation—sensitive) protein and the induction of the serine pro- 
tease plasminogen activator (PA) • LETS protein is a large glyco­
protein with a molecular weight of 230,000 to 240,000 found on a 
large number of cell types (Hynes 1976). Althou^ the function of 
LETS protein is not known, its loss correlates well with malignant 
transformation in the variety of cells examined (Blumberg I981) .
The addition of TPA (1.6x10*^) to exponentially growing cultures 
of a CEP primary cell line leads to a decrease in the amount of 
LETS protein on the surface of the cells, with the total amount 
decreased by 8ofc at 3 days (Blumberg et al. 1976). The treated 
cells regain LETS protein within 3 days of subculture into medium 
without TPA.
Plaaninogen activator (PA) is involved in the fibrinolytic 
system, which is responsible for the breakdown of blood clots in 
the body. It comprises one or more specific serine proteases 
which cleave the serum globulin plasminogen (prof ibrinolysin) , to 
yield plasm in (fibrinolysin), which breaks the fibrin threads with­
in clots at lysine—arginine bonds (Meyers et al. 1976) . Although 
PA is not unique to transformed cells, being detectable in many 
normal tissues in the body, in most cell types examined in vitro, 
malignant transformation is accompanied by marked increases in the 
levels of PA (Blumberg I98I). In CEP, for example, transformation 
by RSV leads to greatly elevated levels of fibrinolysis while non­
transforming viruses have no effect (Unkeless et al. 1973)* The 
observation that TPA is an inducer of PA in CEP and a number of 
other cell types, including HeLa and ETC rat hepatoma cells (Wigler 
and Weinstein 1976), is therefcpe Important because this is a bio­
chemical response to TPA with a possible role in oarcinogenesis.
  ^9In CEP, PA is induced by concentrations of TPA as low as 3x10 M
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and maximal induction (10—20 times controls), comparable to that 
found in RSV-transfortned cells, occurs at 1.3% 10*^ (Wigler and 
Weinstein 1976, Weinstein et al. 1977)# Induction requires de 
novo RNA and protein synthesis; it is observed as early as 3hr 
after exposure to TPA; and persists as long as TPA remains in the 
medium. Following the removal of TPA, PA gradually returns (over 
12—24hr), to control levels. For a series of phorbol esters and 
related diterpenes of the resiniferonol and ingenol series induct­
ion of PA correlates with tumour—promot ing potency (Weinstein et 
al 1978) . In CEP transformed by RSV, TPA markedly increased the 
already elevated levels of PA, enhancement being apparently syner­
gistic rather than additive (Weinstein et al. 1977)* Both TPA and 
RSV require RNA synthesis for the reversal of their effect. Rever­
sal can occur either spontaneously, after removal of the inducer 
(TPA), or after shifting to a non-permissive temperature (temper­
ature-sensitive mutants of RSV) (Weinstein et al. 1977, Diamond et 
al. 1980) . The involvement of PA induction in tumour promotion is 
questioned by the finding that several agents which block promotion 
in mouse skin, including retinoic acid, theophylline eind dexameth- 
asone, fail to block elevation of PA levels by TPA in CEP or HeLa 
cell cultures (Weinstein et al. 1978). Furthermore, promoting agents 
which are not structurally related to the phorbol esters do not in­
duce PA (Weinstein et al. 1978).
Studies on the effects of TPA and other phorbol esters in 
mouse skin and on isolated membrane preparations (I.3) suggest 
that the cell surface membrane may be the major target for the ac­
tion of these tumour-promoting agents. Findings of investigations 
into the effects of these compounds on the membranes of intact 
cells in vitro reinforce this hypothesis. The changes in cell
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morphology and orientation, escape from contaot-inhibition of 
growth, and loss of lETS protein, induced by TPA in various cell 
cultures, are suggestive evidence of phorbol ester—induced alter­
ations in the cell surface membrane. Changes in certain physical 
parameters, most probably due to direct effects on the cell mem­
brane, have also been reported. Vfenner et al. (1974) observed 
that TPA, at 10 M̂, decreased the electrophoretic mobility of 
Ehrlich-Lettre ascites tumour cells by 19^, while non—promoting 
4(X—FDD had no effect. The decrease in mobility could be reversed 
by washing the cells. The fluorescence polarization of 1,6-diphenyl- 
1,3,3-he%atriene embedded in cell membranes decreases after treat­
ment of lymphoblaetoid or rat embryo cells with promoters but not 
with non-promoters (Castagna et al. 1979, Fisher et al. 1979)# It 
is proposed (Fisher et al. 1979) that the lipid moieties of the 
cell membrane are rendered more fluid in the presence of promoters.
A number of biochemical effects of phorbol ester tumour pro­
moters on cells in culture are almost certainly the result of mem­
brane modifications. The rapid onset of these effects and the fact 
that they do not require prior RNA and protein synthesis strongly 
implies that these are direct effects of phorbol ester exposure.
TPA (5%10*^M) stimulates uptake of ^^b^, a K*** analog, and of 
in quiescent, serum-free cultures of Swiss 3T3 cells within 3-10 
min of addition (Wenner et al. 1978). The stimulation of uptake is 
ouabain sensitive, suggesting that membrane—bound Na^/k"*^ATPase is 
the target for TPA. TPA also stimulates the rate of facilitated 
diffusion (transport) of glucose, in several cell types. Addition 
of 1.6xlO*^M TPA to cultured human lymphocytes causes an approxim­
ately 2-fold increase in the cellular uptake of 2-deo3Qrglucose, 
which is observable as early as 3Bin after treatment (Estensen et
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al. 1974)# In resting CEP cultures TPA and several other tumour- 
promoting phorbol esters have been shown to stimulate 2-<ieozy- 
glucose transport (Driedger and Blumberg 1977) • TPA is maximally 
effective at approximately 2x10*^, and a good correlation is 
demonstrable between the activity of phorbol esters in this system 
and their in vivo tumour-promoting potency.
As in mouse skin in vivo, an early membrane—related effect of
TPA treatment of certain cell cultures is increased i^ospholipid
synthesis. Treatment with TPA stimulates the incorporation of
^H-choline into phospholipids of HeLa cells (Suss et al. 1971) and
bovine lymphocytes (Wertz and Mueller 1978) . The response of bov—
—8ine lymphocytes to TPA (10* M) is insensitive to the inhibition of 
membrane movement by cytochalasin B, as well as inhibition of RNA 
and protein synthesis, by actinomycin D and cycloheximide respect­
ively. In addition, structure-activity studies show that the abil­
ity of several phorbol diesters to increase ^H-choline incorporation 
parallels their potency as tumour promoters.
It has been shown that TPA causes the release of arachidonic 
acid, by déacylation of membrane phospholipids, from CEP and other 
cell types (Weinstein et al. 1979)• Arachidonic acid is the pre­
cursor of the series of prostaglandin hormones, and increased avail­
ability of free arachidonic acid is not surprisingly associated 
with increased prostaglandin synthesis. The response in CEP cul­
tures to 8x10*^ TPA is rapid, elevated accumulation of arachidonic 
acid and prostaglandins PGE^ and PGP^ in supernatant medium is 
detectable within Ihr and maximal at 3hr (Weinstein et al. 1979)* 
Such a response is not seen with non-promoting diterpene esters. 
Thou^ these findings may help to explain the mild anti-promoting 
gictivity of the prostaglandin synthesis inhibitor indomethacin.
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the fact that stimulation of arachidonic acid release and prosta­
glandin synthesis is dependent on protein synthesis (Weinstein et 
al 1979), suggests that while it may he important, it is not the 
initial effect of TPA on cells.
It has been shown that TPA and related tumour promoters are 
extremely potent inhibitors of the binding of the polypeptide hor­
mone, epidermal growth factor (EGP) to cell surface receptors 
on several cell types (Weinstein et al. 1979)* This effect is, 
apparently, not due to competitive antagonism, but due to altered 
conformation or clustering of BGP receptors (Weinstein et al. 1979), 
possibly as a result of a general membrane perturbation induced by 
TPA and related promoters (Diamond et al. I980). Two of TPA's 
striking effects on normal blood elements are also worthy of men­
tion as they are likely to be membrane—related phenomena. Pirstly, 
Zucker et al. (1974), report that TPA at 10*^M and above causes 
irreversible aggregation of human platelets. Secondly, TPA 
(1.6x10**̂ M) affects polymorphonuclear leucocytes in a manner simi­
lar to phagocytosable particulates such as bacteria, causing the 
rapid development of surface membrane-derived vacuoles and the dis­
appearance of specific granules (White and Estensen 1974)•
Much of the recent interest in phorbol ester tumour promoters 
was stimulated by the finding that these compounds inhibit terminal 
differentiation of various cell types in culture (Table 1.2a). This 
finding is in agreement with observations in mouse skin where effec­
tive promoting doses of TPA were found to cause reversal of the 
differentiation (kératinisation) of epidermal cells (see I.3).
The inhibition of keratiniz at ion-1 ike differentiation in pri­
mary cultures of newborn mouse epidermis has sdready been mentioned 
above. Of the other examples given in Table 1.2a, the most thorough-
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TABLE 1.2. EXAMPLES OP MODULATION OP CELL DIFFERENTIATION 
IN VITRO BT TPA.
Cell System ^pe of Differentiation Reference
a. Inhibition
Primary Newborn Kératinisation Fusenig and
Mouse Epidermis Samsel (1978)
Friend Murine Erythroid Diamond et al.
Erythroleukaemia Cells (1978) Yamasaki 
et al. (1977)
Balt/o3T3 Adipose Conversion Diamond et al.
Mouse Fibroblasts (197?)
Murine Neuro­ Neurite Formation I Ail at al.
blastoma Cells (1978)
Chick Ekabryo Myogenesis Cohen et al.
Myoblasts (1977)
b. Induction




Human Promyelocytic Myeloid Hubersan and
Leukaemia Cells Callaha. (1979)
Human Melancma Melanogenesis Huberman et al.
Cells (1979)
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ly studied has been the inhibition of spontaneous or induced differ­
entiation of Friend murine erythroleukaemia cells (FELC) (Diamond 
et al. 1978) • FELC undergo erythro id differentiation to form hae­
moglobin producing, benzidine-staining cells. In cultures of FELC 
clones which display a hi^ rate of spontaneous differentiation — 
40-75^ benzidine-positive cells - TPA (1.6x10 and 1.6x10"" h) 
markedly reduces the proportion of benzidine—positive cells by 4 
days after its addition. The block on differentiation is maintained 
only as long as the promoter is present, control levels of benzidine- 
positive cells being restored within 4 days of the removal of TPA.
For a series of phorbol esters there is a positive correlation be­
tween known tumour-promoting activity and ability to inhibit spon­
taneous differentiation in the FELC system. Yamasaki et al. (1977) 
used FELC clones which yielded spontaneously less than Yjo benzidine- 
positive cells. In the presence of $nM hexamethylene bisacetamide, 
4mM dimethyl sulphoxide or 1.2mM butyric acid, the proportion of 
benzidine—positive cells, however, rose to between 60 and 89^. TPA 
blocked the differentiation induced by the first two of these 
agents by at least 90^ and the last by 40 to $0)̂ . Again TPA*s in­
hibitory action was reversible. Given that carcinogenesis is like­
ly to involve major disturbances of cell differentiation (Spom 
1978, Weinstein et al. 1979)» the observation that TPA and other 
phorbol esters are capable of inhibiting terminal differentiation 
in a variety of cell culture systems is likely to be of considera­
ble importance with regard to the tumour-promoting activity of 
these compounds.
Recently, cell culture systems have been found in which TPA 
induces rather than inhibits terminal differentiation, (Tables 
1.2b) . This has prompted the suggestion that certain diterpene
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esters may be of use in the therapy of neoplasms which retain 
the capacity for differentiation (Weinstein et al. 1979)* In­
deed, anti-leukaemic activity has already been reported for 
several of these compounds including 12-O-tigloyIphorbo 1-13- 
decanoate from croton oil (Evans and Soper 1978, Hecker 1978).
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1,8 Mutations and Mutagens
Deoxyribonucleic acid (DM) is the material of inheritance of almost 
all living things. The normal DNA molecule is a double helix, con­
sisting of a pair of polynucleotide strands coiled around each 
other and held together by hydrogen bonds between pairs of comple­
mentary purine (adenine (a) or guanine (G) ) and pyrimidine bases 
(cytosine (C) or thymine(T) )• The only base pairs normally per­
mitted by hydrogen bond distances and covalent bond angles within 
the DNA molecule are AT and GC, The order of bases on one strand 
of a cell’s DNA (the sense strand) constitutes a genetic message 
which contains all the information necessary to determine the spec­
ific structures and functions of that cell. Each piece of inform­
ation is transcribed to give a messenger ribonucleic acid (m—RNA) 
molecule, whose polynucleotide strand is complementary in base seq­
uence to the sense strand of the DNA, In a process involving ribo­
somes and transfer RNA (t—RNA), the genetic message is translated to 
yield a specific polypeptide chain. Each amino acid component of 
the polypeptide is specified by a triplet of successive bases in the 
m-RNA (a codon), A segnent of DNA in which the sequence of bases 
ultimately determines the sequence of amino acids in a single poly­
peptide is termed a gene.
The DNA of eukaryotic cells is invariably associated with two 
major classes of proteins - the histones and the non-histones - in 
a nucleoprotein fibre (chromatin) subdivided amongst one or more 
thread-like structures known as chromosomes. Prokaryotic cells poss­
ess analogous structures, but consisting of DNA (or in some viruses 
RNA) only. In cells of all types, prior to division, DNA replicates 
by the separation of its two strands and the use of each as the tem­
plate for the formation, from individual nucleotides, of a new com—
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plementary daughter strand by normal AT and GC base-pairing*
A mutation is any heritable change in the sequence or number 
of bases in the DNA. It may occur spontaneously or be caused by an 
external agent - a mutagen. Such changes obviously alter the num­
ber or constitution of cellular polypeptides and hence important 
cellular characteristics. Mutations are broadly classified as gene 
mutations or chromosomal mutations.
Gene mutations:
These are changes which affect only single genes and hence single 
polypeptide gene products, they are alternatively referred to as 
point mutations. Using a standard termed ’wild type’ as a reference, 
gene mutations are classified as being forward mutations (wild type —> 
mutant) or reverse mutations (mutant—>wild type)•
Gene mutations can be induced by mutagens either directly, by 
the induction of DNA base-mispairing; or indirectly, by the genera­
tion of premutational lesions, which are converted into mutations as 
a consequence of their misrepair by error-prone (mutation-prone) en­
zymatic DNA repair processes (Auerbach 1976, Drake and Baltz 1976, 
Goodenough 1978, Hart et al. 1978) • Many mutagens act via both these 
mechanisms.
Directly induced basennispairing results when a mutagen trans­
forms the chemical structure of a purine or pyrimidine in the DNA, 
confering on it the base-pairing properties of a different base.
The mutations consequently generated represent the substitution of 
one base pair for another and can be divided into two types:
(l) those in which a purine is replaced by a differ­
ent purine, or a pyrimidine by a different pyrimidine 
(transitions); and
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(2) those in which a purine is replaced by a py­
rimidine and vice versa (transversions)•
The large group of alkylating mutagens act, in part, by this mech­
anism. Of the various alkylated products that occur in DNA foll­
owing treatment with these agents, 0^-alkylguanine and 0^-alkyl- 
thymine almost certainly undergo mispairing with thymine and guan­
ine respectively, to generate G C A T  and TA->CG transitions (Drake 
and Baltz 1976) .
It is widely held that misrepair mutagenesis results when a 
mutagen-induced premutational lesion interrupts dau^ter strand 
elongation during DNA replication, the resulting gap in the dau­
ghter strand becoming a substrate for an enzymatic error-prone post- 
replication DNA repair mechanism (Drake and Baltz 1976, Hart et al. 
1978, Hanawalt et al. 1979) • Thus when such gaps are filled, both 
transition and transversion mutations can be generated by the mis— 
pairing of bases. The gaps may also be filled with too many or too 
few nucleotides. Such additions or deletions unequal to multiples 
of three produce a special type of mutation known as a frameshift, 
the consequence of which is a disruption of the reading of the gen­
etic message subsequent to the mutation and the formation of a great­
ly altered polypeptide. DNA lesions that induce misrepair are pro­
duced by alkylating agents, ultraviolet light and ionizing radiar- 
tions (Drake and Baltz 1976, Goodenough 1978, Hart et al. 1978, 
Hanawalt et al. 1979)•
Chromosomal mutations:
Usually referred to as chromosomal aberrations, these mutations are 
much less delicate than gene mutations, indeed in eukaryotic cells 
many of them are observable in cytological preparations under the
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microscope. They are of two main classes:
(1) Structural chromosomal aberrations, which involve 
changes in the arrangement of chromosomal material 
within the cell. They include deletions, duplications 
and inversions of sections within chromosomes and ex­
changes (or translocations) of sections between chromo­
somes (Savage 1975)• Their formation involves the 
breakage (with or without subsequent incorrect reunion) 
of chromosomal material which has sustained any of a 
variety of different types of molecular lesion (Morin 
et al. 1977, Goodenough 1978). In general they are 
produced by the same agents that produce gene mutations 
(.Auerbach 1976, Tsutsui et al. 1977).
(2) Numerical chromosomal aberrations, which involve 
changes in chromosome number (ploidy changes). Such 
changes can result in polyploidy, in which a cell ex­
hibits three or more tiroes its haploid number of chrom­
osomes, or aneuploidy, wherein one or a few chromosomes 
are lost or gained. In nature and origin these muta­
tions are different from gene mutations and structural 
chromosomal aberrations (Auerbach 1976)•
1.8.1 Mutagens
In the proposed investigation it was necessary to utilise three 
chemical mutagens - ethyl methanesulphonate, mitomycin C and 
NMnethyl—N'^-nitro-N—nitro so guanidine - and one physical mutagen — 
ultraviolet light — to induce both gene mutations and structural 
chromosomal aberrations. Two of the chemical agents were also used 




CHo —  S  O  Co He3 II
o
M.W.124.2g
This compound is an alkylating (ethylating) agent of the alkyl 
alkanesulphonate class. At 20^0 it is a clear liquid of density 
1.21 gem  ̂which is miscible with water. In serum-containing 
mammalian cell culture medium at 37°C and 0.49'̂! concentration it 
has a reported half-life of 2,2hr (jensen et al. 1977).
ET'IS is capable of inducing gene mutations in bacteriophage 
(Auerbach 1976), bacteria (McCann et al. 1975), yeast (Drake and 
Baltz 1976) and mammalian cells (Kao and Puck I968, I969; Cole and 
Arlett 1976; Arlett 1977b), and structural chromosomal aberrations 
in mammalian cells (Kao and Puck I969) . EMS is a known carcinogen 
(McCann et al. 1975)» It is a monofunctional alkylator i.e. each 
molecule can donate a single alkyl (in this case ethyl) group at a 
nucleophilic site within a biological macromolecule. The suscept­
ible positions of the purine and pyrimidine bases in DNA are the 
Nl, N^, N3, 0^, N7 and C8 of guanine; the N1, N3, N^, N7 and CB of 
adenine; the N3 and of cytosine, and the N3 and of thymine 
(singer 1977) • The superscript notation signifies ezocyclic sites 
and the nonsuperscript notation endocyclic sites. The internucleo— 
tide phosphates of the DNA are also potential sites of alkylation 
(singer 1977) • For EI'ÎS and most other alkylating agents the major 
DNA reaction product is 7—a-lkylguanine, however, there is strong 
evidence to suggest that mutagenesis (and carcinogenesis) results 
primarily from alkylation at the 0^ of guanine and 0^ of thymine 
(Auerbach 1976, Drake and Baltz 1976, Singer 1977)• In vitro studies
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"by Morin et al. (l977) have revealed that EMS is also capable of inducing 
covalently linked nucleic acid-nucleic acid (DNA-DNA, DNA-RMA and 
RNA-RNA) and protein-nucleic acid complexes. In chromosomes in 
vivo strong covalent bonds between chromosomal macromolecules may 
prevent normal DNA transcription and replication and at the time 
of cell division cause chromosome loss and/or the generation of 
structural chromosomal aberrations.
In bacteriophage, bacteria and lower eukaryotes EMS produces 
a high proportion of transition type base-pair substitutions among­
st induced mutations (Auerbach 1976). In Escherichia coli about 
30̂ - of EMS mutagenesis occurs indirectly by misrepair whereas in 
yeast mutagenesis occurs almost entirely by this mechanism (Drake 
and Baltz 1976). This implies that in higher organisms direct 
avoidance of mispairing is hi^ly evolved and thus in mammalian cells 
virtually all EMS mutagenesis, as in yeast, may occur via misrepair. 
Because of its low toxicity at doses which produce large numbers of 
mutations, EMS is regarded as a very 'efficient* mutagen for the 
production of viable mutant organisms and is sometimes termed a 
supermutagen (Auerbach 1976).







MC is a bifunctional alkylating agent produced by Streptomyces caes- 
pitosus (lyer and Szybalski I964) . At 20°C it is a crystalline solid
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which, though only sparingly soluble in water, can be dissolved 
in aqueous NaCl solution. Originally discovered as an antibio­
tic (Hata et al. 1956), MC is sometimes used in anti-cancer chemo­
therapy; though only as a second line drug, because of its high 
toxicity. MC requires chemical or enzymatic activation before it 
behaves as an alkylating agent (lyer and Szybalski I964).
MC causes gene mutations in bacteria (lyer and Szybalski 
1964) and mammalian cells (Carrano et al. 1978) and is capable of 
causing structural chromosomal aberrations in plant and animal cells 
(ishii 1981). It is also one of the most powerful inducers of sis­
ter chromatid exchange (Perry and Evans 1975) and a known carcino­
gen (McCann et al. 1975)• As a consequence of its bifunctionality 
as an alkylating agent, MC is capable of cross-linking nucleophilic 
sites within or between molecules. MC is known to cross-link com­
plementary DNA strands (lyer and Szybalski I964)» an action which 
is compatible with a variety of biological effects of the compound, 
including its cytotoxicity and mutagenicity in bacteria and its 
cytotoxicity and chromosome-breaking activity in mammalian cells 
(Ishii 1981). Experimental evidence suggests that MC also causes 
DNA-protein cross links and that these lesions may be largely res­
ponsible for the induction of sister chromatid exchange in mammal­
ian cells (Ishii I98I).
Although much attention is focused on MC's action as a cross- 
linking agent, reaction products in DNA resulting from single alky­
lation events (mono-adducts) outnumber cross-links by between 5 and 
10 to 1 and may be biologically significant. MC appears to prefer­
entially react with the guanine moiety of DNA, probably predominant­
ly at the 0^ position (Tomasz et al. 1974)« This suggests that mono- 
adducts are important, because an excellent correlation between mut—
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6agenesis and alkylation of guanine 0 has been demonstrated for 
other alkylating agents (Auerbach 1976, Drake and Baltz 1976)•
N-Methyl—N'^-Nitro-N-Nitro so guanidine (ICNNG)
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KNNG is a monofunctional alkylating (methylating) agent. At 20°C 
it is yellow/orange crystalline solid which has a solubility limit 
of 4mgml  ̂ (27mM) in water. In serum-containing mammalian cell 
culture medium at 37^0 and 6.8x10 concentration it has a rep­
orted half-life of 14min (jensen et al. 1977). Ï'H'JNG is a nitroso 
compound and like all such compounds requires chemical activation 
before it displays biological activity (Auerbach 1976).
MNîvG is capable of inducing gene mutations in bacteriophage, 
bacteria and yeast (Auerbach 1976, Drake and Baltz 1976) and in 
mammalian cells (Kao and Puck I968, 1969, O ’Neill et al. 1977). It 
also induces structural and numerical chromosomal aberrations in 
mammalian cells (Kao and Puck 1969» Bempong 1979) . MN1\̂ G is a knoi-m 
carcinogen (McCann et al. 1975). As it is an alkylating agent, the 
same nucleophilic sites within DNA as are listed for possible EMS 
action (see above) are susceptible to attack by MNNG (Drake and 
Baltz 1976) . However, unlike M S  and most other alkylating agents 
MNNG is capable only of inducing nucleic acid-protein macromolecular 
complexes in vitro and not, in addition, nucleic acid-nucleic acid 
complexes (Morin et al. 1977),
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M M G  preferentially mutates DNA in the vicinity of the rep­
lication fork with the frequent production of multiple closely 
linked mutations (Drake and Baltz 1976)• The simplest model for 
replication fork specificity is an enhanced reactivity with single­
stranded DNA. MNNG specifically induces transitions in phages and 
bacteria, with biases between AT-»GC and GC->AT changes that differ 
among organisms (Auerbach 1976, Drake and Baltz 1976). Although 
these mutations are likely to be a result of directly induced base- 
mispairing MIT G can also trigger misrepair and hence evokes a var­
iety of mutational pathways in most cellular organisms, including 
some that produce deletions and frameshift mutations (Drake and 
Baltz 1976) . Like EMS, MNNG is efficient in the induction of viar- 
ble mutants and is classed a supermutagen (Auerbach 1976) .
Of unknown relevance is the probable decomposition of MNNG in 
vivo to form both nitrous acid (HNO^), another mutagen (though un­
likely to exhibit biological activity at typical, near neutral, 
treatment pH's) and diazomethane (CH^N^, a potent methylating 
agent (La Polla et al. 1972, Drake and Baltz 1976).
254^  Wavelength Ultraviolet Light (UV)
Ultraviolet light is a component of the electromagnetic spectrum 
and includes all electromagnetic radiations of wavelengths between 
lOnm and 400nm.
DNA absorbs UV-li^t strongly at 254^ wavelength and as a 
consequence a number of different UV absorption products (photo- 
products) are formed in the nucleic acid (Setlow I968). The main 
photoproducts in double-stranded DNA are eyelobutane-type dimers 
formed between neighbouring pyrimidines on the same strand. Although 
all possible kinds of pyrimidine dimer are formed, those between two
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thymines are the most frequent and the most stable. To a smaller 
extent, UV also produces cross links between complementary strands 
of DNA and between DNA and protein. Single-chain breaks and purine/ 
pyrimidine hydrates also infrequently arise.
UV has lethal effects and causes gene mutation in both pro­
karyotic and eukaryotic micro-organisms (Auerbach 1976, Drake and 
Baltz 1976, Smith 1978) and in mammalian cells (Kao and Puck I969, 
Arlett 1977a and b, Trosko et al. 1977» Pujiwara and Tatsumi I980). 
It is also capable of inducing structural chromosomal aberrations 
in mammalian cells (Kao and Puck I969). The high proportion of 
pyrimidine dimers among UV—induced lesions in DNA does not necess­
arily mean that these photoproducts are the main causes of the leth­
al and mutagenic effects of UV. However, for ordinary conditions 
of treatment, in all cell types examined, there is a close correla­
tion between the proportion of dimers formed and the reduction in 
survival and induction of mutation (Auerbach 1976).
The mutagenicity of UV light is known to be virtually com­
pletely dependent upon the misrepair of mutagen-induced premutation­
al lesions by error-prone post—replication DNA repair systems (Auer­
bach 1976, Drake and Baltz 1976, Hart et al. 1978, Smith 1978, Han­
awalt et al. 1979)• Because it triggers misrepair, UV is capable 
of producing a wide variety of mutational types, including transit­
ions, transversions, additions, deletions and frameshifts (Drake and 
Baltz 1976). The exact frequencies and types of UV-induced mutation 
observed in a given cell type are greatly dependent on the comple­
ment of DNA repair mechanisms (error-free as well as error-prone) 
possessed by that cell type (Auerbach 1976, Drake and Baltz 1976).
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1.9 Aims of the present study
The initiation of two—stage carcinogenesis is widely regarded as 
a heritable change in the genetic material of target cells. This 
is compatible with the theory that cancer cells arise from normal 
cells as a result of somatic mutation; the so-called somatic muta­
tion theory of carcinogenesis (Boveri 1929)• This contention is 
supported by the fact that virtually all tested initiating carcin­
ogens, or their activated molecules, interact covalently with DNA 
(Drake and Baltz 1976, Singer 1977, Brookes et al. 1979)• Further­
more, for the group of known carcinogens, a good qualitative corr­
elation exists between tumourigenicity in experimental animals and 
mutagenic activity in metabolically supplemented bacterial (McCann 
et al. 1975) and mammalian cell systems (Clive 1977, Hsie I980)•
Should initiation, as the first stage in carcinogenesis, be a 
mutation event, an attractive proposition is that tumour-promoting 
agents act to enhance mutagenesis at the gene and/or the chromosome 
level. The purpose of the present study was to determine if phorbol 
ester-type tumour promoters can induce or enhance gene mutation 
(chaper 4) , sister chromatid exchange (chapter 5) , or structural 
chromosomal aberration (chaper 5) ir cultured mammalian cells. It 
was envisaged that results obtained might not only provide insights 
into the mechanism of tumour promotion, but also reveal specific 
promoter—induced changes capable of serving as end-points in a 
short-term tumour promoter screening test. There is an urgent need 
for such screening tests, because testing environmental chemicals in 
the mouse skin system, or any of the other presently available in 
vivo models of two-stage carcinogenesis, is prohibitively expensive, 
both in terms of expenditure and time.
It was realised at the outset that it is unlikely that a screen—
5 1
ing test capable of detecting all classes of tumour promoters is 
attainable; given that results in different tissues and species 
in vivo cannot be extrapolated to each other and that all the un­
related chemical structures possessing promoting activity are un­
likely to act via a common mechanism. A realistic aim is the dev­
elopment of a screening test capable of detecting diterpene ester- 
type tumour promoters and non—diterpene promoters with a similar 
mode of action. This would be the first stage in the development 
of a battery of short-term screening tests capable of detecting 
tumour promoters from all classes. This battery would serve as 
the first phase in a testing strategy (tier system) for promoting 
activity; phase two, verification, being conducted using one or 
more of the in vivo model systems of two-stage carcinogenesis.
As well as determining if induction or enhancement of genetic 
alterations can serve as screening-test end-points, it was also in­
tended to investigate the possibility of using a human lymphocyte 
system to detect promoters. There is sufficient suggestive evidence 
to warrant this investigation. Moreover, if such a screen were val­
idated, because the biological material employed is human, results 
would be more relevant to man than those from non—human systems.
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CHAPTER 2 
GENERAL MATERIALS AND METHODS
2.1 Bqpiipment 
Laminar flow hood:
2m, horizontal displacement type (Fell Clean Air (l97l) Limited, 
Newhaven, Sussex), used for most aseptic preparation and cell 
culture work.
Incubator;
LEBC (Laboratory and Electrical Engineering Company, Kottin^am) , 
PP2 anhydric incubator with forced air circulation. Thermostatic 
controls were adjusted to give a temperature of 37«5°C. Uniform­
ity of temperature throu^out the incubator was confirmed with 
thermocouple probes.
Bench centrifuge;
MSB-Minor, model 5-61 (MSB Scientific Instruments, Crawley,
Sussex). Periodically the speed control of the centrifuge was 
accurately recalibrated by means of a rev. counter.
Adjustable replicating pipettes:
Volume Range Pipette
2 - 20 pi Pipetman P20
5 - 50 pi Pinnpipette 11
50 - 200 pi Pinnpipette 12
200 - 1000 pi Pinnpipette 13
1 - 5 pi Pipetraan P5OOO
Pipetman pipettes, with tips (Anachem Limited, Luton, Beds). 
Finnpipettes, with tips (Jencons Limited, Kernel Hempstead, Herts).
All pipettes were checked periodically by a gravimetric 
method (10 replicates of a set volume of water, at 20^0, were each
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weighed on an analytical balance) tc ensure they were delivering 
accurately and reproducibly.
Pipette fillers:
Pi-pump suction pumps (Glasfim Giessen via Jencons Limited), were 
used for all pipette filling. Pipetting by mouth was not under­
taken.
Liquid nitrogen refrigerators:
Two types were used. Union Carbide model no. LR-33-10 (Union Car­
bide UK Limited, Aycliffe Indust.Estate, Cleveland), in which spec­
imen ampoules are held on canes in the liquid refrigerant cr 
its overlying vapour. Union Carbide model no. lA 40 
in which all ampoules are shelved in the vapour phase of liquid 
Biological freezer:
Union Carbide BP-6 biological freezer. A plug-type device, design­
ed for use with the liî—33—10 refrigerator, capable of cooling up to 
9 2ml ampoules at between 0.5^0 and 7^C min*"̂  to below -70^C. 
Haemocytometers:
Standard, single or double grid, improved Neubauer-type blood cell 
haemocytometers, with coverslips (Pisons Limited, Lou^borou^, 
Leics)•
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2.2 Microscopes and Photomicrography 
Binocular dissecting microscope:
Standard laboratory model (C. Baker Limited, London). Allowing 
subject examination at x 20.
Inverted biological microscope:
Wild M40 (Wild Heerbrugg Limited, Heerbrugg, Switzerland) . This 
instrument was fitted with appropriate condenser and objectives 
(x 10 and x 20) for phase contrast microscopy of growing cell 
cultures at magnifications of x 187 and x 375*
H i^ power research microscope:
Ampival microscope with mf basic body and 35mm camera attachment 
(Carl Zeiss Jena, CZ Instruments, Boreham Wood, Herts). This 
instrument, with fitted condenser and both plain and phase—ringed 
plane field objectives (x 16, x 40 and x lOO), allows transmitted 
li^t and phase contrast microscopy of cyto logical and cytogenetic 
preparations at magnifications of x 256, x 64O and x I6OO.
Photomicrographs were taken on Kodak Technical Pan 2145 
film (black and white) or Kodak Ektachrome 50 (colour) (Eastman 
Kodak Limited)• In the absence of equipment for photoelectric 
exposure determination, a table of exposure times, appropriate 
for different illuminations, aperture settings, objectives and the 
presence or absence of specified filters, was constructed from the 
results of trial exposures. The black and white negative film was 
processed according to the manufacturers' instructions; the colour 
slide film was processed by Colour Processing Laboratories Limited, 
Bristol.
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2.3 Sterilising Membrane Filtration
Autoclave—labile liquids, solutions, media and sera, where necess­
ary, were sterilised by membrane filtration.
Snail volumes were filtered throu^ autoclave sterilised 
23mm Swinnex units (Millipore UK Limited, Abbey Road, London), 
fitted with 0.2 pm pore size Sartorius membrane filter discs (V.A. 
Howe and Co.Limited, Peterborou^ Road, London) . Small volumes of 
hazardous solutions were filtered from luer-locked syringes through 
disposable Millex-GS units (Millipore), fitted with membrane filters 
of 0.2 pn pore size.
Any non- aqueous solvents, e.g. dimethyl sulphoxide incom­
patible with normal cellulose nitrate membrane filters were fil­
tered through disposable Millex—FG units (Millipore) fitted with 
Fluoropore hydrophobic membrane filters resistant to virtually all 
organic solvents, again of 0.2pm pore size.
Large volume (generally> 250ml) solutions and media were 
filter sterilised, under positive pressure, using the apparatus 
illustrated in Fig 2.1. Filtration was under positive pressure, 
rather than suction, to prevent frothing and to minimise loss of 
COg from bicarbonate containing media.
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Pig. 2.1 Apparatus for Membrane Filtration of Large Volume Cell 
Culture Solutions and Media
1. Pressure vessel, 10 litre voliane, fitted with eccentric lid, 
(AB Stalmanufaktur, Stockholm, Sweden).
2. Pressure gauge.
3. Medical grade silicone tubing, 0.25" internal diameter, 
(Millipore).
4* Adapter, 0.25” outer diameter (ribbed, for tubing connection) 
to 0.25" threaded female connection (Millipore).
5. Swinnex 47nim diameter filter holder (Millipore) . A wrap of 
non—adhesive Teflon tape was applied to all threaded connections 
and all tubing connections were clipped. Filter sequence (inset).
6. 47mm diameter type AP25 (Millipore) prefilter.
7. 47mm diameter Dacron filter separator (Millipore).
8. 47mm diameter filter disc , 0.2 jm  pore size (Sartorius, from 
V.A. Howe and Co. Limited)*
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2.4 Gases and Gassing Procedures 
Gases:
Cylinders of N^, CO^ and ^  CO^ in air mixture (9^ CO^ and 20gS 0^ 
in Ng) were all obtained from Air Products Limited, Bristol#
Gas flowmeter:
Floating-needle type, 0.1 - 1.01 min  ̂(Rotameter Manufacturing Co. 
Limited, Croydon) calibrated for use with CO^.
Plastic incubation boxes:
Rigid, clear plastic boxes, 3.25 litre volume (A. Gallenkamp and 
Co. Limited, Finsbury Square, London EC2).
Gas-ti^t tape:
British standard gas-ti^t vinyl tape, 2.5cm wide (Intech Tapes 
Limited, Manchester).
All cell culture media contained a bicarbonate pH buffer 
system designed to equilibrate with an atmosphere of 5^ CO^ in air. 
All air—ti^t culture bottles and flasks were therefore charged 
with such a gas mixture, introduced at low flow—rate throu^ a 
sterilised Pasteur pipette plugged with non-absorbent cotton wool. 
Cell culture dishes and other non-sealable vessels were placed in 
plastic incubation boxes, into which a metered volume (l5Cknl) of 
pure COg was introduced throu^ a plugged pipette. These boxes 
were sealed with gas-ti^t tape. If only a few plates were put in 
a particular box, an open $cm petri dish filled with water was add­
ed, to prevent excessive evaporation from culture medium during 
incubation.
58
2#5 Glassware and Recycling of Glassware
125 and 500ml bottles, for storage of solutions, media, etc., were 
obtained (with caps) from Plow Laboratores Limited, Irvine, Scot­
land. The 125ml soda glass medical flat bottles in which cells 
were routinely cultured, all other bottles and caps, general lab­
oratory glassware and RBS 25 detergent were obtained from Pisons 
Limited, Lou^borough.
Glassware was placed in water immediately after use and, 
except for pipettes, was washed and processed as follows: Initially 
all articles were soaked in hand-hot RBS 25 solution (20ml per 
litre of tap water) for 30 min; then thoroughly cleaned using a 
China brush on all surfaces. All articles were subsequently rinsed 
in three changes of tap water, leaving for 30 min in the last rinse; 
three changes of fresh single distilled water, again leaving for 
30 min in the last rinse; and finally, rinsed and left for 30 rain in 
a large volume of recently collected double glass distilled water. 
After drying in a hot air oven, all items were capped/closed with 
foil and sterilised at 160^C for a minimum of one hour.
Graduated pipettes were washed with tap water in a pipette 
washer for at least 30 min and then rinsed and left for 30 min in 
a large volume of recently collected double glass distilled water. 
After drying in a hot air oven, the pipettes were put in cannisters 
and sterilised at 160^C for a minimum of one hour. Periodically 
pipettes were cleaned in chromic acid. Following such treatment 
they were left in the pipette washer overni^t, before normal pro­
cessing.
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2*6 Recycling of Non-Glass Items
Specifically - tips for replicating pipettes, see 2.1; bottle 
caps and membrane filter holders, see 2.3.
These items were placed in water immediately after use. 
They were cleaned by boiling in three changes of fresh single 
distilled water. After this they were rinsed and left for 30 
mine in a large volume of recently collected double glass dis­
tilled water. After drying in a warm air oven, all items were 
sealed in autoclave bags (D.R.G. Hospital Supplies, Dixon Road, 
Bristol), and sterilised in an autoclave at 121^0 for 15 mine.
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2.7 Disposable Cell Culture Plasticware
25cm and 75cffl tissue culture (T/C) flasks;
100mm z 16mm T/C tubes with screw caps;
50mm X 13mm and 90mm x 15mm T/C petri dishes, both 
with vented lids.
These were all of tissue culture grade polystyrene and obtained, 
ready sterilised, from Sterilin Limited, Teddington, Middx. 
Ampoules for storage of cells in liquid nitrogen — 2ml volume, 
polypropylene, with silicone rubber—washered screw tops — were 
obtained, ready sterilised, also from Sterilin.
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2.8 Cell Culture Materials
2.8.1 Simple components:
Mammalian cells in culture are extremely sensitive to toxio 
substances. Therefore materials of h i^ purity were used in 
the preparation of all solutions and media coming into direct 
contact with living cells.
Double glass distilled water (DD H^O) was used in the 
preparation of all solutions and media. This water was produced 
by a 6kW Pistreem still (model 2903» Pisons, Loughborough). The 
still was descaled once a week, and the pH of the DD H^O checked 
regularly to ensure it was between pH6 and pH8. All inorganic 
salts were of AnalaR grade and obtained from either Pisons, or 
BDH Chemicals, Poole, Dorset.
2.8.2 Balanced Salt Solution (BSS):
Dulbecco's phosphate buffered saline was routinely employed, 
either with or without calcium and magnesium ions, solutions 
designated PBS and PBS(A) respectively.










Sterilised PBS(A) was prepared by dissolving 1 Dulbecco A tablet 
in 100ml of fresh DD H^O and autoclaving for 30 min at 115.5^0. 
Complete PBS was prepared by aseptically adding 0.5ml of Dulbecco B 
solution per 100ml of PBS(a) . Dulbecco A tablets and Dulbecco B
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solution were obtained from Oxoid Limited, London, Both PBS and 
PBS(a) were stored at room temperature#
2.8.3 Trypsin solution;
A filter sterilised 2*5^ W/v solution of trypsin (tryptic activity 
1:250, as defined by US National Formulary, Vol.14» 1975) in BSS 
was obtained from Flow Laboratories Limited, Irvine, Scotland,
This solution was diluted to working strength (0.05^ W/v) with 
PBS (A) and stored in approximately 8ml volumes in 10ml glass bi­
jou bottles at —20°C. Prior to use contents of bottles were thaw­
ed in a 30^C water bath,
2.8.4 Additives for Cell Culture Media
Antibiotic solution: Penicillin (5,000 lU ml )̂ and streptomycin
(5»0'00 jp.gnl )̂ solution obtained in 100ml unit quantities from Flow 
Laboratories. The ready filter sterilised solution was sub-divided 
into 10ml volumes in bijou bottles and stored frozen at —20°C (max­
imum 1 yr) .
0.6mM Hypoxanthine (6-hydroxypurine) : 8l.6mg hypo xanthine, mini­
mum assay 999̂  (BDH Chemicals) , was dissolved in 50ml of boiling 
DD HgO, made alkaline with 2 drops of concentrated ammonium hydrox­
ide, and made up to final 1000ml volume. The solution was steril­
ised by membrane filtration (2.3) and stored at protected from 
light (maximum 1 yr) in 100ml volumes.
200mM L-Glutamine : obtained in 100ml unit quantities from Plow Lab­
oratories. The ready filter sterilised solution was sub-divided in­
to 10ml volumes in bijou bottles and stored at -20°C (maximum 1 yr).
lOOmM L-Proline: a filter sterilised solution of chroraatographic­
ally homogeneous L-proline (BDH Chemicals) in DD H^O. Five ml vol­
umes were stored frozen in bijou bottles at —20°C (maximum 1 yr) #
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3mM Thymidine ; a filter sterilised solution of chromatograph­
ically homogeneous thymidine (BDH Chemicals) in DD H^O* Stored 
frozen in 5^1 hijou bottles at -20°C (maximum 1 yr)•
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2,8.5 Media
Modified Ham’s P12 medium (MP12) :
Ham’s P12 medium (Ham I965) , lacking only NaHCO^i was obtained in
powder form from Plow Laboratories and stored in a vacuum desicca^
0tor at 4 C. Powder to prepare 1 litre of single strength medium 
was dissolved in 800ml of freshly collected DD H^O, Ten ml of pen­
icillin (5,000 lU ml""̂ ) and streptomycin (5,000 ^gml"^) solution 
and 10ml of 200mM L-glutamine (giving a 2mM L-glutamine supplement 
to the P12 medium) , were added. NaHCO^ (l.2g) was added last, 
either as powder or dissolved in DD H^O. The medium was made up 
to volume, rendered slightly acidic by bubbling CO^ through it, to 
compensate for inevitable CO^ loss on filtration,and membrane fil­
ter sterilised under positive pressure (see 2.3), The sterilised 
medium was stored in 100ml volumes at 4^C and used within 4 weeks. 
Modified Ham’s PIO medium (MPIO):
This was prepared aseptically. It comprised the following compon­
ents, added in the order given:- 
428ml Sterilised DD H^O
50ml 10 X concentrate of Ham’s PIO medium (Ham I963), 
lacking L-glutamine and NaHCO^ components (from Plow 
Laboratories, stored at 4°0)
^ 1  Penicillin (5,000 lUml"’̂ ) and streptomycin 
(5,000 pgml*^) solution
1 ml lOOmM L-Proline 
7.5ml 200mM L-Glutamine 
8ml 7.955 H/V HaHCO
The prepared medium was stored in 100ml volumes at 4^0 and used 
within 4 weeks.
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Modified Ham’s PIO medium without thymidine MPlO(-dT) :
Hamfe PIO without hypo xanthine, thymidine and NaHCO^ was obtained in 
powder form from Plow Laboratories, it was stored at 4°C in a vac­
uum desiccator.
Powder to prepare 1 litre of single strength medium was 
added to approximately 800ml of freshly collected DD H^O. Once 
dissolved the following were added in order:—
10ml Penicillin (5,000 lU ml and streptomycin 
(5,000 ̂ gnl solution 
2m1 lOOmM l^Proline 
l6ml 7.5^ w/v NaHCO^ or 1.2g powder 
50ml 0.6mM Hypoxanthine 
The medium was made up to volume with DD H^O, rendered sli^tly 
acidic by bubbling CO^ through it and membrane filter sterilised 
(see 2.3)• The sterilised medium was stored in lOOml volumes at 
4°C. As this particular medium was only used occasionally and in 
small volumes, the storage life*was greatly extended (to 1 yr) by 
omitting its most unstable component — l-glutamine - which was 
added to each 100ml aliquot of medium just prior to use (iml 
200mM L-glut am ine/lOOm1 medium)•
* Storage conditions and maximum storage lives of all cell culture 
materials were as advised in the Plow Laboratories catalogue or 
by Earn and Puck (I962).
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2.8.6 Sera
All cell culture media were supplemented with 5 or 10?̂  V/V foetal 
bovine serum (PBS). The serum content of any given medium is 
indicated by the Roman numeral succeeding the medium abbreviation 
e.g. MF 10% is modified Ham’s PIO containing 5^ serum. Serum was 
not added to medium until just prior to use; then for 10^ serum
11.1ml was added to lOOml of medium; and for 5^ serum, 5*3ml,
PBS from two different batches was used during the course 
of this study. Both serum lots were obtained from Sera-Lab Ltd., 
Crawley, Sussex and were selected after the evaluation of PBS 
samples from a number of commercial sources for the ability (as 
a supplement to culture medium) to satisfactorily support the 
clonal growth of relevant mammalian cells.
Batch 1 : Sera^Lab batch number 801121
Batch 2 : Serap-Lab batch number 001090
The ready filter sterilised serum wais supplied in bottles of 50(kal, 
which were allowed to thaw at 4^C and then sub-divided into 100ml 
quantities. These were frozen and stored (maximum 18 months) at 
—20^0. 100ml bottles were withdrawn from stock and thawed at 4°C
as required. In each case the serum was further sub-divided into
25ml aliquots in glass universal bottles, which were stored at 4°C.
2.8.7 Cryoprotectant8 
Dimethyl sulphoxide (DMSO);
Sigma grade 1 (Sigma London Chemical Co. Limited, Poole, Dorset), 
was obtained in 100ml quantities and stored, protected from li^t, 
at room temperature in ti^tly sealed bottles. Pellets (l/l6 ) 
of 4A Union Carbide sodium aluminosilicate molecular sieve (BDH 
Chemicals) were added to withdraw water. DMSO was filter steril­
ised through 0.2 pm Millex-PG filter units (see 2.3).
67
Glycerol!
AnalaR grade (Pisons) was stored at room temperature, protected 
from moisture. 2-3ml volumes were sealed in glass ampoules and 
sterilised by dry heat (l60^C for 1 hr)#
2.8.8 Mitotic spindle inhibitor
Colchicine, dry powder (BDH Chemicals) was stored at room temp­
erature . Stock solution (O.^mgol"^, 1.25mM) was prepared in 
DD HgO and stored frozen at —20^C. For working strength solu­
tion, stock was diluted 1 in 10 with further DD H^O. The work­
ing strength solution was stored at —20^C in 5^1 bijou bottles 
and thawed at room temperature prior to use.
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2.9 Materials for Microscopy
Microscope slides, 26 x 76mm, frosted write—on slides and cover— 
slips, 22 X 50ram (Chance Propper Limited, Warley. West Midlands).
Fixative components glacial acetic acid and absolute 
methanol, acetone and clearing agent xylene, were all of AnalaR 
grade from BDH Chemicals.
Solutions
Hypotonic saline solution:
0.07^1 KOI, prepared by 1 in 10 dilution (with single distilled 
water) of 0.75# (55*&8gi"^) KCl stock solution.
Double strength saline sodium citrate buffer (2 x 55̂ ) (Buckton 
and Evans 1973):
A solution of 0.3M sodium chloride and 
0.03M tri—sodium citrate 
adjusted to pH 7 
Sorensen’s phosphate buffer, pH 6.8 (Sorensen 1909):
50.8ml 1/15 M potassium dihydrogen phosphate
49*2ral 1/15 M disodium hydrogen phosphate 
All salts reagent grade (BDH Chemicals) and all solutions prepared 
in single distilled water.
Bact0-Trypsin :
Vials of freeze—dried Bacto—Trypsin (Difco Laboratories Limited, 
West Molsley, Surrey), were reconstituted by adding 10ml of normal 
saline (O.^ W/v NaCl in single distilled water) • The resulting
enzyme solution, with a tryptic activity equivalent to that of a
solution of 1:250 trypsin (as defined by U.S. National Formu­





Improved Gurr’s R66 Giemsa solution (Hopkin and Williams Limited, 
Chadwell Heath, Essex).
Jenner’s stain:
0.5g of powdered stain (BDH Chemicals) dissolved in 100ml of 
MgSO^ -dried absolute methanol, the stain was prepared within 
7 days of use.
Leishman's stain:
Neat staining solution from Hopkin and Williams#
Methylene blue:






All necessary safety precautions were taken when handling mutagens/ 
carcinogens or tumour promoters and when recycling or disposing of 
contaminated apparatus#
2#10#1 Mutagens/Carcinogens 
Ethyl methanesulphonate (EMS) ;
The pure liquid (from Signa) was stored, protected from li^t and 
moisture, at 4^C# Working strength solution (20mgml~’̂,0#l6 K) was 
prepared in DDR^O and stored protected from li^t at 4°C for a max­
imum 2 weeks. Over this period and under the same conditions,
Gupta and Siminovitch (I980) report that the mutagenic activity 
of such a solution remains unchanged# Stock solution was diluted 
in sterilised DD H^O immediately before addition to cell cultures. 
Mitomycin C (MC) ;
Obtained in rubber septum—sealed vials from Signa. Vials contained 
2mg crystalline MC and 48mg NaCl (to increase the solubility of MC); 
they were stored protected from li^t at 4^C# Immediately before 
use 2ml of sterilised DD H^O was injected per vial and the con­
tents dissolved. This solution was further diluted with sterilised 
DD EgO and added to cell cultures. All handling of MC was carried 
out under red li^t.
N-fljethyl—N^—nitro—N—nitrosoguanidine (MNNG) :
Obtained in crystalline form (Signa) and stored protected from 
li^t at -20°C# An approximately lmgnl"’̂(6#8inM) stock solution 
was accurately prepared in DD H^O (excluding li^t) and stored fro­
zen at —20^0. Under such conditions it was established (employing 
the spec tro photometric assay method of La Pol la et al. (1972)) that 
the stock solution underwent no significant degradation over a max­
imum 4 week storage period. Stock solution was thawed at 4^0 on
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the day of use and diluted in sterilised DD H^O immediately before 
addition to cell cultures.
ÜV radiation:
Produced by a 4cm Pen^Ray Lamp, with a G—275 filter, at an incid­
ence dose rate of 0.075 \  Lamp and filter, Triton Instru^
ments Limited, Westbury, Wiltshire.
2.10.2 TPA, Phorbol Derivatives and Resiniferatoiin
These compounds were received in nitrogen purged glass ampoules,
which were stored at —20°C in the dark until required for use.
Stock solutions were prepared in filter sterilised 1X4SO (See 2.8.
7) at 1 or 2 mgnl"^ then sub-divided into approximately 0.5ml 
volumes in Irai glass sample vials with foil—lined screw caps (Pisons). 
Each solution was bubbled with nitrogen before vials were sealed 
and stored at —20^0. Schmidt and Hecker (1975) report that under 
such storage conditions phorbol esters remain stable for many 
months.
12-0-Tetradecanoylphorbo 1-13—acetate (TPA) was from three 
different batches:
Batch 1, lOmg, obtained from Sigma Chemical Co.
Limited, Poole.
Batch 2, ÿng, from a phorbol ester research 
package supplied by Lifesystems Co. Newton,
MA., U.S.A.
Batch 3, 10mg, obtained from Consolidated Midland 
Corp., Brewster, NT., U.S.A. Manufacturers batch 
no. 026.
Imgml"^ solutions in sterilised DM SO were prepared from each batch.
A purity check was done on each stock solution, using both the TLC 
systems described below, before it was used in experiments. DMSO
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solutions were spotted directly onto TLC plates. In all cases no 
significant contaminant spots were observed#
TLC system 1, derived from Evans et al. (1975)*"“
Layer ; 0.25mm silica gel 0, buffered at pH 7.0 with Sorensen’s 
phosphate, activated at 110—120^0 for 3o minutes.
Solvent system : toluene/hexane/ethylacetate/ether (20; 40; 30; I5). 
Plates were eluted twice in a saturated chamber.
For visualisation the plates were sprayed with 60^ W/W sulphuric 
acid and heated at approximately llO^C until spots appeared.
Under daylight TPA produced a brown spot at Rf 0.22 — 0.24.
TLC system 2, derived from Schmidt and Hecker (1975):—
Layer : as in system 1.
Solvent system : water saturated diethyl ether.
Plates were eluted once without chamber saturation. For visualis­
ation the plates were sprayed with 55̂  w/v vanillin in concentrated 
sulphuric acid and heated at approximately llO^C until spots appear­
ed. Under daylight TPA produced a purple-black spot at Rf 0.61 — 
0.67.
4-0-Kethyl—12-0—tetradecanoylphorbol-13—acetate (MeTPA) , 10mg 
was obtained from Consolidated Midland Corp. Manufacturer’s batch 
no. 207.
Phorbol—12,13-dibutyrate (PDBu) , Img from Sigma Chemical Co. 
Manufacturer’s batch no. 50F-O453.
Phorbol, 5®g? Phorbo 1-12,13-didecanoate (PDD) , Img; Phorbo 1-12,13- 
dibenzoate (PDB) , Img; Phorbol diacetate (PDA), Img; and 4<>< -Phorbo 1- 
12,13-didec ano ate (4o(-PDD) , Img, were all obtained in the afore­
mentioned phorbol ester research kit from Lifesystems Co.
Stock solutions of 2mgml"^ in WiSO were prepared for all these com­
pounds close to their time of use.
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Resiniferatoiin was a gift from Dr. P.J. Evans, London 
School of Pharmacy; received as a lagnl"^ DM SO solution. It was 
sub-divided into 0.5ml volumes in sample vials, purged with nit­
rogen and stored at —20^0 in the dark.
Stock solutions of all the above compounds were diluted 
with filter sterilised DMSO immediately before addition to cell 
cultures. Such dilutions or dilution series were carried out in 





It was intended at the outset of this studĵ  to determine the 
effects of tumour-promoting phorbol esters on mutation (at 
more than one specific locus), chromosomal aberration and sis­
ter chromatid exchange (SCE) in one cell type. To facilitate 
this investigation it was decided to use a well characterised 
cell type which had been extensively used in previous genetic 
and cytogenetic studies. Cell line CHO—K1 was selected; this 
is an established cell line, American Type Culture Collection 
(aTCC) Certified Cell Line (CCL) 61. It was derived as a sub- 
clone from the parental CHO line by Kao and Puck (I968) and 
shares most of its properties. CHO itself was one of a series 
of clones isolated from a culture initiated in 1957 from a bi­
opsy of Chinese hamster ovary (Puck et al. 1958). The cells of 
the primary culture from which CHO came were fibroblast—like 
(Puck et al. 1958) and so initially was CHO (Ham 1983, 1985)* 
However, the cells have undergone several hundred passages since 
then and the cells of the K1 subclone are epithelial-like (ATCC 
catalogue, CCL 6l) .
Both CHO and CHO-Kl are hardy and reliable and are rou­
tinely grown at 37*5°C as monolayers on glass or plastic cul­
ture flasks in nutrient media containing relatively low levels 
of foetal bovine serum (Ham 1983, 1985? Kao and Puck 1989? O ’Neill 
et al. 1977). Under optimum conditions the cells grow rapidly, 
with a doubling time of less than l6hr, and show high single—cell 
plating efficiencies (Kao and Puck I988; O ’Neill et al. 1977)*
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These characteristics coupled with an ability to grow as easily 
in suspension as on solid surfaces (Thompson and Baker 1973) are 
advantageous in many types of experiment, particularly quanti­
tative mutagenesis determinations*
CHO-Kl requires proline for growth, this was first noted 
for CHO by Ham (I963) and the daughter cell line was subsequent­
ly shown to have the same requirement (Kao and Puck I968)• The 
cells apparently lack an active gene form needed for proline 
synthesis. The block in the biosynthetic pathway was found to 
lie in the step converting glutamic acid to glutamic ÿ- semialde— 
hyde (Kao and Puck I967). It was postulated that the proline 
requirement resulted from loss of part of the chromosomal comple­
ment during karyotype alterations and subsequent mutation of the 
critical gene on the homologous chromosome. The behaviour of 
proline—independent revertants was compatible with such a haploid 
state for the gene concerned (Kao and Puck I967)•
The two clones exhibit changes in karyotype from the nor­
mal Chinese hamster cell. CHO and CHO-Kl possess stemlines with 
21 and 20 chromosomes respectively, whereas normal diploid cells 
have a complement of 22 (Kao and Puck I969)• For CHO the loss of 
one centromere corresponded with an approximate 3^ reduction in 
chromatin compared with ordinary cells. In CHO-Kl another small 
telocentric chromosome is missing but there is no further detect­
able reduction in total chromatin (Kao and Puck I969). In both 
CHO and CHO-Kl abnormal chromosome number (aneuploidy), is accom­
panied by structural rearrangements in many chromosomes, with 
evidence of translocations, deletions and inversions in those 
affected (Kao and Puck I969, Deaven and Petersen 1973). Though 
the cells are aneuploid, they are quasi-diploid and as long as they
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are maintained in vigorous growth show only a small degree of 
variability in chromosome number (Kao and Puck I967)• These char­
acteristics coupled with a low chromosome number facilitate both 
karyotype analysis and determination of the cytogenetic effects 
of physical and chemical agents in the cells. The original flu­
orescent plus Giemsa (PPG) technique for differential staining of 
sister chromatids and visualisation of sister chromatid exchange 
(SCE) was developed using CHO cells (Perry and Wolff 1974)» A 
substantial volume of data on carcinogen or mutagen elevated SCE 
frequency in these cells is now available (Perry and Evans 1975» 
Carrano et al. 1978; Loveday and Latt 1979» Thomson and Evans 
1979).
Conducive to the investigation of mammalian cell mut agen­
esis in CHO and its K1 subclone is the availability of a number 
of valuable or potentially valuable selective systems for mutation 
at different genetic loci. An assay of mutation induction at the 
hypoxanthine-guanine phosphoribosyl transferase (HGFRT) locus, 
resulting in resistance to 6-thioguanine, has been developed and 
ful]ydefined (O’Neill et al. 1977; O ’Neill and Hsie 1979). The 
assay allows quantitative study of dose-response relationships 
for chemical mutagenesis in this cell culture system (O’Neill and 
Hsie 1977) and has possible application as a mutagen screening 
test (Hsie I980). Mutation to ouabain resistance has also been 
thoroughly studied and optimum cell and drug concentrations plus 
expression times for this marker defined (Baker et al. 1974)»
Gupta and Siminovitch I980). Selection conditions have also been 
determined for a number of other less commonly utilized genetic 
markers in a large study by Gupta and Siminovitch (I980). The 
systems studied included resistance to the protein synthesis in—
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hibitors emetine and diphtheria toxin, resistance to methyl- 
glyoxalbisguanylhydrazone which affects polyamine transport and 
resistance to the nucleoside analogue toyocamycin.
The above are all forward mutations to drug resistance. 
Mutation to auxotrophy has been demonstrated (Kao and Puck I968) 
but utilization of such systems as mutation assays is limited 
(Kao and Puck I969) because selection of mutants is a tedious 
two-step process, with bromodeoxyuridine—visible light ablation 
of wild-type cells preceeding clonal growth of mutants. Reversion 
of CHO cells to prototrophy from their proline requirement has 
also been used in studies of induced mutagenesis (Kao and Puck 
1968, 1969)• The most frequently studied mutation systems in 
CHO and CHO-Kl cells have been introduced here. However, work 
with at least 60 different mutations, dominant and recessive, has 




Ampoules of liquid stored CHO-Kl cells (originally obtained 
from Flow Laboratories Limited, Irvine, Scotland) were kindly 
provided by Dr. A. McDermott (Regional Cytogenetics Centre, 
Southmead, Bristol). At receipt the cells were at passage num­
ber 440-450.
3.2.2 Transfer to F10 medium
Both Ham’s F10 (Ham I963) and F12 (Ham I965) media were designed 
specifically to support the growth of CHO cells. It was intend­
ed to culture cells in anPlO medium because in some experiments 
media lacking hypoxanthine or thymidine would be required and FIG 
without these components is commercially available. Cells were 
received in ampoules containing 5*10^ cells in 1ml of an P12 med­
ium supplemented with 59̂ foetal bovine serum (MF12%, see 2.8.5/ 
2.8.6) (with 5^ M S O  as cryo protectant) and therefore required 
transfer to F10 medium. Each ampoule of cells was thawed rapidly 
and inoculated into 19ml of MF12% in a 75cm^ T/C flask. The flask 
was gassed with ^ 0  00^ in air (2.4) and incubated at 37.5°C. The 
cells were subcultured when 70—90^ confluent, and then in a rou­
tine protocol every two-three days (see 3.3.4).
Direct substitution of an F10 medium supplemented with ^ 0  
serum (MF10Î , 2.B.5/2.8.6) for MF123T was attempted at two or three 
passages post-recovery. The cells grew in the new medium for only 
a short time (approximately 24hr) before cessation of growth, 
round in g-up and detachment from the culture surface. CHO-Kl bells 
have a proline requirement and PIO medium contains less I^proline 
than F 12. It was found that addition of 2.0x10 ^ mol 1  ̂L-proline 
to FIO, to give the same proline concentration as in F12, permitted
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normal growth of cells and single step transfer from MF12% to MF 10%.
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3.3. Cell Culture Methods 
3.3*1 Maintenance of cell line
CHO—K1 is capable of growth on glass surfaces and thus stock cul­
tures were routinely maintained in MF10% medium in 125ml clear 
soda glass, ’medical flat’ bottles at 37*5°C. Under these con­
ditions cells grew as a monolayer on the bottom surface of each 
horizontally placed bottle. Cultures were not allowed to become 
excessive, that is, reach the point where release of cells from a 
confluent monolayer began; since this can lead to increased heter­
ogeneity within cell populations (Ham and Puck 1982). The routine 
subculture protocol (detailed in 3*3*4) was designed so that cells 
remained at all times in a condition of active growth and never 
achieved complete confluence#
3*3*2 Preparation of cell suspensions from monolayer cultures 
The essential manipulation involved in maintaining the CHO-Kl cell 
line is subculture. This operation requires that cells be obtained 
in suspension prior to transfer to fresh culture vessels. Cells 
once in suspension can also be greatly diluted and plated so that 
colonies arise from single cells, a procedure which is fundamental 
to many experiments.
A monolayer culture was examined by naked eye and under phase 
contrast inverted microscope. For a routine sub-culture the med­
ium had to be clear with no floating cellular debris and not un­
duly acidic or basic as colour—indicated by its phenol red compon­
ent. Cell growth was required to be greater than 50^ confluent and 
the cells had to have a normal appearance i.e., normal epithelioid 
morphology with no refractile granules in the cytoplasm. If the 
culture did not fulfill these requirements it was discarded.
The medium was removed from the culture and the cells rinsed
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gently with $ml of 0.05a trypsin solution (2.8.3)* This solution 
was then discarded and another 1.5ml of trypsin added. The cul­
ture was incubated for about 5min at. 37*5°C and then shaken vig- 
ourously. Detachment of cells was checked microscopically. The 
cells were gently aspirated with a Pasteur pipette, to break up 
clumps and produce a uniform suspension and then added to 5m1 of 
complete medium in a l6mm T/C tube. Though the serum and Ca^* and 
Mĝ "*" ions in the medium protected the cells against continued, 
deleterious enzyme action, the carried over trypsin was further 
diluted as soon as possible to minimise any risk of cell damage. 
Subculture or experimental manipulation of cells was therefore 
carried out immediately after trypsinisation#
3.3*3 Determination of cell suspension density 
This was aehieved by means of haemocytometer count (haemocyto- 
meters, see 2.1). Cells were thoroughly mixed immediately before 
sampling. A small volume was withdrawn from just below the sur­
face of the suspension and introduced into the haemocytometer 
chamber. A total cell count was performed on between one and 
eight large squares of the haemocytometer grid under low power 
(x256) phase optics. If cell clumping was observed, the count 
was disregarded, the suspension aspirated to break up clumps and 
a new sample taken. For a routine subculture 100 cells were 
counted and for a dilution-plating (3*3*7), 200. If the cell 
density was greater than I50 per large square, at which point cell 
counting was impeded by crowding, the suspension was diluted with 
medium and sampling and counting repeated. In the event of a very 
low density (less than 25 per square), the cells were concentrated 
by centrifugation (MSE-Minor, lOOOrpm for ^in) and resampled. A 
minimum of two independent counts were made on each cell suspen—
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sion, meaning that for a subculture at least 200 cells were count­
ed and for a dilution—plating at least 4OO.
3.3*4 Subculture routine
Cells were subcultured at low inoculation density three times a 
week in the following protocol;
MONDAY -------------► VffiDNESDAY  ► FRIDAY
Inoculate Inoculate Inoculate
5x10^ cells/culture 5^10^ cells/culture 2x10^ cells/culture
{_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ J
Fresh cultures had to be initiated with small inocula not only 
because cells were to be maintained in vigourous growth, but also 
because FIO medium, which was designed to support the clonal growth 
of CHO cells (Ham I963), is not particularly well suited to supp­
orting dense cell populations (Ham I965). Aliquots of counted 
cell suspension were added to 14*5nil volumes of NFIOI in standard 
125ml culture bottles and evenly distributed by gentle aspiration 
followed by agitation. To limit carry over of trypsin, the re­
quired numbers of cells were added in volames of less than 0#5ml.
Because Ham’s FIO contains a bicarbonate pH buffer system 
designed to equilibrate with a 5̂  CO^ in air atmosphere (Ham I963) , 
such a gas phase had to be provided in all cultures. Therefore 
culture bottles were purged with the said gas mixture for 10—15 sec 
and capped air-tight, prior to incubation (see 2.4)» Bottles were 
incubated flat to present the maximum surface area for growth. In­
cubation, at 37*5°C, was in the dark because cytotoxic photoproducts 
are known to form from certain components of mammalian cell culture 
media (Wang et al. 1974)*
Cultures for experimental use were put up at the subculture
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immediately preceeding experiment(s) • For a culture to be used 
three days later, 2x10^ cells were inoculated; for a culture to be 
used two days on, 5x10^ cells; and a culture required the following 
day was initiated with 1.5x10^ cells.
3.3*5 Cell storage
Cells were routinely stored frozen in the presence of cryoprotect- 
ant in liquid (at -196°C) or its overlying vapour (at less 
than -150°C) . 5^ dimethyl sulphoxide (MSO) was initially used as
cryoprotectant but was subsequently replaced by 8^ glycerol.
A culture ready for routine subculture was selected. Cells 
for storage were required to be in an actively growing state. This 
was confirmed, on microscopic examination, by the presence of num­
erous spherical mitotic cells amongst the flat, epithelioid inter- 
phase CHO-Kl cells (Paul 1975)* The culture was trypsinised (3*3*2) 
and the cells mixed with excess MFIOI in a l6mra T/C tube. The 
cells were centrifuged, re suspended in about 5^1 of ÏÎFIOÜC, and the
density of the suspension determined by haemocytometer count (3*3*3)*
5A pre—decided number of cells was withdrawn and adjusted to 5^10 
cell ml first with more MPIOZ and finally with the required vol­
ume of cryoprotectant. The cell suspension was thoroughly mixed 
and 1ml volumes immediately distributed into sterilised 2m1 screw- 
capped polypropylene ampoules (2.7)* Cells could be kept at this 
stage for many hours, at room temperature or 4°C, without noticea­
ble deleterious effects.
At freezing, batches of ampoules were cooled at 1°C min 
in a simple biological freezer atop an LR-33—10 liquid refrig­
erator (2.1) , to below —70°C and then quickly transferred to a 
liquid Ng refrigerator for long-term storage. Following every 
freezing operation, an ampoule was removed after a few days in stor—
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age* The freezing procedure was considered to he successful if 
cells could he recovered to normal growth*
3.3.6 Recovering cells from storage
After removal from the liquid refrigerator the contents of an 
ampoule were rapidly thawed at 37°C. The cells were transferred 
hy Pasteur pipette to 14ml of MFIOIT in a culture bottle and gently 
mixed. The bottle was gassed with 5^ CO^ and incubated. Invaria­
bly, within a couple of hours cells attached to the bottom glass 
surface and after three days had grown up sufficiently to be pass­
aged and subsequently handled as a routine stock culture.
3.3*7 Dilution-plating
The key operation in many experiments was the plating of small 
numbers of cells into petri dishes and subsequent growth of in­
dividual cells into macroscopic colonies. This single—cell plating 
technique allowed isolation of clonal populations (see section 3*4), 
and also permitted the determination of the proportion of cells 
in a given population which were viable, as assessed by the abil­
ity to undergo indefinite reproduction. The exact dilution-plating 
procedure varied with the nature of the experiment being undertaken, 
the following is the basis of the various modifications used.
Aliquots of 4*9ml MP103E in 50mm T/C dishes were equilibrated 
at 37*5°0 with a humidified 5^ 00  ̂atmosphere (see 2.4) * Other 
media and solutions were prewarmed to 30°C.
The starting material for dilution—plating was a dense cell 
suspension obtained by trypsinisation of a cell monolayer (3*3*2). 
This was diluted with at least twice the volume of serum-contain­
ing medium, to inhibit further tryptic action,and the cell density
determined by haemocytometer count (3*3*3)* The counted cell sub—
2pension was serially diluted to a final concentration of 5x10 to
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2x10^ viable cells ml At each step of the dilution 0.5ml of 
cell suspension was diluted with 4»5ml of MF10% in a l6mm T/C 
tube and whirlimixed for 3-4sec. Replicate 0.1ml volumes of the 
final dilution were added to the equilibrated petri dishes, to 
ultimately produce between 50 and 200 colonies per plate. Dishes 
were gently agitated to effect distribution of the cells.
Mammalian cells, being quite large, settle rapidly and also 
have a tendency, especially in warm medium, to attach to surfaces 
(Ham and Puck I962). Therefore dilution—plating was performed as 
quickly as possible without interruption and with frequent mixing 
to maintain uniform cell suspension. The diluent medium was pre— 
warmed to 30°C rather than 37°0 to minimise cell attachment. In­
oculated dishes were placed in plastic incubation boxes and pro­
vided with a jfo CO g in air atmosphere (see 2.4) • The sealed box­
es were incubated at 37.5°C protected from li^t. They were left 
undisturbed during incubation, to prevent the disruption of dev­
eloping colonies and the formation of erroneous satellite colonies.
Plated CHO—K1 cells produced macroscopic colonies after 7—8 
days. To determine the proportion of plated cells capable of clonal 
growth (the cloning, or plating, efficiency) medium was poured off 
and colonies stained with O^jfo methylene blue in 5̂ 9» methanol (2.9) . 
After 30min the stain was removed, the plates rinsed twice with tap 
water and allowed to dry. Colony scoring was by naked eye against 
a white background, aggregates of 50 or more cells were counted.
Any colonies of marginal size were examined under a binocular dissect­
ing microscope (2.2.) to confirm that they fulfilled this criterion.
For most experiments (all those including test and control treatments) 
plates were scored ’blind*, being coded and randomised by an uninvolved 
person before colony counting.
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3*4 Isolation of CHO-KIA Subclone
Genetic heterogeneity within a cell line is markedly reduced in 
populations derived from single, cloned cells (Ham and Puck I962). 
The isolation of a subclone from CHO-Kl for use in experimental 
work was therefore undertaken.
Fifty CHO—XI cells were plated into each of four 50mm T/C 
dishes containing 10-20 sterilised, broken coverslip pieces 
(approximately Q.5cm square) and 5>̂ 1 MF 10%. After 3 days incub­
ation two coverslip pieces, bearing single developing colonies, 
were aseptically transfered to l6mm T/C test tubes and 2ml MF10% 
added. The tubes were purged with 5^ CO^ in air, capped gas-tight 
and incubated for 4 days to allow propagation of the clones. After 
discarding the medium, cells were washed in PBS, trypsinised and 
inoculated into culture bottles containing 14.5*nl MF10%. The two 
cultures were gassed,and incubated until they showed greater than 
30^ confluent growth.
Before designating a cell population clonal it is custom­
ary to perform two clonings in sequence (Ham and Puck 1962). The 
cloning operation was therefore repeated on the two cell popular 
tiens obtained from the first cloning. From the second cloning a
single truly clonal population, designated CHO-KIA, was obtained#
5 5At first subculture inocula of 5x10 and 2x10 cells were trans­
ferred to fresh culture bottles. Cells were frozen down (3*3#5) 
from these cultures after 2 and 3 days respectively. A seed stock 
of 13 ampoules of CHO—KIA (each containing 5x10^ cells in 1ml 
MF 10% with 5^ DM so) was thus obtained. The lineage of cells from 
receipt through cloning is given in Table 3*1. Cells were obtained 
22 passages past a previously set starting point. This inherited 
numbering sequence was continued.
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TABLE 3.1
HANDLING AÎTD LINEAGE OF CELLS FROM RECEIPT THROUGH CLONING
Passage Number St or age/Cu Iture conditions Period
22 Liquid N^ storage Indefinite
23 Monolayer culture 3 days
24 Clonal growth on 
coverslips
(i) in dishes 3 days
(ii) in tubes 4 days
25 Monolayer culture 5 days
26 Clonal growth 
(as passage 24)
7 days
27 Monolayer culture 5 days
28 Monolayer culture 2 and 3 days
28 Liquid N^ storage 
(seed stock)
Indefinite
29 Monolayer culture 2 or 3 days
30 et seq. Routine maintenance 
in monolayer culture 
(with supplementation 




The sterility of CHO-XIA was tested hy inoculating 5ml 
volumes of used culture medium into 40nil of Tryptone Soya Broth 
in each of two 125ml bottles. The bottles were incubated, ©neat 
37°C for 7 days and the other at 25°C for 14 days, with approp­
riate negative and positive control (US Pharmacopoeia) • They 
were examined daily for the absence of microbial growth. As a 
further check of sterility an ampoule of CHO—KIA cells was recov­
ered from liquid inoculated into 14ml of antibiotic-free MFIOI 
and incubated. At the first passage of this culture the used med­
ium was subjected to the sterility test outlined above.
Supernatant medium from an antibiotic—free culture was 
also screened for Mycoplasma sp. at an independent laboratory (see 
acknowledgements). Medium was plated directly onto New York Starch 
Agar (Faur et al. 1974) and incubated at 37°C in an atmosphere of 
95?̂  Ng/5^ COg# After three days plates were examined under disect— 
ing microscope for typical 'fried egg'-like Mycoplasma colonies.
The presence of Mycoplasma pneumoniae was additionally checked for 
by flooding plates with sheep erythrocytes, which adsorb onto col­
onies of M. pneumoniae, facilitating their detection (Bailey and 
Scott 1974).
Even when cultures are kept under optimum conditions, a cer­
tain amount of genetic variation arises with time, due to spontane­
ous mutation and/or chromosomal aberration (Ham and Puck I962). 
Therefore routinely maintained CHO—KIA cultures were replaced with 
cells freshly drawn from liquid storage at least every 4 weeks.
So that the original seed stock was not rapidly exhausted, it was 
greatly enlarged with cells frozen down only two or three passages 
post-cloning (see Table 3.l)•
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3*5 Growth Characteristics of CHO-KIA
Inocula of 2x10^ CHO—KIA cells at passage 32 were suhcultured with 
5ml MPIOZ into a number of 25cm^ T/C flasks and incubated at 37*5°C. 
At intervals a culture was removed and its total cell number deter­
mined as follows.
The medium in the culture flask was withdrawn and placed in a 
l6mm, graduated, V—bottomed test tube (MSE Scientific Instruments, 
Crawley, Sussex) . The cell monolayer was washed with 2ml of trypsin 
solution and then disaggregated in 1ml of trypsin (3*3*2). Both wash 
solution and suspended cells were added to the medium in the tube. To 
remove residual cells the flask was rinsed successively with two 1ml 
volumes of PBS. Removal of all cells was confirmed by microscopic 
examination. To minimise cell loss, due to adherence to glass sur­
faces, a single siliconed Pasteur pipette (see 6.6.1) was used for 
all above transferences. Cells were sedimented by centrifugation 
(MSE—Minor : l^OOrpm, ^in) and re suspended in about 0.5ml of super­
natant. The suspension was adjusted to an expected cell density of 
2.5x10^ - 1.5x10^ cells ml"^ with PBS and the volume of this final 
cell suspension measured. The cell density was determined by haemo— 
cytometer counting a minimum 400 cells (3*3*3) and the total cell 
number of the culture calculated.
Typical data for determination of growth parameters are plotted 
in Pig 3*1* Prom this growth curve cultures were determined to have 
a lag time (a) of 6.5 - 7br. After about I5hr incubation cell growth 
was exponential and could be represented by the equation
N . r= N 2 ^  t o
where is the cell number at time 0, is the cell number at time 
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Fig.3.1. Growth of CHO-KIA cells in MF102: Cell number per culture
plotted on a log scale as a function of incubation time.
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The logarithmic form of this equation is 
Log = Log + kt Log 2 
The calculated value of k from Pig 3.1 is 0.083hr The mean
generation time T (the inverse of k) is 12.0hr; in very good agree­
ment with the generation time of 12—13 hr reported for CHO—K1 hy 
O'Neill et al. (1977) under a similar set of growth conditions.
Exponential growth ended after approximately 40hr and the cells 
proceeded to stationary phase by 60hr. liHien examined under inverted 
microscope the 60hr culture was found to be subconfluent. Its cells, 
though static, had a normal epithelioid appearance. By 72hr however, 
more than ^0^ of cells had rounded up and a few had become detached 
from the culture surface. Degeneration of the culture was even great­
er at 78hr. Mhen ^ 1  of fresh MPIOI was added to a static ?2hr cul­
ture the cells quickly regained their normal appearance and after l6hr 
re incubât ion numerous mitotic cells were observed in the population. 
Over this same period the cell number per flask increased from 
2.85x10^ to 3•58x10^. An attempt to recover a 72hr culture by supple­
menting its spent medium with 3xlO*’̂ moll"”̂  L-proline was unsuccessful.
The results stress the necessity of subculturing regularly and 
at low inoculation density when maintaining CHO-Kl cells in FIG med­
ium. They also established that the observed movement of cultures in­
to stationary phase was due to nutrient depletion, not contact- or 
density-inhibit ion of growth. With regard to this latter point, a].«, 
though L—proline may have been exhausted, it was shown not to be the 
only nutrient affected#
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3.6 Fixing and Staining Cells
CHO—IQ cells in culture were found, on examination under inverted 
phase contrast microscope, to be epithelioid. Permanent, fixed and 
stained preparations were made and photomicrographs taken to re­
cord their appearance.
A sterilised coverslip was placed in a 50mm T/C petri dish 
and a cell suspension containing 2x10^ CHO-KIA cells (at passage 
35) in 4ml MFIOX added. The plate was incubated in 5^ CO^ at 
37«5°0 for 24hr. The coverslip, with cells growing on it, was
I
gently washed in 30ml PBS at 37^0. After rinsing, the cells were 
fixed by placing the coverslip in absolute methanol for ^in They 
were then stained ; 5min in Jenner's stain being followed by lOmin 
in Giemsa (l in 10 in DD H^O) . After a thorough rinse in DD H^O 
the stained preparation was rapidly dehydrated with acetone follow­
ed by 50:50 acetone-xylene, cleared in xylene and then mounted in
DPX. The fixation and staining technique was taken from Paul 
(1975) • Materials used are detailed in section 2.9#
Plate 3.1 shows CHO—KIA cells at XI4OO. The cells are
clearly epithelioid i.e., closely adherent and of regular rounded 
shape (Zakharov et al. 1964). Nuclei and nucleoli are well defin­
ed.
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Plate 3.1. CHO-KIA cells x 1400 magnification, 
The nucleolus is arrowed in the nucleus of the 
cell at upper left.
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3.7 Studies of Chromosomal Constitution
Analyses of the chromosome complement (karyotype) of both CHO-Kl 
and its KIA subclone were made: a) to ensure that neither popu­
lation was contaminated with another cell line; b) to confirm a 
modal chromosome number of 20, as reported by Kao and Puck (I968, 
1969); and c) to assess karyotype heterogeneity within these cell 
populations.
3.7.1 Chromosome spreading technique
In both karyotype and chromosome aberration studies metaphase 
cells were obtained from actively growing monolayer cultures in 
25cm^ T/C flasks. P̂ ondair.ental to any cytogenetic study (study of 
the appearance of chromosomes) is the preparation of metaphase 
chromosome spreads. The preparation technique used in this work 
was derived from procedures published by Buckton and Evans (1973), 
Perry and Wolff (l974), Evans and O'Hiordan (1977) and Nichols et 
al. (1977).
Metaphase cells were accumulated by adding 1.25 priol l""̂  
colchicine, a mitotic spindle inhibitor, to a 48hr culture for the 
final 2-4hr of incubation. Cells were then harvested, either of 
two methods being employed. In the first the culture was trypsin- 
ised as detailed in 3*3.2. In the second, rounded-up, loosely an­
chored mitotic cells were detached from the culture surface by vig- 
ourous agitation of the culture flask and removed with overlying 
medium.
The harvested cells were centrifuged (MSE-Minor : lOOOrpm,
5m in) in a l6mm screw—capped glass test tube (6.5) and re suspended 
by aspiration with a Pasteur pipette in about 0.2ml of supernatant. 
10ml of hypotonic 0.075M KCl (at 37°C) was added with continuous 
gentle mixing and the resulting cell suspension kept at 37°C in a
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water bath for lOmin, The cells, swollen by the hypotonic treatment, 
were spun down and resuspended in about 0.2ml of supernatant. Approx­
imately 3ml of 3:1 methanol, glacial acetic acid fixative (prepared 
within an hour of use) was then added drop-wise by Pasteur pipette, 
with constant agitation of the tube. The fixed cells were spun down, 
re suspended in 0.2ml of supernatant and 3m1 of fresh fixative added 
exactly as in the previous step.
Chromosomes were spread after the cells had been in fixative 
for a minimum 30min. Immediately before spreading, the cells were 
centrifuged and either resuspended in sufficient fresh fixative 
(usually about 2ml) to give a slightly turbid suspension or in a 
fixed 0.5ml, in cases where mitoses only had been harvested by agit­
ation (or 'shake-off'). A chromosome preparation was made by running 
3—5 drops of fixative cell suspension down a clean microscope slide 
(2.9) held at 45°* The slide was allowed to air-dry in a vertical 
position and then checked for adequate metaphase density under low 
power phase optics. Further drops of cell suspension were spread on 
the slide if the density of metaphase cells was too low. If the metar- 
phase spreads themselves were not satisfactory, i.e. did not show sep­
arate well defined chromosomes in one plane of focus, the cells were 
subjected to further changes of fixative and were spread on wet or 
chilled microscope slides. Alternatively, the cells were resuspended 
in 1:1 methanol, acetic acid and the spreading procedure repeated. 
Though this change in fixative did improve poor results, it has been 
reported that it may interfere with staining techniques used to visu­
alise sister chromatid exchanges (Nichols et al. 1977) and therefore 
it could not be used in some instances.
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3.7*2 Chromosome frequency distribution
This was determined for cells both pre-cloning (CHO-Kl) and post­
cloning (CHO—KIA). Inocula of 4%10^ cells from each population 
were inoculated with 5m 1 MPIOI into 25cm T/C flasks and incub­
ated, Metaphase chromosome spreads were prepared from these cul­
tures as detailed above. The chromosome preparations were rinsed 
in Sorensen's phosphate buffer, pH 6.8, then stained for 3-5min 
with a 5^ v/v solution of Giemsa (2.9) in the same buffer. The 
slides were rinsed in neutral deionised water, dried and mounted 
in DPX.
Slides were scanned methodically for metaphase cells under 
low magnification (x256) • The positions of 100 such cells from 
each cell population were recorded, using the vernier cross- 
reference on the microscope stage. To counter natural bias to­
wards selection of well spread cells, which may not be truly rep­
resentative of the whole population, only those metaphases ob­
viously damaged during slide preparation or so badly spread as to 
make chromosome enumeration impossible were excluded. To reduce 
the effect of any inter—culture or inter—slide variation 25 cells 
were selected on each of two slides prepared from replicate cul­
tures. This completed, all cells were re-examined under high power 
(xl600) and their chromosome numbers determined. The distributions 
of chromosome number observed for CHO-Kl and CHO-KIA cells are ill­
ustrated in Pigs 3*2a and 3*2b respectively.
Both cell populations had a modal chromosome number of 20. 
Cloning increased the proportion of modal cells considerably, from 
66 to 77^* However, at only 5 passages after cloning CHO-KIA exhib­
ited significant inconsistency in chromosome number. Aberrant mit­
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Fig.3.2. Distribution of chromosome number for CHO-Kl cells at passage 
26 (a) and for CHO-KlA cells at passage 31, five subcultures after 
cloning (b).
cause chromosome variation to re-emerge rapidly after cloning. The 
results justify the strategy employed (3*4) to minimise genetic 
heterogeneity and any consequent, unwanted,non—uniformity in the 




Various techniques are available for producing banding patterns in 
animal chromosomes (McDermott 1975)* These patterns are charact­
eristic and reproducible for individual chromosomes and permit the 
specific identification of all components of a karyotype. Even 
non—homologous chromosomes which are otherwise morphologically 
identical can be differentiated. Banding also greatly facilitates 
the detection of structural rearrangements between or within chrom­
osomes, these being revealed by changes in the banding sequences of 
affected regions.
In this study the chromosomes of CHO—K1 were banded using a 
G—banding technique, so called because, following a variety of 
pre—treatments, bands are produced with Giemsa stain. The method 
used was modified from Seabri^ t  (l97l) and involved trypsin dig­
estion of chromosomes prior to staining.
G-banding technique:
A slide, spread with metaphase cells at least 7 days previously, 
was washed successively in methanol and normal saline. It was then 
transferred to a Coplin jar containing 0.25^ trypsin solution 
(1:250 Bact0-Trypsin in normal saline, see 2.9) held at 0°C in an 
ice bath. Trypsin digestion was continued for lOsec — 2min, the 
older the slide the longer the treatment, then immediately halted 
by washing the slide in nonnal saline containing 5^ serum. After 
a saline wash the slide was stained for 5niin in 10^ Giemsa in 
I/15M Sorensen's phosphate at pH 6.8 (see 2.9), washed in neutral 
deionised water and blotted dry. Metaphases were then examined 
under high power optics (xl600). If satisfactory, the preparation 
was allowed to dry thoroughly, cleared in xylene and mounted in DPX.
If chromosomes were not banded sufficiently well, the prepar-
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at ion was destained in methanol and the whole procedure repeated 
with an appropriate extension of the trypsin digestion time. It 
was sometimes found that even after such adjustment of the enzyme 
treatment the chromosomes remained poorly handed. Various pro­
cesses were employed, before trypsinisation, in an attempt to 
improve results in these cases. The most effective was found to 
be a 2hr pre—treatment in double strength saline sodium citrate 
(2xSSC, see 2*9) at 60°C (Buckton and Evans 1973).
G—band pattern of CHO—K1 chromosome complement:
Using the above methods, metaphase spreads from a single 48hr 
culture of uncloned CHO-Kl cells at passage 25 were banded. Four 
processed slides were scanned until 10 adequately banded meta­
phases had been found and photographed#
The photomicrographs were printed so that medium—sized 
chromosomes were about 2cm long. Idiograms, diagrammatic represent­
ations of karyotypes, were then prepared for all 10 cells, by cutt­
ing out chromosomes from each print and arranging them in order of 
decreasing size on cards. These idiograms were prepared whilst 
simultaneously examining the original metaphases, to identify and 
eliminate any errors due to photographic distortion. Chromosome 
lengths were measured using the method suggested by Ham and Puck 
(1962) . When two chromosomes were of idential length, the chromo­
some with the most eccentric centromere i.e., with the greater long 
arm (q)/short arm (p) ratio, was püaced first.
Plates 3*2 and 3.3 show a G—banded CHO-Kl metaphase and its 
assembled idiogram respectively. On comparison of Plate 3.3 and 
the nine other idiograms with the G-band karyotype for normal, 
diploid female Chinese hamster cells (Plate 3.4, with permission 
from Deaven and Petersen 1973) it was found that numerous rearrange-
%
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Plate 3.4. G-Banded chromosomes of a normal 
diploid female Chinese hamster cell. Reproduced 
from Deaven & Petersen (1973) .
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ments had occurred in the CHO-Kl chromosomes. Evidence of trans- 
location, deletion or inversion of genetic material was found in 
nearly all chromosomes. Only one normal homologous chromosome 
pair was present. Designated Nl, it corresponded well with the 
two largest, metacentric chromosomes of the diploid karyotype.
In some cells however, including the one shown, even this pair 
was incomplete, one homologue having been involved in yet another 
structural change. The structures of many chromosomes were ob­
served to vary from cell to cell in this way.
Though there was inconsistency in arrangement, the amount 
of chromosomal material varied little between cells. A comparac­
tive measure of chromatin was achieved by summing the lengths of 
chromosomes in each cell idiogram and dividing by the length of 
an Nl chromosome, at least one of which appeared in every cell. 
The mean content of chromosomal material expressed by this ratio 
was 8.71 with a standard deviation of only 0.44, (coefficient of 
variation 5*1^) for the ten cells examined. Thus it appears that 
although CHO-Kl cells have a tendency to regularly change their 
chromosomal structure, the total amount of chromatin per cell is 
kept within strict limits.
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3.8 Toxic Response Tests
Mutation and chromosomal aberration analyses of the types detailed 
in chapters 4 aJid 5 are costly and time consuming. It is therefore 
necessary to have a strong indication of mutagen doses likely to 
yield meaningful results before embarking on such experiments. In 
this connection dose—response curves for cytotoxicity can be util­
ised, because for a given mammalian cell the dose range over which 
a mutagenic agent produces lethality is usually very similar to that 
over which it induces significant mutation and chromosomal aberrac­
tion (Kao and Puck 1969, Roberts 1977, Tsutsui et al. 1977, Carver 
et al, 1979)" Kill curves were therefore constructed for ethyl 
methane sulphonate (MS) , N-methyl-N—nit ro-N-nitro so guanidine (MNNG) 
and 254nm ultraviolet (UV) radiation.
The toxicity of 12-0—tetradecanoylphorbo 1—13—acetate (TPA) , 
the control tumour—promoting compound used throughout these studies, 
was also determined at proposed test concentrations .
3.8.1 Determination of EMS toxicity : treatment of cell monolayer 
The dose range investigated, from 10*" to 4x10"” mol 1 hr, was
suggested by the results of O'Neill and Hsie (1977, 1979).
5 25x10 CHO-KIA cells were inoculated into a number of 250m
flasks in ^ 1  MPIOZ. After a 20-24hr growth period, medium was
removed from each culture and replaced with 5̂ )1 MPlOY containing
test concentrations of EMS. Control cultures were treated with
fresh medium alone. At the end of mutagen exposure, the culture
medium was discarded and the cells, after being washed three times
with ^ 1  of PBS, were suspended in 2ml of trypsin solution (3.3.2).
Trypsinisation was stopped by the addition and mixing of 2ml of
serum—containing medium and cell density then determined by haemo—
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cytometer count (3.3*3). Each treated cell population was serially 
diluted and plated for cloning efficiency determination (3*3.7). 
Depending on the expected lethality,100—1000 cells were inoculated 
into four replicate 50mm T/C dishes containing 4ml MP10Ï. When 
the likely cytotoxicity was uncertain, cells were plated at more 
than one density. Plates were incubated in the usual way for seven 
days; then stained and scored (3.3*7) 'blind*.
The data obtained are presented in Table 3*2 and the cytotox­
icity dose-response plot from these data is given in Fig 3*3. Rela­
tive cell survival (P.) was calculated as
o
where = plating efficiency of cells after treatment i,
= plating efficiency of cells after treatment o (control), 
and plating efficiency is defined as the fraction of cells plated 
that produce macroscopic colonies.
In cases where cells were inoculated into dishes at more than one 
density, the relative survival was calculated from the plating 
which yielded the highest number of colonies per plate under 200 
(above which upper limit colony crowding began to occur).
Due to the size of the study, toxicity determinations were 
carried out in groups on a number of different days. All work was 
undertaken with a single culture at succeeding passages and the 
same batches of serum, medium and all other cell culture materials 
were used throughout. A carrier control was included on each day 
to take account of other, uncontrollable,variables. Compilation 
of data as in Fig 3*3* is justified by the consistency of the con­
trol plating efficiency over the different days —  82.2 - 2.7^.
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-1 2 EMS dose (moll hr) x 10
Fig.3.3. Relative cell survival of CHO-KIA cells,treated in 
monolayer culture, on a log scale as a function of EMS dose.
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from the plot produced by O ’Neill and Hsie (1977, 1979)i who, using 
CHO—K1 cells in a similar protocol, obtained a linear relationship, 
when cell survival was plotted on a log scale against EMS dose. 
Nevertheless the unit of survival from Fig 3.3, 2.2x10  ̂mol l""̂  
hr, is comparable with the value of 2.4^10  ̂mol 1  ̂hr es­
timated from the results of these earlier workers. The value, 
defined as the dose required to kill 63^ of a cell population, is 
a valid and widely applicable measure of cytotoxic potency (Carver
et al. 1979).
3.8.2 Determination of EMS toxicity ; treatment of single cells 
In the ouabain-resistance mutation assay, cells are often seeded 
into dishes prior to mutagen treatment (Arlett 1977c»;Lankas et al. 
1977, 1978, 1980; Trosko et al. 1977). Following treatment, plates 
are left undisturbed, except for the addition of ouabain to select 
for mutant colonies. As it was intended to perform mutation ex­
periments of this type, termed in situ tests (Arlett 1977a) it was 
necessary to determine the toxicity of selected mutagens towards 
single, plated cells, rather than cells in monolayer culture# 
Therefore EMS was investigated over the concentration raàge 4x10”"̂ - 
6.5x10 ^  for its lethal effects on single cells. A l6hr exposure 
period was used so that mutagen was present over a little more than 
one complete generation time (see 3.5).
5x10^ CHO-KIA cells/20ml MFIOZ were inoculated into a 125ml 
culture bottle, gassed with 5^ CO^ and incubated. After two days 
growth the cell monolayer was suspended in 2ml of trypsin solution, 
then added to 8ml MFIOI in a large glass test tube and well mixed# 
Cell density was determined by haemocytometer count and adjusted to 
10^ cells ml  ̂with more medium. Aliquots of the diluted suspen­
sion were used to seed prenneasured quantities of medium at differ—
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ent cell densities. After thorough mixing, 5^1 volumes of these 
seeded media were pipetted into the required numbers of ^cm dishes. 
The inoculated plates were incubated in the usual way (3.3.7) for 
2-4hr, to allow recovery from trypsinisation and permit cell att­
achment and then test concentrations of M S  were added. After 
l6hr mutagen exposure, medium was replaced with 5nil of fresh MPIOX. 
All plates were reincubated, undisturbed, for seven days, then 
stained and counted ’blind*. The data obtained are presented in 
the dose-response plot given in Fig 3*4« By interpolation the 
value for M S  on single CHO—KIA cells was calculated to be 
2.9x10 very close to the value of 2.8x10 ^  M S  (also l6hr 
exposure) for parental CHO cells, estimated from the results of 
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EMS concentration (M) x 10^
Fig.3.4. Relative cell survival of single, plated CHO-KIA cells on 
a log scale as a function of EMS concentration. Mutagen exposure 
time 16 hr. Control plating efficiency 87%. Four plates per point,
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3.8.3 Determination of the toxicity of MNNG
The cytotoxicity of M M G  towards CHO—KIA was investigated in the 
same two protocols as used with EMS i.e., treatment of cells in 
monolayer culture and of single plated cells.
Treatment of monolayer cultures:
One set of parallel CHO—KIA cultures at passage 32 were treated 
with MNNG l&-23hr after initiation, mutagen was added in 20 yil 
of vehicle (water). Exposure in all cases was for 2hr, before 
a washing, cell dispersal and dilution—plating sequence identic­
al to that used following EMS treatment (3.8.1).
The concentration range investigated was from 1.36x10”’ to 
6.8xlO””'̂ M. The data obtained are given in Table 3.3#
TABLE 3.3
Survival of CHO—KIA cells, as assessed by plating efficiency, 







Mean ^ plat- Relative 
ing efficiency survival
Vehicle
control 100 83.0 - 2.9 83 1.00
1.36x10*7 100 27.5 - 3.7 28 0.33
2.72x10*7 200 21.2 1 1.2 11 0.13
6.80x10*7 200 5.2 i 2.0 2.6 0.03
If 400 9.5 - 1.3 2.4 0.03
These results are comparable with those of O ’Neill et al. (1977) 
who produced a CHO-Kl survival curve for MNNG (effective response 
time 2hr) using a similar experimental protocol. Though the data 
in Table 3.3 are insufficient to produce a survival curve and hence 
to determine a reliable value, meaningful comparison of findings
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-1is possible. In the present study concentrations of 1.36x10 
and 2.72x10 MNNG resulted in 33^ and 13^ relative survival 
respectively. These doses produced approximately 29^ and 5^ 
survival on the plot presented by O ’Neill et al. Thus the 
CHO-Kl cells used here (CHO-KIA) showed a marginally lesser sen­
sitivity to MNNG than that previously reported for such cells.
Treatment of single cells:
Initially MNNG concentrations were selected from the survival data 
for parental CHO cells, presented by Kao and Puck (I968). However, 
in preliminary studies these doses were found to be far too toxic 
towards single CHO—KlA cells and were therefore reduced by a fac­
tor of 10. Thus MNNG concentrations selected for this study were
7 —6in the range 1.36x10* to 2.72x10 M. A series of dishes were in­
oculated with various densities of cells (CHO-KIA, passage 25) as 
in the corresponding EMS toxicity experiments. These were incubated 
for 3hr, to allow recovery from trypsinisation and cell attachment, 
then dosed with MNNG in 50 ^1 of vehicle (water) . After 2hr mutagen 
exposure, the medium was replaced with 5^1 of fresh MPIOI. The 
treated cells were re incubated for 7 days, before staining and 
counting of macroscopic colonies. The data obtained are plotted 
in Pig 3.5.
The survival curve shows an immediate simple exponential 
reduction in relative cell survival with increasing MNNG concentra­
tion. By interpolation at 0.37 relative survival the value for 
MNNG in this experiment was found to be 2.3x10 M. Below 0.03 sur­
vival the gradient of the survival curve decreased markedly, suggest­
ing that a small subpopulation within CHO-KIA was significantly less 












6.8 13.6 20.4 27.2O
MNNG concentration (M) x 107
Fig.3.5.Relative cell survival of single, plated CHO-KIA cells on 
a log scale as a function of MNNG concentration. Mutagen exposure 
time 2 hr. Control plating efficiency 88%. Four plates per point,
1 1 4
3•8.4 Determination of the toxicity of 254nni UV radiation towards 
single cells plated at high density
A survival curve for exposure to this physical mutagen was con­
structed following preliminary dose-ranging experiments.
Inocula of 1.5x10^ CHO-KIA cells at passages 32—34 were 
seeded into 90mm T/C dishes with 10ml MP103T and incubated for 
5-7hr to allow cell attachment. The medium was discarded from each 
plate and ^ml of PBS(a) (2.8.2) added. Cells were maintained in 
this balanced salt solution for exactly 13min, within which period 
they were irradiated for the required time with 254^^ UV light from 
a Pen-Ray lamp (2.10.1), positioned to deliver 0.075 The
PBS(a) was withdrawn and 1ml of trypsin solution added. After 5- 
lOmin at 37.5°^ the cells were thoroughly suspended and transferred, 
with a 4ml MPIOZ wash of the dish, to a l6mm T/C tube. The density 
of the cell suspension was determined by haemocytometer count. Cells 
were diluted and plated into 50mm T/C dishes containing 4.9ml MFIOY# 
The inoculated dishes were boxed, gassed and incubated at 37.5°C for 
7—8 days. Plates were stained, coded and randomised and counted 
'blind*.
Data are presented as a survival curve in Fig 3.6. The curve 
shows a long initial shoulder down to about 50^ relative survival 
and then an exponential portion do\-m to 11^ survival at 50Jm  ̂ (the 
highest UV dose tested). The D̂ ,̂  value for UV 254^^ irradiation of 
















- 2UV fluence (Jm )
Fig.3.6. Relative cell survival of CHO-KlA cells on a log scale as 
a function of UV fluence (dose). Control plating efficiency 85%. 
Four plates per point.
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3.8.5 Determination of TPA toxicity
The viability réponse of CHO—K1 cells to the control tumcur-promoting
•»7 «-écompound was determined at two concentrations (1.6x10 and 1.6x10 M) 
reported to induce lymphocyte activation (cstensen et al. 1974)i ele­
vate sister chromatid exchange frequency (Kinsella and Radman 1978) 
and enhance specific locus mutation induced by physical (Trosko et 
al. 1977) or chemical agents (Lankas et al. 1977). A concentration 
slightly above the maximum reported aqueous solubility of TPA 
(3*7x10 Van Duuren et al. 1976) was also tested.
Cells were exposed in a treatment—plating regime, i.e. were 
treated in monolayer culture and subsequently single-cell plated. 
Cultures were treated l8-24hr post—initiation for 4 or 24hr then wash­
ed, dispersed, diluted and plated. TPA was from batch 1 (see 2.10.2).
Data obtained for CHO—K1 cells (at passage 26) after 4hr ex­
posure and for CHO-KIA cells (at passage 32) after 24hr exposure are 
given in Tables 3.4 aJid 3*5 respectively. In Table 3*5 the results 
from two idential experiments, (l and II) are presented and pooled 
for mean plating efficiency and relative survival determinations.
TABLE 3.4
Survival of CHO-Kl cells, assessed by plating efficiency, following 
4hr treatment of monolayer cultures (21—24hr post-initiation) with 












(0.1^ DMso) 100 83.0 i 3.0 83 1.00
1.6x10"? 100 78.0 ± 3.8 78 0.94
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TPA was markedly cytotoxic to CHO-KIA when present at 1.6x10 %  
for 24hr; it reduced cell survival to 0.02 of untreated controls 
(see Table 3.5). TPA did not significantly reduce plating effic­
iency (below control levels) at any of the other test doses in 
Tables 3.4 and 3*5.
An incidental observation was that TPA treatment of cells 
—T 6(at 1.6x10 and 1.6x10 M) resulted in them becoming more elon^ 
ated and fibroblast-like. These morphological changes were evid­
ent at ?4br, but not 4hr, after addition of TPA.
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3*9 Discussion
It was decided to use CHO—K1 cells in an investigation of the 
effects of phorhol ester-type tumour promoters on gene mutation, 
chromosomal aberration and sister chromatid exchange in mammalian 
cells. CHO—K1 was selected because it is a well characterised cell 
line, with a small quasi—diploid chromosome complement amenable to 
karyotype analysis and scoring of chromosomal aberrations. In 
addition, conditions for selection of cell variants, resulting 
from heritable changes affecting several different gene loci, have 
been thoroughly defined for these cells (Baker et al. 1974, O'Neill 
et al. 1977, Gupta and Siminovitch I980) and provide a number of 
alternative systems for assaying gene mutation.
Initially cells, received as CHO—Rl, were cultured in Ham's 
FI2 medium supplemented with 5% FBS. After effecting transfer to 
Flo medium,which had to be supplemented with 2x10 ^ mol 1 ^
L-proline, (3.2.2), a variety of cell culture procedures were 
standardised (3*3) and a subculture routine established (3.3.4)#
Before beginning investigative experimental work the nature 
of the biological material to be employed had to be unequivocally 
confirmed. When examined microscopically; either in culture, under 
phase contrast optics, or after fixation and staining (3.6); cells 
had the epithelioid morphology expected of CHO—Rl (aTCC catalogue, 
CCL6I) . The need to supplement FIG medium with extra L—proline, 
before it would satisfactorily support cell growth (3.3*2) likewise 
agreed with a known absolute requirement of CHO—Rl for this amino 
acid (Kao and Puck I968) . Furthermore, the mean generation time of 
the presumptive CHO—Rl cells, once in exponential growth phase, was 
found to be 12.0hr (3*5)* This is in good agreement with the gener­
ation time of 12-13hr reported for CHO-Rl by O'Neill et al (1977)*
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All the above cellular characteristics, though they are con­
sistent with cells being CHO—Kl, might conceivably be exhibited by 
cells from other lines. Unambiguous identification of cells as 
CHO-Kl required the analysis of chromosomal constitution reported 
in 3«7* Initially it was established that cells had. a modal 
chromosome number of 20 (3*7*2), as does CHO—Kl (Kao and Puck 1968, 
1969)• Next, after perfecting a G—banding technique, chromosomes 
were banded and idiograms mf metaphase cells compared with the G— 
band karyotype of normal, diploid, female Chinese hamster cells,
(3.7.3). It was found that, although many intror- and inter-chromo- 
somal rearrangements had occurred, chromosomes retained G—band sequ­
ences recognisable in the normal karyotype. Taken together with the 
modal chromosome number of 20, this was considered sufficient evid­
ence that cells were CHO—Kl,
The étudies of chromosomal constitution, as well as certifying 
cells as CHO-Kl, reveal the nature of the CHO—Kl karyotype. These 
established cells are aneuploid and show many structural changes in 
their chromosomes when compared with normal, diploid cells. In 
addition the karyotype shows both numerical and structural variation 
within the CHO-Kl population, i.e. there is variation in the number 
of chromosomes per cell (3.7*2) and in the structure of those chrom­
osomes (3.7*3). The karyotypes of CHO (Kao and Puck I969, Deaven 
and Petersen 1973) and several other established Chinese hamster 
cell lines (Zakharov et al. I964) have previously been reported to 
have these same characteristics. Indeed these are characteristics 
common to the karyotypes of most established cell lines (Paul 1975)* 
The fact that the nature of the CHO—Rl karyotype is different from 
that of a normal diploid karyotype must be borne in mind when inter­
preting results and when attemptingto extrapolate findings obtained
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with these cells, in vitro, to normal cells in vivo*
A characteristic of established cell lines, such as CHO and 
CHO—Kl, is that genetic variation arises within these cell popular 
tions with time in culture (Kao and Puck I962). Genetic hetero­
geneity can lead to unwanted non-uniformity in the phenotype of 
cells used in experimental work and so it must be countered. Cell 
populations derived from single cells (clonal populations) show 
reduced genetic heterogeneity (Kao and Puck I962). Therefore, as 
detailed in 3.4, a clonal population, CHO-KIA, was isolated from 
the original CHO—Kl cell strain and a large seed stock of these 
cells placed in liquid nitrogen storage for use in all proposed 
studies. That CHO—KIA was indeed more homogeneous than the parent­
al cell strain, was demonstrated by the fact that in CHO—KlA 77^ 
of cells exhibited a modal chromosome number of 20, whereas only 
66^ of cells were modal in the original CHO-Kl population (3.7*2).
Following the isolation of this clonal strain its survival 
responses following exposure to various mutagens or the tumour pro­
moter TPA were determined. Primarily these constituted dose—rang­
ing studies to aid selection of doses of these agents to be used 
in mutation and chromosomal aberration experiments (see chapters 
4 and 5)* However, they also prompted comparisons of results with 
the survival responses previously reported for CHO-Kl and CHO.
Findings with EMS are consistent with earlier reports on the 
lethal effects of this agent on CHO—Kl and CHO cells. In a regime 
in which cells were single—cell plated after mutagen exposure 
(3*8.1), the dose required to kill 63^ of the CHO—KIA population 
(the value) was determined to be 2.2x10 mol 1 hr. This is 
closely comparable with a of 2.4x10  ̂mol 1 ^hr, estimated 
from the results of O'Neill and Hsie (1977), who treated CHO—Kl
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cells under similar experimental conditions. However, O'Neill and 
Hsie reported that, after an initial shoulder region, there is a 
linear relationship between the logarithm of relative CHO—Kl cell 
survival and M S  dose (expressed as mol 1 ^hr) • A log-linear plot 
of the experimental data given in Table 3.2 yields a sigmoidal 
survival curve (Fig 3.3). The sigmoidal curve seems more likely 
than the shouldered linear profile, because M S  has a reported half- 
life of only 2.2hr in serum-contained medium at 37°C (Jensen et al.
1977)• Thus at extended exposure times calculation of mutagen dose 
as a simple product of M S  concentration and treatment time will 
yield a value which is unrealistically high. The exponential por­
tion of the cell survival curve will correspondingly show an err­
oneous reduction in its negative gradient (as in Fig 3*3).
When CHO—KIA cells were single—cell plated, then exposed in 
situ to various concentrations of M S  (for l6hr) (3*8.2), the sur­
vival curve obtained (Fig 3*4) was found to be superimposible upon 
that presented by Kao and Puck (I968), who treated CHO cells (again 
for l6hr) in this same plating-treatment regime. As well as yield­
ing very similar values, 2.9%10"^M for CHO-KIA and 2.8xlO"^M 
for CHO, the two curves both exhibit an initial shoulder region 
extending down to between 10 and 20^ survival, prior to an expon­
ential killing phase.
A very large shoulder on the CHO-KIA M S  survival curves 
(Figs 3*3 and 3*4), irrespective of the mutagen treatment regime 
employed, may, as Kao and Puck (1969) suggest, indicate one or more 
of the following:
(1) the need for a minimum concentration of the 
agent in the medium, in order to overcome processes, 
e.g. active transport, which prevent the agent from
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reaching critical sites within the cell;
(2) multiple structures in the cell which must be 
individually inactivated or 'hit* by the agent; or
(3) cellular repair mechanisms (including DNA repair 
activities) whose capability must first be saturated 
before damage can be elicited.
The lethal effects of MNNG treatments of CHO—KIA cells
(3.8.3) indicate that CHO—Kl is significantly more sensitive to 
this mutagen than CHO. When monolayer cultures were treated,
CHO—KIA showed survival responses to MNNG (see Table 3*3) compar­
able with those previously reported for CHO-Kl, at corresponding 
doses, by O'Neill et al. (l977)• However, in the alternative, 
plating-treatment regime, in which single cells were treated, though 
both the CHO—KIA survival curve (Fig 3*5) aJid the corresponding MNNG 
survival curve for CHO (Kao and Puck I968) showed an immediate sim­
ple exponential reduction in relative cell survival, i.e. had an 
apparent 'hit' number or extrapolation number of 1 (Drake 1970), 
they displayed two noticeable differences. Firstly, though the 
mutagen exposure period was longer in Kao and Pucks' experiments 
(meaning that D^^ values cannot be compared) , 10-fold higher con­
centrations of MNNG were required to elicit levels of lethality in 
CHO equivalent to those seen with the CHO—KIA cells. Thus CHO—KIA, 
and possibly all CHO-Kl populations are much more sensitive to MNNG 
than CHO. Secondly, below 3^ survival the negative gradient of the 
CHO—KlA survival curve decreases. The CHO MNNG survival curve, on 
the other hand, shows no deviation from exponential kill down to at 
least 1^ survival (Kao and Puck I968). Unlike the case of the EMS 
experiment discussed above, this feature of the CHO—KIA survival 
curve cannot be attributed to the breakdown of mutagen at longer 
exposures, because a single (2hr) treatment time was employed through—
12 4
out. It may be that an MNNG—resistant sub—population resides within 
CHO-KIA, possibly corresponding with cells which have retained the 
relative MNNG-insensit ivity of ancestral CHO cells. Several re ar­
sons can be envisaged as to the reason for CHO—KIA*s relative hy­
persensitivity to MNNG compared with CHO, including ; an altered 
plasma membrane structure, facilitating cellular uptake of the 
mutagen; the loss of an enzyme capable of inactivating MNNG, or a 
lethal chemical species derived from it; the loss of a DNA repair 
system.
Interestingly, the results in Pig 3.6 suggest that for UV rad­
iation the situation is the reverse of that with MNNG, i.e. CHO-KIA 
is rather insensitive to UV compared with CHO. Thompson et al.
(1980) exposed CHO cells to 8.3 Jm  ̂254^ UV light under conditions 
which were identical to those detailed in 3.8.4, except that the dose 
rate, at 0.25 Jm was higher than the 0.075 Jm  ̂used in the
present study. At this dose Thompson et al. reported a relative cell 
survival of 0.39* Interpolation onto the UV survival curve in Fig. 
3.6 shows that for CHO—KLA a relative cell survival of 0.39 corres­
ponds with a dose of 35Jm Thus CHO—KIA appears to be over four 
times more resistant to UV at 254^m wavelength, than CHO. This 
finding merits further investigation, by determining the relative 
DNA repair capacities of these two cell populations, since DNA re­
pair capacity can have a significant effect on the sensitivity of 
both bacterial and mammalian cells to the lethal effects of UV light 
(Hanawalt et al. 1979).
Finally, the toxicity of TPA was determined at two proposed 
test concentrations and one much higher concentration. Results are 
given in Tables 3.4 and 3.5» The phorbol ester was found to be non-
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toxic at both 1.6x10 and 1.6x10 M, when presented to cells for as
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long as 24hr. However a 24hr treatment with 1.6xlO"^M TPA caused 
a very great reduction in CHO-KIA singl&pcell plating efficiency 
(down to 2^ of untreated controls) These observations are con­
sistent with the findings of other workers regarding the toxic 
effects of TPA treatment of established Chinese hamster cells.
Lankas et al. (1977), Trosko et al. (1977) and Kinsella and Radman 
(1978) all presented data showing that chronic exposure to 1.6x10 
TPA does not reduce or increase the plating efficiency of V79 Chin­
ese hamster cells (V79, like CHO-Kl, is a much used aneuploid cell 
line). However at the higher concentration of 8x10 ^mol 1 TPA 
completely inhibits the growth of these cells (Kinsella and Radman
1978) .
The CHO—KIA subclone has been shown to possess the typical 
characteristics of certified CHO-Kl cells with respect to morphol­
ogy, growth characteristics and karyotype. The survival responses 
of the cells to EMS, MNNG, UV light and TPA were comparable with 
those reported for CHO or CHO-̂ Cl cells by previous workers. It was, 
therefore, concluded that the CHO-KIA cells were suitable for use in 
the investigations reported in Chapters 4 aî d 5«
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CHAPTER 4 
THE EFFECTS OF TPA ON GENE MUTATION 
IN CHO-Kl CELLS
A possible mechanism for tumour promotion is the enhancement of the 
yield of somatic mutations induced by initiating carcinogens (see 
1»9)• The work reported in this chapter constitutes an investiga­
tion of the effects of the tumour promoter TPA on spontaneous and 
mutagen-elevated gene mutation frequencies in CHO—Kl cells.
With the exception of genes coding for ribosomal or transfer 
RNA, each gene within a DNA molecule determines the structure of a 
single polypeptide within a protein (1.8). The structural and 
catalytic properties of the proteins, in turn, determine the ana­
tomical and metabolic properties of cells. Thus a gene mutation — 
a DNA alteration affecting a single gêne and leading to an altered 
protein — can bring about a profound change at the level of cell 
structure and function.
Certain gene mutations affecting dispensible cellular functions 
can be detected because the resultant mutant organisms possess phen­
otypic traits which allow them to be distinguished from normal (or 
wild—type) members of a population. In cultured bacterial or eu— 
cary otic cells a mutation may, for example, inactivate an enzyme in 
a non-essential biosynthetic pathway and cause affected cells to be­
come dependent on their environment for one or more growth factors 
(a phenotypic condition termed auxotrophy). Auxotrophic mutants 
can be detected by selecting against growth factor-independent 
(prototrophic) cells by a variety of techniques. These invariably 
involve the selective killing of dividing cells in a minimal medium 
capable of supporting the growth of prototrophs but not auxotrophs
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and subsequent plating in a supplemented medium so that auxotrophic 
mutants can produce macroscopic colonies. Thus the proportion of 
such mutants in a cell population can be ascertained and the mut ac­
tion frequency at the gene concerned determined. Use is made of 
mutant selection systems of this type to assay the mutagenicity of 
physical and chemical agents.
There are several bases for mutation assays other than sel­
ection for specific auxotrophic mutants. Many assays are based on 
reverse mutation (l.8) from auxotrophy to prototrophy. Mutant sel­
ection in these cases is a simple one-step process involving plat­
ing of mutagen—treated cells into medium lacking the crucial growth 
factor. The Ames test (Ames et al. 1973), which is used to screen 
environmental chemicals for mutagenicity and hence potential carcin­
ogenicity (1.9), is an example of this type of assay and is based on 
reversion of histidine-requiring Salmonella typhimurium bacteria to 
prototrophy. Many chemicals are not carcinogenic to mammals until 
they have been metabolized by a class of liver enzymes known as 
mixed function oxidases. Since bacteria do not possess a full com­
plement of these enzymes, a microsomal rat liver fraction — S9 — 
is included in this test system.
A further group of mutation assays, widely used with mammalian 
cells, are based on forward mutation (I.8) to drug-resistanoe. Re­
sistance results when a mutation renders the cell membrane imperm­
eable to the drug concerned or when an enzyme crucial to the drug’s 
cytotoxic action is either structurally altered or lost altogether. 
Mammalian cell mutation assays most commonly employ resistance to 
the antimetabolite 6-thioguanine (Cole and Arlett 1976, Arlett 
1977a and b, O ’Neill et al. 1977, Gupta and Siminovitch I980), to 
the steroid compound ouabain (Baker et al. 1974, Cole and Arlett
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1976, Gupta and Siminovitch I980) or to high concentrations of the 
nucleoside thymidine (Anderson and Fox 1974, Cole and Arlett 1976, 
Clive 1977).
Assays of the mutagenicity of chemical and physical agents, 
whatever cell type they employ, always involve the same three steps 
— cell treatment, mutation expression and mutant selection. At 
cell treatment a standardised population of cells is exposed to 
mutagen under a well defined and reproducible set of conditions. 
During the subsequent mutation expression period, time is allowed 
for DNA lesions to yield mutations and for the transcription and 
translation of mutated genes. This period also allows for the 
disappearance of existing gene products, both by dilution at succ­
essive cell divisions and by normal degradation. Finally, specific 
mutants are selected by imposing treatments or growth conditions 
on the cell population which kill or inhibit normal cells but which 
permit each mutant cell to ultimately give rise to a macroscopic 
colony.
A particular problem with many mammalian cell mutants, is 
that when they are in direct contact with normal cells they can en­
gage in metabolic cooperation. This is a process whereby mutant 
cells can receive certain substances from normal cells. In the case 
of enzyme deficient mutants the substances are presumed to be normal 
enzyme products which render the cells phenotypically normal and 
therefore unselectable (Simons 1974, Abbondandolo 1977) as mutants. 
In a mutation assay this can lead to a reduced yield of mutant col­
onies and a consequently low value for the mutation frequency. To 
circumvent this problem mutants must be selected at cell densities 
which do not permit cell-cell contacts to arise.
The effect of TPA on gene mutation was to be determined by
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selecting both ouabain-resistant and thioguanine-resistant mutant 
clones following various mutagen and promoter treatments of mamm­
alian CHO-Kl cells. The biochemical and genetic bases of these 
two mutations to drug-resistance are discussed in subsequent 
sections.
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4.1 Mutation to Ouabain—Resistance (Oua^)
Active sodium and potassium ion transport in mammalian cells has 
been associated with the Na*̂ —K*^-Mg^"^-activated ATPase of the plas­
ma membrane (EC 3.6,1.3, hereafter abbreviated Na'̂ ’/K'^ATPase) (Baker 
et al. 1974). The steroid compound ouabain (Oua) inhibits the 
growth of mammalian cells by the specific inhibition of this enzyme 
and is ultimately cytotoxic (Bciker et al. 1974, Davies and Parry
1974) .
It has been found that clones of both established and primary 
cell lines can be obtained, by single-step selection in Oua^ontain— 
ing culture medium, which have greatly increased resistance to Oua 
cytotoxicity when compared with wild-type cells (Baker et al. 1974, 
Davies and Parry 1974, Cole and Arlett 1976, Arlett 1977a) . This 
property has been shown to behave as if it reflects a mutant geno­
type :
(1) The phenotypes of Oua^ clones are stable, being 
reproducible after long intervals of growth in the 
absence of the selecting drug (Baker et al. 1974,
Cole and Arlett 1976)•
(2) Classical Luria-Delbruck fluctuation analyses
pindicate that Oua cells arise randomly in wild-type 
populations of both mouse L cells and CHO cells, as 
expected of spontaneous mutations (Baker et al. 1974) .
(3) Treatment of wild-type cell populations with EMS 
and other mutagens causes a substantial increase in 
the frequency of Oua^ cells (Baker et al. 1974, Davies 
and Parry 1974, Cole and Arlett 1976, Arlett 1977a and
b, Gupta and Siminovitch I980)•
R S(4) Hybrids of Oua and Oua-sensitive (Oua ) wild-type
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CHO cells show drug -resistance intermediate between 
that of the two parental cell strains, establishing 
that Oua^ is a co—dominant trait (Baker et al. 1974)•
On the basis of these characteristics it is considered that 
Oua^ arises by virtue of a gene mutation which alters Na**'/K**’
ATPase, or an adjacent membrane component, so that it has a re­
duced affinity for Oua or gives an altered response to the bound
p
drug. The nature of the mutations responsible for Oua is sugg­
ested by the classes of mutagens which are most effective inducers
p
of Oua mutants. M S  and UV—li^t, mutagens capable of inducing 
base-pair substitutions (1.8), are effective inducers of such mut­
ants (Baker et al. 1974» Arlett 1977a)• Ionising radiation and 
tritium decay of ^H—thymidine incorporated into DNA which cause 
chromosomal deletion—type mutations and 8-methoxypsoralen (8-Ĵ OP) , 
which is known to produce frameshift mutations (1.8) that result in 
inactivation (or functional deletion) of gene products, are incapa- 
ble of enhancing mutation to Oua^ (Arlett 1977b, Gupta and Simino­
vitch 1980). These observations are readily explained on the basis 
that Na'̂ /K**’ ATPase is essential to the survival of the cell and 
mutations which result in its deletion or inactivation are lethal.
pMutations to Oua are therefore likely to be base-pair substitutions 
resulting in single amino acid changes and subtle conformational 
alterations in the relevant gene product, be that Na'̂ /K’̂ ATPase 
itself or some adjacent membrane component.
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4.2 Mutation to 6-Thioguanine-Resistance (TG^)
RAn understanding of TG requires an understanding of the mechanism 
of the cytotoxic action of this drug, which in turn requires some 
knowledge of the pathways of nucleic acid synthesis.
The polynucleotide chains of both DNA and RNA are built up 
with individual purine and pyrimidine nucleotides by various poly­
merase enzymes. The constituent purine and pyrimidine nucleotides 
can be produced from small molecules by de novo synthesis; purine 
nucleotides from phosphoribosyl pyrophosphate, glutamine, glycine 
and aspartate and pyrimidine nucleotides from aspartate and carbarn- 
yl phosphate. Alternatively, cells can utilise exogenously pro­
vided purine and pyrimidine bases to produce nucleotides along so 
called 'salvage’ pathways. The inter-relationships of the de novo 
pathways for purine and pyrimidine nucleotide biosynthesis with 
certain salvage pathways are illustrated in Pig 4.I* The sites at 
which the folic acid antagonist aminopterin blocks nucleotide meta^ 
bolism are included for future reference.
As can be seen in Pig 4.I; exogenous guanine (g) and hypox-
anthine (HX) can be converted to guanosine monophosphate (GMP) in
one of the salvage pathways, by the enzyme hypoxanthine-guanosine
phosphoribosyltransferase (IMP:pyrophosphate phosphoribosyltrans-
ferase, EC 2.4»2.8, hereafter abbreviated HGPRT) and after further
enzymic reactions can be incorporated into DNA and RNA. TG, which
is a guanine analogue, can similarly be taken up by mammalian cells,
/converted by HGPRT to the corresponding nucleoside 5 -monophosphate 
(thioguanosine monophosphate, also known as thioguanylic acid) and 
ultimately incorporated into nucleic acids in place of guanine. 
However, although TG is sufficiently like guanine to be metabolised 





































alter the DNA ajid RNA into which it is incorporated and thus to 
cause cell death (Meyers et al. 1974» Arlett 197Tb).
Clones of rodent and human cells (from both established and 
primary cell lines) have been isolated which are markedly more re­
sistant to the cytotoxic action of TG than their parental cell 
strains (Abbondandolo 1977)• The biochemical basis of this TG^ 
is almost certainly HGPRT deficiency. This has been established 
by the observation of greatly reduced or altered HGPRT enzyme ac­
tivity in cell—free extracts from TG^ clones of both CHO-Kl (Hsie 
et al. 1975) and human lymphoblastoid cells (Epstein et al. 1977).
It has been found that 98^ of TG^ CHO—Kl clones will not incorpor­
ate ^H—hypoxanthine into their nucleic acids, presumably because 
they have lost the ability, through loss of HGPRT, to metabolise 
this purine (Hsie 1975)• Use has also been made of a ’back selec­
tion* system to prove that TG^ cells are HGPRT-negative (HGPRT").
As shown in Fig 4*1» aminopterin (AP), which non—competitively 
inhibits the enzyme dihydrofolate reductase, blocks the de novo 
synthesis of inosine monophosphate (iMP) (and hence the de novo 
synthesis of all purines) and additionally, the méthylation of 
deoxyuridine monophosphate (dUI-IP) , which yields thymidine mono­
phosphate (dTMP). Nonetheless, normal cells can survive in the 
presence of AP, as long as they are provided with exogenous hypox- 
anthine to circumvent the block on de novo purine synthesis and with 
thymidine (dT) to similarly by-pass the block on dTMP production. 
However, HGPRT cells cannot utilise hypoxanthine because the approp­
riate salvage pathway is missing and so when plated into hypoxan— 
thine—aminopterin-thymidine (or HAT medium) they are growth-inhib­
ited and eventually killed. It is necessary to include glycine in 
HAT medium as the conversion of serine to glycine also involves
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dihydrofolate reductase, O'Neill et al, (1977) have shown that 
989̂  of TG^ CHO-Kl clones are incapable of growth in HAT medium 
and are thus presumed to be HGPRT .
In both man and the hamster, the gene coding for the HGPRT 
enzyme is located on the X chromosome (Abbondandolo 1977) • Thus 
the HGPRT gene is functionally hemizygous, only one gene copy being 
present in male cells and only one being expressed in female cells 
— in which one X chromosome is always heterochromatic and genetic­
ally inactive (McDermott 1975)* Therefore, any deletion or enzyme 
-inactivating mutation affecting the single HGPRT gene will result 
in TG • Not surprisingly, because the simple non—function of an
penzyme coded by a hemizygous gene is involved, TG has been shown 
to behave like a recessive genetic trait in appropriate cell hybrids 
(Paul 1975).
In the absence of analyses of the base sequence of the HGPRT 
gene and the amino acid sequences of HGPRT proteins in TG variants,
pthe evidence that a phenotypic change to TG represents a true gene 
mutation, though considerable, is necessarily indirect. Such evid—
pence, with particular reference to TG CHO-Kl cells, is as follows;
(1) TG is associated with a deficiency in a known 
gene product, namely HGPRT, in a high proportion of 
independently derived mutant clones,
(2) Fluctuation analyses of the appearance of the
p
TG phenotype in wild-type CHO-Kl populations demon­
strate its random nature and yield a presumptive 
spontaneous mutation rate of 2—4x10 ^ mutations/cell/ 
generation (Hsie I980)•
(3) The TG^ phenotype has been shown to be stable for 
over 100 generations among 200 variant CHO—Kl clones
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(Hsie 1980)• Furthermore, Cole and Arlett (1976)
p
report that TG variants from the L5178Y mouse 
lymphoma cell line can be maintained in the absence 
of the selective sigent for several months with no 
consequent diminution of their cloning ability in 
TG—centaining culture medium.
(4) Physical and chemical mutagens induce TG^ var­
iants in a dose—dependent manner in CHO-Kl cell pop­
ulations (O'Neill et al, 1977 )•
(5) Use of a back selection system, similar in nat-
pure to the HAT system, has revealed that TG CHO-Kl 
variants are revertible following mutagen treatment. 
Furthermore, some revertant clones exhibit HGPRT act­
ivities in cell—free extracts which have altered ther­
mosensitivity and kinetic properties when compared 
with normal enzyme (Hsie I980),
(6) The spontaneous frequency of reversion, at 
IxlO" revert ants/clonable TG CHO-Kl cell, is very 
low (Hsie 1980).
(7) TG^ cannot be induced in near-tetraploid CHO-Kl 
cells (Hsie I980)• In such cells two functional X 
chromosomes are expected and hence two functional 
HGPRT genes. Thus the improbable occurrence of a 
structural gene mutation in each of two specific genes 
is required before a cell is rendered HGPRT and conse­
quently TG^,
Results in CHO-Kl (O'Neill et al, 1977, Hsie I980) V79 (Arlett 
1977a and b) and L5178Y mouse lymphoma cells (Cole and Arlett 1976, 
Arlett 1977b) demonstrate that all classes of chemical and physical
1 3 7
pmutagens are capable of inducing mutation to TG • Thus it is like­
ly that many types of mutation—including base-pair substitutions, 
frameshifts and small chromosome deletions (l.8) — can result in
p
TG • Probably the only requirement is that the mutation causes the 
inactivation or deletion of the gene coding for HGPRT while not 
resulting in the loss of other, vital, functions necessary for the 
continued viability of the HGPRT cell. Indeed it has been sugg-
pested that TG variants can result from all conventional classes 
of mutation, save large or whole chromosome deletions (DeMars and 
Jackson 1977).
Interestingly, cells of individuals displaying the hereditary 
Lesch—Nyhan syndrome, a recessive X-linked disorder, are HGPRT and
pthus TG • Such individuals are typically subnormal in intelligence, 
spastic, destructive and self-mutilating (Groodenou^ 1978).
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4*3 Enhancement of Mutagenesis In Vitro by TPA
Several groups of workers have investigated whether tumour promoters 
possess mutagenesis-enhancing or *co-mutagenic* activity in cultured 
bacterial or mammalian cells, utilising mutation assays of the types 
outlined above.
TPA alone was reported to be non-HTiutagenic in S.typhimurium 
in the Ames test (McCann et al. 1975) • Subsequently, Evans and 
Soper (1977) investigated the co-nnutagenic action of TPA (l.6xlO M̂) 
in S.typhimurium. They constructed R—factor containing auxotrophic 
bacterial strains with base—pair substitution and frameshift mut ac­
tions to histidine—dependence, capable of reversion by N-methyl-N'— 
nitro-N-nitrosoguanidine (MNNG) and 4^mitroquinoline-l-oxide (NQQ) 
respectively. TPA markedly enhanced the elevated frequency of mut ac­
tion to histidine-independence seen in the presence of the two chem­
ical mutagens without affecting mutagen—induced loss of cell viabil­
ity. TPA on its own was neither mutagenic nor toxic to the test or­
ganisms. Phorbol, the parent diterpene of TPA, a promoter of leukaemia 
and lung and liver tumours in mice (see Table l.l) exhibited no co— 
mutagenic activity.
Early reports obtained with mammalian cells, though they in­
dicated TPA—enhancement of mutagenesis, showed some differences from 
findings with bacteria, Trosko et al. (Trosko and Chang 1976, Tros—
ko et al. 1977) reported that following UV-irradiation of V79 Chinese
R Rhamster cells, the recovery of both TG and Qua mutant clones was 
not only enhanced by TPA treatment (1.6x10 M̂) but also, to a less­
er extent, by phorbol (also 1.6xlO"^M). The greatest recovery of 
UV-induced Oua^ mutants (98O mutants/lO^ survivors, compared with 
260 mutants/10  ̂survivors following UV alone) occurred when TPA 
treatment was started 6hr before the end of a 48hr mutation express—
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ion period and continued through mutant selection. Of potential 
importance were results obtained by this group which showed that 
TPA (1.6x10 M̂) increased the recovery of TG^ clones, though not 
Oua clones from unirradiated V79 cell populations (Trosko and 
Chang 1976); implying that TPA can be mutagenic. Phorbol shov;ed 
no such action (Trosko et al. 1977)•
TPA and phorbol (again at 1.6x10””̂ M) also were reported to
penhance mutation to Oua induced by the chemical agents MNNG and 
methylazoxymethanol acetate (MAM) in V79 cells (Lankas et al.
1977) • Neither TPA nor phorbol were mutagenic per se, but both 
(TPA more so than phorbol) increased the recovery of mutants from 
MNNG— and MAM-treated cell populations. As with the enhancement 
of UV mutagenesis by TPA, it was established that both phorbol and 
TPA were maximally effective as co-mutagens when cells were first 
exposed at late expression times and exposure was continued through 
mutant selection. Following these findings, Lankas et al. (1978) 
determined the effects of certain non—diterpene ester-type compounds 
on chemically-induced mutation in these same V79 cells. Linear 
alkanes of even number chain length between 6 and I6 carbons (all 
at 0.12mM and 1—phenyldodecane (0.7mM) were each tested for the 
ability to enhance mutagenesis following MAM treatment of cells.
TPA was included as a positive control. Of the simple alkanes, 
n-decane, n—dodecane and n-tetradecane caused statistically signif-
pleant increases in the yield of Oua clones. These findings mirrored 
results of experiments in mouse skin, where, within the series of 
linear alkanes tested, these three compounds had the highest tumour- 
promoting activities (Sice I966). The other test compound, 1-phenyl— 
dodecane, another mouse skin tumour promoter, also enhanced MAM mut­




4.4 Aims of the Present Study
If confirmed as a real effect rather than an experimental artefact 
the CO—mutagenicity of tumour promoters reported above would not 
only support the hypothesis that such agents act in vivo by en­
hancing the mutagenic effects of carcinogens, but also, by im­
plication, the mutation theory of carcinogenesis itself. An in 
vitro system in which known tumour promoters demonstrate co-muta^- 
genicity might also serve as the basis of a rapid and informative 
screening test for tumour-promoting environmental chemicals.
A significant step towards establishing co*^utagenicity as 
a real and characteristic activity of tumour promoters would be 
its demonstration in a cell type other than V79» In a different 
cell line the promoter-enhancement of mutagenesis mi^t also be 
markedly greater, which would obviously be advantageous when 
screening for weak tumour promoters and when making quantitative 
comparisons between the effects of different treatments. There­
fore, as part of an overall study of the effects of TPA on mutagen- 
induced genetic damage in CHO-Kl cells, it was proposed to deter­
mine whether TPA could enhance mutagenesis by MNNG, ethyl methane- 
sulphonate (EMS) or UV light in this cell line. The phorbol ester 
was to be tested at a single concentration (1.6x10'^M) which was 
maximally effective in the previous studies of its possible co­
mutagen ic activity outlined above (4.3)•
It was decided to determine the effect of TPA on the frequency
R R(per survivor) of both Oua and TG mutants, following various treat­
ments with the different mutagens. These two mutation assay systems 
were selected because they are particularly well complemented. The 
one, selection of Oua mutants, detecting predominantly base—pair 
substitutions (see 4*1 above) and the other, selection of TG^ vari—
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ants, detecting mutations of all classes save large or whole 
chromosome deletions (see 4*2 above). It was envisaged that if 
TPA were shown to enhance mutagenesis, it may be possible, by 
using these two mutation assays and mutagens with different modes 
of action, to infer what types of mutagenic event are potentiated 
by the tumour promoter.
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4*5 Special Materials and Methods
4.5»1 Chemicals 
Aminopterin (ap):
A gift from Lederle Laboratories. Crystals were stored at -20°C 
protected from light. 10 ^  stock solution was prepared in
0.5^ w/V sodium carbonate and filter sterilised through a Millex- 
GS unit fitted with a 0.2 pm pore size filter (2.3) . This solu­
tion was stored frozen, in volumes, again at —20°C protected 
from light, for a mrotimum 4 weeks.
Ouabain (Oua) :
Ouabain octahydrate crystals (sigjna Chemical Co.Limited) , stored 
at room temperature protected from light.
6—Thioguanine (TG):
Obtained in crystalline form, assay approximately $8^ (Signa) and 
stored at room temperature protected from light. lOmM stock solu­
tion was prepared in 0.5^ W/V sodium carbonate and filter steril­
ised through a Millex-GS unit. This solution was stored frozen, 
in 9^1 volumes at -20°C protected from light, for a maximum 4 weeks,
4.5.2 Media
Ouabain medium (Oua medium):
Modified Ham's PIO medium supplemented with 5a FBS (MFIOI see 
2.8.5/2.8.6) containing 3ml‘î ouabain.
Ham's Flo medium without hypoxanthine, thymidine and NaHCO^ 
was obtained in powder form from Flow Laboratories Limited. It was 
stored at 4°C in a vacuum desiccator. Powder to prepare 1 litre of 
single strength FIO medium was dissolved in approximately 450ml of 
freshly collected DD H^O. 2.305g ouabain octahydrate (giving
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— 13mmol 1 in the final medium) was dissolved in another 450ml 
DD H^O,being protected from light. These two solutions were 
mixed and then the following were added in order:—
10ml Penicillin (5,000 lUml )̂ and streptomycin




l6ml 7*5a NaHCO^ or 1.2g powder 
50ml 0.6ml.i Hypoxanthine
The medium was made up to volume with DDH^O, rendered slight­
ly acidic by bubbling CO^ through it and membrane filter sterilised 
(see 2.3). The sterilised medium was stored in lOQnl volumes, at 
4°C protected from light and used within 4 weeks.
Since Oua medium was always supplemented with 5^ PBS on the 
day of use, the Roman numeral suffix, indicating the percentage 
serum content, is omitted from the abbreviation for this medium.
Hypoxanthine-free medium (MPIO(-HX)):
Modified Ham's FIO medium without hypoxanthine.
Powder for the preparation of Ham's PIO medium, lacking hy­
poxanthine, th,\Tnidine and NaHCO^ components was dissolved in approx­
imately 800ml of freshly collected DD H^O and the following added in
order:
10ml Penicillin (5,000 lUml )̂ and streptomycin




16ml 7.5̂  W/v NaHCO^ or 1.2g powder
14 5
The medium was made up to volume, rendered slightly acidic by 
bubbling CO^ through it and membrane filter sterilised (2.3)•
The medium was stored in 100ml volumes at 4°C protected from 
light and used within 4 weeks.
Thioguanine medium (TG medium):
Modified Ham's PIO medium without hypoxanthine supplemented with 
5^ PBS (MPIO(-HX)v) containing 10 ^  or 30 yiM thio guanine.
lOmM thioguanine stock solution was added to MP10(—HX)% to 
give the desired concentration. The medium was prepared within 
24hr of use and stored at 4°C protected from light.
HAT medium:
Modified PIO medium supplemented with 5^ PBS (MP103T) containing 
10 ^M aminopterin.
1ml 10 aminopterin stock solution was added per 100ml 
of MPIOZ. The medium was prepared within 24hr of use and stored 
at 4°C protected from light.
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R4.6 Design and Validation of Oua Mutation Assay
pWhen assaying mutagenesis by the enumeration of Oua mutants, 
cells were plated, treated with mutagen and then left undis­
turbed except for the addition of selective agent. Such a mut­
agenesis protocol is known as an in situ protocol. In a much 
used alternative schedule, cells are dispersed and respread 
immediately before the addition of selective agent. In this way 
mutant and drug-sensitive cells are separated before selection 
and thus the process of metabolic cooperation, which acts against 
the phenotypic expression of mutants, cannot occur. This re- 
spreading protocol could not be used in the assay of Oua muta- 
tions because it is known that trypsinisation (necessary for the 
dispersal of cells) leads to the loss of newly arisen Oua^ mutant 
cells, probably because they are less able to withstand the action 
of trypsin than wild-type cells (Arlett 1977%).
Apart from mutagen dose and the condition of cells, with 
respect both to growth phase and cell density, at the time of 
mutagen treatment, three major variables are recognised as having 
a potentially significant effect on the recovery of drug-resistant 
mammalian cell mutants as macroscopic colonies:
(1) the drug concentration used for mutant selection;
(2) the length of mutation expression time between 
mutagen exposure and mutant selection, and
(3) the density of cells at the time of mutant sel­
ection.
Each of these variables must be considered whichever of the two alt- 
ernative treatment protocols is used. The routine Oua mutation 
assay used in the present study was established empirically by det­
ermining the optimum conditions for mutant recovery for each of the
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three variables.
4.6,1 Determination of Oua concentration to be used for the 
selection of Oua^ mutants
The yield of Oua colonies following mutagen treatment, was det­
ermined for concentrations of the drug ranging 0.4 - 4*0mI«I. The 
initial cell inoculum per 90mm dish was standardised at 2x10^ 
mutagen-treated cells and the mutation expression time at 48hr.
Aliquots of 2x10 trypsin-dispersed CHO—KIA cells, at pass­
age 33, were inoculated into four $Omm T/C dishes containing 10ml 
MF102 and incubated for 4 hr to allow recovery from trypsinisation 
and for cell attachment. MîfNG at 1.36x10 M concentrations was then 
added to each plate. After 2hr mutagen treatment the culture medium 
was discarded and replaced with 10ml of fresh MFIOY and plates re­
incubated. 46hr later, the medium in each plate vjas replaced with 
10ml of T1F10Z containing a defined concentration of Oua. The 
plates were incubated for a further 7 days, then stained and scored 
for macroscopic colonies (aggregates of 50 or more cells, see 3.3.7)•
The numbers of colonies observed on the plates are given in 
Table 4*1• Plates which had contained Oua at O.^mM showed a 'lawn' 
of cell growth within which no mutant colonies were distinguish­
able. Mutant colonies were easily distinguished in all other plates. 
The results in Table 4*1 are consistent with those of Baker et al.
(1974) who reported that Oua at concentrations ^ I m M  selected for a
subpopulation of CHO cells with overt resistance to the drug. The 
fact that in the present study a slightly higher yield of mutant
colonies was observed in ImM Oua than in 2 or 4niM Oua (see Table 4*l)
p
suggests that certain CHO-Kl cells with marginal Oua can grow at 
this drug concentration. To exclude these cells, which may not be
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true mutants, a more stringent selection condition was adopted as 
standard — exposure to 3mM Oua, a concentration sufficient to re—
pduce Oua mutant yield to a stable basal level, as evidenced by the 
numbers of colonies seen at 2 and 4mM Oua in Table 4.1
pTABLE 4.1 Numbers of Oua" CHO—KIA colonies observed following cell 




Numbers of Colonies 
on 4 replicate plates
Total
colonies
0.4 none distinguishable -
1.0 4, 5, 4i 6 19
2.0 2, 1, 6, 3 12
4.0 2, 2, 5, 5 14
4*6.2 Determination of the optimum mutation expression time for
pthe Oua CHO-Kl phenotype
pThe yield of Oua colonies following mutagen exposure was determined 
after allowing between 27 and 6lhr for mutation expression. 2x10^ 
cells were inoculated per 90mm dish and MF10% containing 3mM Oua 
(Oua medium) was used for mutant selection. As in 4.6.1 above, 
cells were plated before being mutagenized. This procedure has the 
advantage that trypsinisation, which may be lethal to newly arisen
pOua mutants, is not interposed between mutagen treatment and mutant 
selection.
5x10^ CHO—KIA cells at passage 33 were inoculated with 20nl 
MP10% into a 125ml culture bottle. The culture was gassed with 5^ 
CO g in air and incubated at 37*5°C. After 2 days the culture was 
trypsinised and cells added to 8ml MFIOY. Cell density was deter—
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mined by haemocytometer count and a volume of cell suspension con­
taining 4*4x10^ cells added to 210ml of MFIOZ. Twenty 90mm T/C 
dishes were each seeded with 10ml of this medium and 1ml was fur­
ther diluted and used to inoculate 50mm dishes (to serve as sur­
vival plates) with approximately 400 cells/5ml medium.
All plates were boxed, gassed with 5^’ 00^ and incubated for 
3hr to allow recovery from trypsinisation and for cell attachment. 
MNNG was then added to all plates at 4*0x10 M concentration. The 
plates were incubated for a further 2hr, before mutagen treatment 
was terminated by aspirating medium and replacing with fresh MP103C. 
Survival plates were reincubated, undisturbed, for 7 days to allow 
colony formation. Mutant selection plates were removed at inter­
vals and the culture medium replaced with Oua medium. After this 
medium change they were reincubated, undisturbed, until a total 10 
days had elapsed since their initial seeding; then they were stain­
ed, coded and scored blind.
The data obtained are given in Table 4*2. The mutation fre­
quencies, in this as in all other experiments, are calculated as 
the number of mutants per 10^ surviving cells, using the following 
formula;
Observed mutation frequency
total number of mutants x 10^
total number of cells plated plating efficiency of cellsX
into mutant selection plates in parallel survival plates
15 0
P —7TABLE 4*2 Numbers of Oua CHO—KIA colonies induced by 4*OxlO"' M
MTLNG after various mutation expression times
Survival plates (402 cells/plate)
Colonies/plate Mean no. colonies/plate Plating efficiency (̂ )
59, 45, 56, 42 50.5 12.6
Mutant selection plates (2.01x10^ cells/plate)
Expression time 
(hr)*
Colonies/plate Total mutants Mutants/lO^
survivors
27 2, 3, 3, 0, 1 9 71.1
39 5, 5, 1, 2, 2 15 118
51 4, 3, 4, 6, 7 24 190
63 6, 5, 4, 3, 3 21 166
* Interval between initiation of mutagen treatment and mutant 
selection.
The results in Table 4*2, which indicate that mutant recovery is 
optimal after 51hr mutation expression, are in close agreement with 
those of Gupta and Siminovitch (I980) for parental CHO cells. These 
workers reported that following a l6hr treatment with EMS, though 
some mutagen-induced Oua^ variants could be recovered immediately 
after mutagen exposure, i.e. after l6hr mutation expression, a max­
imum steady-state level for the mutation frequency was not achieved 
until 4&-60hr after initiation of mutagen treatment.
p4.6.3 Induction of Oua mutants by EMS and further investigation
p
of the optimum mutation expression time for the Oua CHO-Kl phenotype 
A problem with initial experiments utilising MNNG was that this mut-
p
agen proved to be a rather inefficient inducer of Oua CHO—K1 mutants.
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with the result that the numbers of colonies produced in mutant 
selection plates were low (see Tables 4*1 and 4*2)• Therefore, 
the capability of another mutagen - SMS - to induce mutation to
p
Oua in cell line CHO-Kl was determined. This experiment incor­
porated platings for mutant selection at both 48hr and 72hr post- 
mutagen treatment, to ensure that if EMS-induced mutants had a 
longer optimal mutation expression time than MNNG— induced mutants 
this fact would be evident.
A 2 day-old CHO-KlA culture (initiated with cells at
passage 32) was trypsinised and cells added, in 2m1 of trypsin 
solution, to 8ml of LtPlOlT. Cell density was determined by haemo- 
cytometer count and the cell suspension used to seed MF10% medium 
with approximately 2x10^ cells ml ^. 10ml of seeded medium was 
inoculated into a number of 90mmT/C dishes and a portion further 
diluted and used to inoculate several 50mm dishes (survival plates) 
with approximately 200 cells each. Plates were incubated for 2—4hr 
and then M S  was added (O.&nM) • After l6hr mutagen exposure, med­
ium was aspirated and replaced with fresh ME10%. At 48 and 72hr 
post-initiât ion of mutagen exposure, medium in mutant selection 
plates was replaced with 10ml of Oua medium and that in survival 
plates with 5ml of MF10%. In this experiment a separate set of 
survival plates was included for each mutation expression time. 
Plates were reincubated; survival plates to give a total 8 days in­
cubation and mutant selection plates a total 10 days; then stained, 
coded and randomised and counted blind.
Numbers of colonies obtained in survival and mutant selection 
plates, along with calculated mutation frequencies, are given in 
Table 4.3*
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TABLE 4»3 Numbers of Oua^ CHO-KIA colonies induced by O.&nM EMS 
after 48 aJid 72hr mutation expression
Survival plates (204 cells/plate)
Expression 
time (hr)




48 149,134,145,137,145 142 69*6
72 159,169,148,167,177 164 80.3
Mutant selection plates (?.04x.l0^ cells/plate)
Expression 
time (hr)








Comparing the numbers of colonies per mutant selection plate in Table
4.3 with those in Tables 4*1 and 4*2, it is clear that EMS is capable 
of inducing a far higher yield of Oua mutant colonies than 
Furthermore, the two mutation frequencies calculated from the data in 
Table 4*3 establish that the recovery of EMS—induced Oua mutants is 
no greater at 72hr than at 48hr,
The combined results in Tables 4*2 and 4*3 suggest that foll*- 
owing mutagen treatment of CHO—K1 cells a mutation expression time in
p
the region of 50Nr leads to an optimum recovery of Oua mutants. Con- 
sequently, a mutation expression time of 48-52hr for the Oua pheno­
type was adopted for use in subsequent experiments.
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R4.6,4 The effect of cell density on the recovery of Oua colonies 
It was necessary to investigate the effect of cell density at the
p
time of mutant selection on the recovery of Oua mutants because 
it has been shown that cell crowding during mutagenesis can lead 
to impaired recovery of mutant colonies (Chu and Mailing I968)•
Two approaches were used to determine the range of cell den­
sities over which full mutant recovery was possible. The first 
took the form of a reconstruction experiment, in which a fixed 
number of Qua cells was plated with increasing numbers of wild- 
type, Oua-sensitive (Oua"'), cells and percentage recovery of Oua 
colonies in selective medium subsequently determined. The second 
involved plating different numbers of cells from a non-mutagenized 
wild—type population and determining the frequency of spontaneous 
Oua mutants recovered at different cell densities. This experiment 
was also used to establish the contribution of spontaneous mutants 
amongst wild—type cells to the numbers of Oua^ colonies observed in 
the reconstruction experiment.
Isolation of Oua^ strains of CHO—Kl;
It was necessary to isolate and propagate strains of Oua cells for
the reconstruction experiment,
2x10^ CHO-KIA cells at passage 29 were inoculated into two
90mm T/C dishes with 10ml MF10% and incubated for 4hr to allow cell
—7attachment, MMÎTG was then added to culture medium at 4*0x10 M con­
centration and the plates reincubated. Mutagen exposure was assumed 
to be self-limiting because MMTG has a very short half-life (approx­
imately 15min) in cell culture medium (jensen et al, 1977)• Medium 
was aspirated from both plates after 3 days and replaced with 10ml 
of Oua medium. Plates were incubated for a further 7 days, then one
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discrete colony of Oua^ cells was located on eeich, Medium was as­
pirated and a sterile glass cylinder (5mm I.D. x 10mm high) whose 
bottom edge had been coated with silicone grease was placed over 
each colony. The cylinder was washed out with a few drops of 
trypsin solution and then a few more drops of trypsin were added. 
After 5miu incubation the cells were suspended by gentle aspiration
with a Pasteur pipette and transferred into 5ml of Oua medium in a
2 / R25cm T/C flask. After 7 days growth the two Oua cultures were
trypsinised and each transferred in 20ml of Oua medium to a 125ml
culture bottle. After two days incubation, the cultures were tryp-
5 —1 ^sinised, suspended at 2.5x10 cells ml in Oua medium plus 5a
DM SO and frozen dovm in 2m1 volumes (see 3.3.5). The two independ­
ent cell strains were designated CHO—KIA Oual and CHO-KIA Oua2.
Reconstruction experiment :
Sets of 90mm T/C dishes containing 10ml KP103T were inoculated with 
different numbers of wild—type CHO-KIA cells at passage 33. All 
seeded plates were incubated for 30hr, then 100 Oua^ cells were 
added to each in a 0.1ml volume. These cells were provided by a 
one day—old culture (in Oua medium) of CHO-KIA Oua2 cells at pass­
age 33, which was trypsinised and then diluted in MPIOX. Plates 
were reincubated for 24hr before the medium was replaced with 10ml 
of Oua medium. The plates were incubated for a further 7 days,
p
stained, coded and randomised and Oua colonies counted.
p
Table 4*4 shows the colonial recovery of Oua cells plated 
with between 1x10^ and 8x10^ wild-type cells/90mm dish.
1 5 5
RTABLE 4*4 Recovery of 100 Oua cells as colonies in the presence 
of 3mM Oua when plated with increasing numbers of wild-type cells




0 (unseeded) 81,94,97,93 91.2
1 X  10^ 102,102,104,114 105.5
2 X 10^ 106, 92,119,112 107.2
4 X 10^ 104, 98,102, 97 100.2
8 X 10 5 91,117, 88, 93 97.2
5 5 5Colonies on the unseeded, 1x10 , 2x10 and 4x10 plates were all
of a similar size range and size distribution. However, colonies
on the 8x10^ plates were smaller, denser and more homogeneous with
respect to size distribution. The mean number of Oua^ colonies per
plate increases with the size of the initial inoculum of wild-type
(Oua^) cells, up to a maximimi at 2x10^ cells/dish and decreases at
higher cell densities.
Effect of cell density on the recovery of spontaneous Oua^ mutants: 
The same wild-type CHO-KIA culture as employed in the reconstruc­
tion experiment was used. Sets of four 90mm T/C dishes containing 
10ml MPIOZ were inoculated with 1, 2, 4 and 8x10^ cells. After 54hr 
incubation the medium in all plates was replaced with Oua medium. 
After 7 days re incubât ion, plates were stained and examined for mac­
roscopic colonies. No mutant colonies arose in any of the 16 sel­
ection plates. Thus, this approach to ascertaining the effect of 
cell density on the colonial recovery of Oua^ mutants was unsuccess­
ful, presumably because the spontaneous frequency of mutation to 
Oua in CHO—KIA was too low to yield any mutants in the number of
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6wild-type cells plated i.e. 6x10 .
This result also establishes that spontaneous mutants made 
no contribution to the colony yields observed in the reconstruc­
tion experiment. In the light of the results of that experiment 
(see Table 4#4) initial inoculum of 2x10^ cells per 90mm dish 
was chosen for use in the definitive mutagenesis protocol below,
4*6.5 Definitive mutagenesis protocol
Having determined the optimum conditions for recovery of Oua 
CHO-KIA colonies with respect to concentration of Oua in select­
ive medium (4.6.1); phenotypic expression time for mutations 
(4.6.2/4.6.3); and initial inoculum of cells in mutant selection plates, 
(4.6.4) the following definitive mutagenesis protocol was evolved.
A volume of MF10% medium (warmed at 30°C) was seeded with 
trypsin-dispersed CHO-KIA cells at an accurately known density 
close to 2x10^ cells ml ^. 90mm T/c dishes were each inoculated 
with 10ml of this medium cell suspension, to serve as mutant sel­
ection plates. After further dilution, a portion of the seeded 
medium was also used to inoculate 50mm dishes with between 100 and 
1000 cells (depending on the expected cytotoxicity of the mutagen) 
in ^ 1  MFIOY^ for survival plates. After allowing sufficient in­
cubation time for recovery from trypsinisation and for cell attach­
ment (at least 2hr), plates were dosed with mutagen. At the end of 
the mutagen exposure period medium was aspirated and replaced with 
fresh MFIOY. Plates were re incubated. 4^52hr after initiation of 
mutagen exposure the medium in the mutant selection plates was re­
placed with 10ml of Oua medium and that in parallel survival plates 
with 5rnl of MFIOY. Following this medium change, plates were incub­
ated for a further 6 (survival plates) or 7 days (selection plates).
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then stained, coded and randomised and counted ’blind’ (3.3.7)•
4.6.6 Statistical tests
Significance tests of differences between any apparently elevated
R Rfrequencies of mutation to Oua (and later TG ) in TPA—treated
cell populations and mutation frequencies in corresponding TPA-
untreated populations were done by the method of Stevens (1942).
This method was previously used by Trosko and Chang (1976) to test
the statistical significance of any effect of TPA on spontaneous
or mutagen-elevated mutation frequency in V79 cells. It involves
the calculation of an upper probability limit for the control
mutation frequency. Any mutation frequency higher than this limit
is assumed to be significantly elevated above control level. All
tests were one-tailed and carried out at the 5^ significance level
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4»7 The Effect of TPA on MNNG—Induced Mutation to Oua^
The tumour promoter TPA has been reported to enhance the recovery
p
of Oua mutants from V79 Chinese hamster cell populations prev­
iously treated with the chemical mutagen MNNG (Lankas et al.1977) • 
Therefore, as the first part of the study of the influence of TPA 
on mutagenesis in CHO-Kl its effects on the recovery of Oua^ mut­
ants induced by MNNG were investigated.For the reasons detailed in 
4.4* the phorbol ester was employed at 1.6x10 concentration in 
all experiments.
4.7.1 Initial investigation
In the initial investigation TPA was added to cells immediately 
after mutagen treatment and then maintained in the culture medium 
for the remainder of the mutation expression period and throughout 
mutant selection, i.e. cells were continuously exposed to the pro­
moter from the end of mutagen treatment until mutant colonies were 
scored. This was to ensure that if cells were only susceptible to 
a mutagenesis-enhancing activity of TPA at a particular stage after 
mutagen treatment, they would be undergoing promoter treatment at 
that time. Trosko et al. (1977) report that in such a treatment 
regime TPA strongly enhances the recovery of mutagen—induced Oua 
V79 cells.
The effect of TPA on the recovery of M T G —induced Oua" mut­
ants and its effect on the recovery of spontaneous mutants in the 
same treatment regime were examined. Four different treatments 
were therefore included — control, TPA alone, MNNG alone and MNNG-+ 
TPA.
The experimental procedure followed the definitive mutagenesis 
protocol (4.6.5.). CHO—KIA cells at passage 37 were plated into four
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batches of mutant selection and survival plates (one for each treat­
ment) and incubated for 3hr to allow cell attachment, MNNG (2.72x 
10 "̂M) or MNNG vehicle (H^O, 10 pl/ml medium) was then added to the 
culture medium. After 2hr mutagen exposure the medium in all plates 
was replaced with fresh MFIOY. TPA or TPA vehicle (DMSO, 1 pl/ml 
medium) was added to plates (TPA from batch 2, see 2.10.2). Foll­
owing a further 48hr incubation, medium in selection plates was re­
placed with Oua medium and that in survival plates with MFIOY. TPA 
or TPA vehicle was added as before. Plates were reincubated, then 
stained and counted after 6 (survival plates) or 7 days (mutant sel­
ection plates).
The numbers of cells plated and mutant colonies recovered, 
the plating efficiencies of cells and the calculated mutation fre­
quencies are given in Table 4*5» together with a diagram summarising
the experimental procedure. The mutant yields and mutation frequen­
cies observed following control and TPA treatments (see Table 4*5) 
show that the tumour promoter did not elevate the frequency of spon-
ptaneous mutation to Oua , this result implying that TPA is non-mut- 
agenic in the Oua system.
With regard to the effect of TPA on MNNG—Induced mutation to 
Oua , firm conclusions cannot be drawn, since the mutation frequency 
following MNNG + TPA treatment was not significant ly higher than 
that following MNNG treatment alone at the 5^ level. However, the 
fact that both the yield of mutants and the mutation frequency were 
higher when mutagen treatment was followed by exposure to TPA sugg­
ested that the promoter might be capable of enhancing induced mutation 
to Oua^ in CHO-Kl cells. It is noteworthy that TPA had no effect on 
the reduced cell plating efficiency seen following MNNG treatment#
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4.7*2 Further investigations of the effect of TPA on M M G —induced
pmutation to Oua
The results presented in Table 4*5 prompted a fuller study of the 
effects of TPA on MH-JG mutagenesis in the Oua system. A series 
of experiments were conducted, in which TPA was presented to CHO- 
Kl cells for different intervals following mutagen treatment, in 
an attempt to establish unequivocally whether or not the tumour 
promoter can act as a co-mutagen.
TPA expos’ure from early mutation expression until the end of mut­
ant selection ;
In the first experiments of the series cells were continuously ex­
posed to the tumour promoter from 3hr after mutagen addition until 
the end of mutant selection,
CHO-KIA cells were plated into mutant selection and survival
•-7plates and incubated for 3-4hr, MNNG (3.40x10 M) was then added 
to the culture medium. In this and all succeeding experiments in 
which MHIIG was employed, the Î IHHG treatment was assumed to be self- 
limiting and a terminating medium change therefore unnecessary. 3hr 
after addition of mutagen, TPA (from batch 2) or TPA vehicle was 
added to each plate. 48hr later the medium in mutant selection 
plates was replaced with Oua medium and that in survival plates with 
MFIOY. TPA or TPA vehicle was added as before. Plates were rein­
cubated and macroscopic colonies scored after 6 or 7 days as in the 
definitive mutagenesis protocol (4.6.5) *
The data obtained in duplicate experiments (l and II) each 
using CHO-KIA cells at passage 33, are given in Table 4*6. The re­
sults show that the mutation frequency observed after MNNG TPA 
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M M G  treatment alone. As in the previous experiment (see Table 
4.5) TPA is without effect on the plating efficiency of cells foll­
owing IIMTG treatment but causes an increase in the yield of mutant 
colonies on mutant selection plates.
TPA exposure from late mutation expression until the end of mut­
ant selection :
The results in Table 4*5 snd 4*6 indicate that TPA is capable of 
enhancing MÎTG mutagenesis in the Qua system, Lankas et al.(1977) 
and Trosko et al, (1977) report that for V79 cells, maximal TPA en­
hancement of mutagenesis occurs when promoter exposure is started 
near the end of the period allowed for phenotypic expression of 
mutations and continued throughout mutant selection. Therefore, 
experiments were undertaken to determine whether greater enhance­
ment of mutagenesis by TPA in CHO—K1 occurs when this treatment re­
gime is used.
CHO—KIA cells were plated into mutant selection and survival 
plates and incubated for 4hr« MHNG (3*40x10 Tu) was then added to 
the culture medium. 43hr after addition of I'lHI'IG, TPA (from batch 2) 
or TPA vehicle were added to each plate, 7hr later the medium in 
mutant selection plates was replaced with Oua medium and that in 
survival plates with ITPIOY, TPA or TPA vehicle was added as before 
and the plates reincubated, Macroscopic colonies were scored in the 
usual way (4*6,5)•
The data from duplicate experiments using CHO—KIA cells at 
passage 33 are given in Table 4*7* The data give no indication of 
an enhancement of mutagenesis by TPA, The observation of a slightly 
higher (though not significantly elevated) mutation frequency foll­
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opposite observation in experiment II. Indeed, mean mutation fre­
quencies are closely comparable, $1.8 mutants/lO^ survivors for the 
two MlvNG treatments and 88.1 mutants/lO^ survivors for the MNNG + 
TPA treatments. Thus, in this treatment regime TPA shows no co— 
mutagenic activity.
TPA exposure during mutation expression only;
The results in Table 4*7 showed that TPA was incapable of enhanc­
ing mutagenesis when presented to mutagenized cells just prior to 
and for the duration of mutant selection. Experiments were there­
fore conducted to determine if the tumour promoter can enhance mut­
agenesis when cell exposure is confined to the period allowed for 
the phenotypic expression of induced mutations.
As in the other experiments reported above, cells were plated 
and after allowing time for attachment (3hr), the culture medium was 
dosed with 3»40xlO""^M MIIIIG. 3hr later TPA (from batch 3) or TPA 
vehicle was added to each plate. After a further 48hr, medium was 
replaced with Qua medium (selection plates) or MF10% (survival 
plates). All plates were reincubated and macroscopic colonies scor­
ed 6 or 7 days later.
Duplicate experiments were carried out using CHO—KIA cultures 
at passage 32. Results are given in Table 4»8* Exposure to TPA 
for the duration of mutation expression resulted in higher mutant 
yields and mutation frequencies in both experiments. However, in 
neither case does the increase represent significant elevation above 
the mutation frequency observed following MNNG alone.
The results of the above series of experiments suggest that 
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Rthe Oua mutation assay system. However, it appears that a signif­
icant enhancement of mutation is not observed unless TPA is pre­
sented to cells immediately after mutagen treatment and maintained 
in the cell culture medium throughout mutation expression and mut­
ant selection periods.
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R4.8 The Effect of TPA on EMS—Induced Mutation to Oua 
M S  was shown to he an efficient inducer of Oua^ mutants in CHO—KI, 
capable of eliciting high yields of mutant colonies (see 4.6.3)• 
Therefore, when the study of the effect of TPA on mutation to Oua 
in CHO-Kl was extended, by looking at its influence on mutation 
induced by agents other than MNHC, M S  was utilised.
MNNG experiments indicated that to have a co-mutagenic effect 
TPA must be present continuously after mutagen treatment of cells. 
Therefore this promoter treatment regime was used in all EMS exper­
iments. Preliminary experiments indicated that higher and more con­
sistent yields of mutants are obtained following long-term (l6hr) 
exposure to low concentrations of EMS (<1.6ml>'l) than after short­
term (2hr) high concentration exposure (^1.6ml>l). Consequently M S  
was added to cells at 0.8mM, a virtually non—toxic concentration, 
and exposure continued for l6hr. This treatment routine had the 
attraction that it induced large numbers of mutants but had little 
effect on cell viability and was therefore akin to the situation in 
two—stage tumour formation in mouse skin, in which the initiating 
carcinogen has no lethal effect on epidermal cells but causes impor­
tant heritable changes in certain of these cells (Boutwell 1974)•
As in the M U G  experiments the definitive mutagenesis protocol
(4.6.5) was used. Cells were plated into mutant selection and sur­
vival plates and incubated for 2-4hr. EMS or M S  vehicle (5 pi H^O/ 
ml medium) was then added to the culture medium. After l6hr mutagen 
exposure, medium in all plates was replaced with fresh MF10%. TPA 
(from batch 3) or TPA vehicle (l ^1 DMSO/ml medium) was added to each 
plate. Following a further 32hr incubation, medium in selection plates 
was replaced with Oua medium and that in survival plates with MF10%.
TPA or TPA vehicle was added as before, then plates were re incubated,
1 6 9
stained and counted in the usual way.
The date from duplicate experiments (I and II) are given in 
Table 4«9« Cells used in experiment I were at passage 32; those 
in experiment II at passage 35* The effect of TPA on the spontan-
peous frequency of mutation to Oua was also determined - experiment 
III using cells at passage 32.
The results of experiments I and II show that both the yield 
of mutant colonies and the mutation frequency were unaffected when 
M S  treatment was followed by TPA exposure. These results there­
fore indicate that, in the treatment regime described, TPA has no
p
influence on EMS—induced mutation to Oua in CHO—Kl cells. Not 
surprisingly, under the same conditions, the promoter also has no 
effect on the recovery of spontaneous CHO—Kl Oua mutants (experi­
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4.9 The Effect of TPA on UV Light-Induced Mutation to Oua^
Having investigated the effects of TPA on chemically-induced muta- 
tion to Oua , experiments were conducted to investigate its effect 
on the recovery of Oua^ CHO-Kl mutants induced by the physical mut­
agen UV light. Trosko et al. (1977) report that TPA can enhance UV 
mutagenesis in V79 cells when presented at various times post- 
irradiation. Hear maximal mutation enhancement is observed when 
cells are exposed to the tumour promoter immediately after mutagen 
treatment and throughout mutation expression and mutant saLection.
This promoter treatment regime was therefore used in these studies.
Although the experimental procedure was essentially as in the 
MHNG (4.7.2) and ETÜS experiments (4.8), there was one necessary 
difference. Instead of plating cells prior to mutagen exposure, a 
large population was treated in a 90mm T/C dish, immediately dis­
persed in trypsin solution and then plated into survival and mut­
ant selection plates. Because of the very short mutagen exposure
ptime loss of newly expressed Oua mutants, due to the action of 
trypsin (see 4.6), was not a problem.
In each experiment 3x10^ CHO-KlA cells/lOml MP103T were inoc­
ulated into a 90mm T/C dish. After 5 ^  incubation, culture medium 
was removed and replaced with of phosphate buffered saline with­
out Ca^^ and Mĝ '*’ ions (PBS(a) , see 2.8.2) . Within a fixed lOmin
period the cells were irradiated with 25Jm 254^ wave length UV
-2 -1 /light at an incident dose rate of 0.075Jni s (for UV light source 
see 2.10.1) . The PBS(a) was then aspirated, 1ml of trypsin solu­
tion added and the plate incubated at 37«5*̂ 0 for 5—TOmin. Cells were 
suspended and transferred to a l6mm T/C test tube. The tube was cen­
trifuged, the sedimented cells re suspended in 5nil of fresh MPIOV and 
cell density determined by haemocytometer count. The cell suspen—
1 7 2
s ion was used to seed a volume of MP10% with approximately 2x10^ 
cells ml  ̂and 10ml of this seeded medium was added to each of 10 
90mm dishes (mutant selection plates)• The seeded medium was also 
further diluted and approximately 200 cells/^ml MP10% inoculated 
into 8 50mm dishes (survival plates). Half of each hatch of plates 
was subsequently dosed with TPA (batch 3) and the remainder with 
TPA vehicle.
After 48 hr incubation, routine medium replacement was carr­
ied out and TPA or TPA vehicle added as before. Colonies in sur­
vival and mutant selection plates were scored after 6 and 7 days 
further incubation respectively. Data obtained in replicate ex­
periments using cells at passage 33 are given in Table 4*10.
The mutant yields and mutation frequencies in Table 4*10 in­
dicate that in the case of the Oua system TPA has no co-mutagenic 
effect in CHO-Kl cells mutagenized with UV light. A noteworthy 
observation is that in all three experiments TPA reduced cell via­





















































P0 H rH ü pu 'H Ch Ch 0
0 X—X-P 0 0 0 rH -P ft 0
0 ft 
rH • 






(TV O o iHCVJ LTV 00 CVJ VO OVvo VO ’0- '4- rn
rn orO mCVJ mcv; oo
CVJ LTV O irv CVJ 00

























4.10 The Effect of TPA on Spontaneous and EMS-Induced Mutation 
to TG^
An investigation was undertaken to determine the effect of TPA on
pthe frequency of both spontaneous and induced mutation to TG" in 
CHO-Kl, to compare with findings in the Oua mutant selection sys­
tem. M S  was chosen as the model mutagen in this study because 
O'Meill and Hsie (l977, 1979) report this agent to be an efficient 
induced of stable TG^ CHO-Kl mutants. In all experiments TPA was 
maintained in the culture medium from the termination of mutagen 
treatment until the scoring of mutant colonies.
p4.10.1 TG Mutagenesis protocol
p
Quantitation of the frequency of mutation to TG employed essenti­
ally the method of O'Neill et al. (1977).
5x10^ CHO-KlA cells were inoculated into 25cm^ T/C flasks in 
5m 1 of modified Ham’s FIO medium, lacking hypoxanthine, supplement­
ed with 5^ FBS (MF10(-HX)%) . After a 20-24hr growth period, M S  
(O.&nM) or vehicle was added to each culture. 24-hr later culture
medium was removed and the cells, after a 5>t̂1 PBS wash, were dis­
persed in 1ml of trypsin solution and transferred with 5̂ :1 of 
MF10(-HX)% to a l6mm T/C tube. The cells were sedimented by cen­
trifugation and re suspended in 3m1 of fresh medium. Cell density 
was determined by haemocytometer count. A portion of the cell sus­
pension was diluted and 200 cells/5ml KF10(—HX)% plated into four 
50mm dishes, for initial cell survival determination. For the mea­
surement of mutant induction, five 90mm dishes were each seeded with 
1.5x10^ treated cells in 10ml of TG medium containing 10 pMTG (see 
4.5.2). From the remaining suspension 10^ cells were inoculated in­
to a 12^1 culture bottle with 20ml MF10(-HX)3T. This culture vjas
1 7 5
sub—cultured every 2 days. At each subculture, five x 1.5x10^ cells 
were plated for mutant selection and parallel survival plates inoc­
ulated for determination of plating efficiency. Mutant selection 
and survival plates were stained and counted following 7 and 7—8 
days incubation respectively. Time of mutagen addition was desig­
nated day 0. Cells were plated as described on day 1, immediately 
following mutagen treatment and on days 3, 5i 7» 9 and 11. On day 
11, ten mutant selection plates were initiated. After 5 daj'-s in­
cubation, the developing TG^ colonies in five of these plates were 
tested for the ability of grovrth in IL'iT medium (4.5*2), to deter­
mine the proportion that were true HGPRT mutant colonies (see 4*2). 
The TG medium was replaced with HAT medium and the plates incubated 
for a further 4 days before colonies were stained and counted.
Yields of presumptive HGPRT"*" colonies in HAT plates were expressed 
as a percentage of colonies in parallel TG plates.
4*10.2 Initial experiment
CHO—KIA cells which had been pregrown for one passage interval 
(33 - 34) in MP10(-HX)% were inoculated into four 25cm^ T/C flasks. 
These cultures were treated and processed as described above (4*10.1) 
except that TPA (1.6x10 ^M, from batch 3) or TPA vehicle was added 
to culture medium immediately following mutagen (or vehicle) treat­
ment and subsequently renewed in each subculture of the cell popu­
lation. The tumour promoter was also added to all mutant selection 
and survival plates. Thus TPA was present throughout the mutation 
expression and selection periods and four treatment modes were in­
cluded in the experiment - control (MS vehicle + TPA vehicle) ; TPA 
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Initial cell survivals and mutation frequencies on days 1,
31 5» 7» 9 11 post-addition of mutagen, for the four different
treatment modes, are given in Table 4*ld« Mutation frequencies are 
plotted as a function of mutation expression time in Fig 4*2.
The developing colonies in half of the day 11 ELIS and M S  + 
TPA mutant selection plates were tested for the ability to survive 
and grow in HAT medium (without TPA or TPA vehicle) . The numbers 
of colonies which developed in HAT medium are given, along with the 
numbers of colonies in parallel TG plates, in Table 4*12.
TABLE 4*12 Ability of TG variants induced by EMS and recovered 
in 10 TG medium with and without TPA present to develop in HAT 
medium
Colonies in Colonies in
Recovery of 
TG^ variants in
Treatment HAT plates TG plates HAT medium(^)
EMS+DMSO
*
12,7,17,14,9 (11.8) 53,67,57,82,80(67.8) 17.4
EMS+TPA 20,14,5,16,16(14.2) 92,80,91,80,75(83.6) 17*0
* Mean number of colonies per plate
The mutation frequency/expression time profile in Pig. 4*2 shows a 
rise to peak mutant recovery at between 7 aJid 9 days following BATS 
treatment of cells. A rise to maxim un mutation frequency at 7 days 
post-mutagen treatment was reported in this same CH0-4C1/TG^ system 
by O'Neill et al. (1977) and O'Neill and Hsie (1977). However, in 
contrast to the data in Pig. 4*2 these workers reported no subsequent 
loss of mutant cells during subculture until at least the 13th day 
of mutation expression.
The control (spontaneous) mutation frequency in this experiment
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was very high compared with reported values (O'Neill and Hsie 1977)»
pparticularly at longer expression times, suggesting that a TG sub- 
population was present in the control culture which further expand­
ed with time. The observation that approximately 17^ of MS-induced
p
TG variants were capable of growth in HAT medium (Table 4*12) im­
plies that some variants were 'leaky' mutants, i.e. were not com­
pletely HGPRT , retaining a less efficient enzyme or a smaller 
amount of the normal one.
It appears from Table 4*11 and Pig. 4*2 that while TPA does
pnot enhance the frequency of spontaneous mutation to TG , it can 
act as a co-mutagen in this system. Without having any noticeable
peffect on the expression time of the TG CHO—Kl phenotype, the tum­
our promoter not only increased the number of mutants/lO^ survivors 
but also the actual numbers of mutants recovered in selection plates, 
The coHTiutagenic effect of the promoter was clearly evident on days 
7 and 11,in which cases the M S  + TPA mutation frequency was signif­
icant ly higher than the M S  mutation frequency.
4.10.3 Modified experiment
In order to confirm the effects of TPA on spontaneous and M S  — in-
pduced mutation to TG in CHO-Kl it was necessary to make the follow­
ing modifications to the protocol used in 4*10.2 above.
(1) HGPRT^ cell strains were isolated and propag­
ated in HAT medium and cells from one of these pop­
ulations, grown in HAT medium for the penultimate 
passage interval, were used. This to minimise the 
frequency of spontaneous TG^ mutants.
(2) Two large cell cultures were treated with either 
M S  or M S  vehicle. Each was subsequently divided
18 0
into two - one culture to be treated with TPA and 
the other with TPA vehicle. This ensured that both 
EMS— and EMS+TPA-treated cultures and control and 
TPA-treated cultures initially received identical 
mutagen or vehicle treatments.
(3) Because maximal mutation induction is not ach­
ieved in the TG system until after approximately 7 
days mutation expression (see Fig. 4«2.) cells were 
first plated into TG medium 6 days after mutagen 
treatment and subsequently on days 8 and 11.
(4) Mutant selection conditions were made more strin­
gent, by increasing the concentration of TG in the 
selective medium from 10 to 30 to reduce the
/ \ Rproportion of leaky mutants amongst recovered TG 
colonies.
Isolation of HGPRT"*" cell strains:
50 CHO—KIA cells at passage 31 were inoculated into each of 4 50mm 
T/c dishes containing 4ml of HAT medium and 10—20 sterilised cover- 
slip pieces. The plates were incubated for 3 days. Coverslip pie­
ces bearing one cell colony were located and transferred to tubes 
containing 2ml of HAT medium. Tubes were incubated for 4 dâ -'s to 
allow propagation of the presumptive clonal populations, then cells 
were trypsinised and transferred to 125ml culture bottles contain­
ing 15ml of HAT medium. After 3 days, cells in each culture were 
dispersed by trypsinisation and HAT medium renewed. When cells were 
between 50 and 80^ confluent they were frozen down in MFIOZ medium
(3.3.5)" Two HGPRT**" cell strains designated CHO—KIA HATl and CHO— 
KIA HAT2, were obtained.
18 1
Experimental procedure:
1.5x10^ CHO—KIA HATl cells at passage 37» which had been grown in 
HAT medium between passage 35 ^<1 36» were inoculated into each of 
two 75cm^ T/c flasks with 20ml MF10(—HX)l, After a 20-24hr growth 
period, O.&nM EMS was added to one culture and EMS vehicle (H^O,
0*5^ V/v) to the other. 24hr later, medium was discarded from each 
flask, cells washed with 10ml of PBS, suspended in 1.5ml of trypsin 
solution and then transferred to a l6mm T/C tube. After centrifug­
ation cells were resuspended in 5ml of medium and cell density det­
ermined. To measure initial cell survival, 200 cells were plated 
into quadruplicate 50mm dishes with 5m1 MF10(—HX)X and incubated 
for 7 days. For mutation frequency determinations, 10^ cells were 
inoculated with 15ml of MF10(-H%)% into each of two 75cm^ flasks. 
These cultures were subcultured every 2-3 days and plated on days
R
6, 8 and 11 for mutation frequency determination as in the TG mut­
agenesis protocol, excepting that selection was in medium containing 
30 ^  TG. One EMS and one control culture were treated with TPA 
throughout mutation expression and selection, the promoter being re­
newed in the culture medium at each subculture and added to both mut­
ant selection and survival plates. The two other cultures were corr­
espondingly treated with DMSO (TPA vehicle). As in the initial ex­
periment, the developing colonies in half the mutant selection pla­
tes inoculated on day 11 were tested for the ability to grow in HAT 
medium.
Initial cell survivals and mutation frequencies at the differ­
ent expression times for the four different treatment modes are giv—
p
en in Table 4*13" The numbers of TG colonies from both EMS— and EMS 
+ TPA-treated cell populations which continued to develop in HAT med­
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Rof the numher of TG variants which gave rise to colonies in para­
llel TG plates.
p
TABLE 4*14 Ability of TG variants induced by SMS and recovered in 
30 pM TG medium with and without TPA present to develop in HAT med­
ium.
Recovery of
Colonies in Colonies in TG^ variants inTreatment HAT plates TG plates HAT medium(^)
EMS+DMSO 7,4,4,3,5(4.6)* 45,34,47,39,48(42.6) 10.7
EMS+TPA 5,16,9,15,12(11.4) 69,65,62,87,57(68.0) 16.8
* Mean number of colonies per plate
The results in Table 4*13, when compared with those in Table 
4.11, establish that the CHO—KIA HATl cells specially isolated for
R
use in this experiment contained far fewer spontaneous TG mutants 
than the wild—type cells used in the initial experiment. They also 
show that the mutation frequencies, determined at comparable ex­
pression times, following identical mutagen/promoter exposures, 
were appreciably reduced (by'V5O^0 in this study. Furthermore, 
whereas in the previous experiment a decline in maximal M S —elevat­
ed mutation frequency was observed after 11 days expression, a stab­
le plateau for the mutation frequency is evident from daj;- 6 to day 
11 in Table 4.13. The average of the mutation frequencies at days 
6, 8 and 11 can thus be given as a mean mutation frequency for each 
of the four different treatment modes.
Once more it was found that TPA does not induce TG^ mutations 
in CHO-Kl cells per se. Importantly, the promoter again displayed 
a co-mutagenic action in SMS-treated cells — the mean mutation fre-
18 4
quency in the cell population treated with EMS + TPA being 42^ 
higher than in that treated with EMS + CM SO. The observed en­
hancement of mutagenesis was more consistent at different mut­
ation expression times and also greater than in the previous ex­
periment (average enhancement over days 7, 9, and 11, 18.% .  In 
this study, TPA was also found to increase the number of EMS— 
induced TG^ variants which could grow in HAT medium (Table 4*14)• 
However, even when mean mutation frequencies were adjusted so 
that they only included mutants which were presumably completely 
HGPRT deficient, the corrected mean for EMS + TPA at 405*5 mut­
ant s/lO^ survivors was still 32^ higher than the 306.2 mutants 
/lO^ survivors for EÎÎS + Î !SO.
1 8 5
4*11 Discussion
Tumour promotion in vivo may occur as a result of the enhancement 
of mutagenesis induced by an initiating carcinogen in cells of the 
target tissue. The mouse skin tumour promoter TPA has been re­
ported to have such a co-nnutagenic effect in both bacterial and 
mammalian cells in vitro (4*3) • The aim of the present study was 
to determine whether TPA possesses co-mutagenic activity in the 
CHO—KIA subclone of the previously untested established mammalian 
cell line CHO—Kl. By examining the effect of the promoter on in­
duced mutation yields in two complementary mutation assays ( the 
Oua and TG systems) and by the use of three different mutagens, 
it was hoped to obtain an indication as to the types of mutagenic 
event, if any, that might be potentiated by TPA in CHO-Kl cells.
pIn the design and validation of an in situ Oua mutation 
assay (4.6) three crucial variables were examined with regard to
Rthe optimum conditions for the recovery of the CH0-4C1A Oua phen­
otype — drug concentration for mutant selection, mutation express­
ion time and cell density in mutant selection plates. In an init­
ial experiment (4.6*1) the yield of Oua^ colonies, following a 2hr
n
1.36x10 M MHNG treatment of cells, was determined for concentra­
tions of the drug ranging 0.4 — 4.0mM. The results, (Table 4*1) 
suggested the adoption of 3mM Oua as a standard concentration for 
the selection of mutants and are consistent with the findings of 
Gupta and Siminovitch (I980) that this Oua concentration is optimal
Rfor the selection of the Oua phenotype in cells of CHO-Kl's parent­
al line, CHO.
With regard to the mutation expression time, it was found 
that following a 2hr 4*0x10 M MNNG treatment the mutation fre­
quency, expressed as the number of mutants per 10^ survivors, was
18 6
maximal at after initiation of mutagen exposure (see Table
4.2). Moreover, it was established that the yield of EMS-induc-
R
ed Oua mutants was no greater after 72hr mutation expression than 
after 48hr (Table 4*3)» These findings are closely comparable with
Rresults for CHO cells, which show a maximum level for induced Oua 
mutation frequency by 4&-60hr after initiation of mutagen (EMS) 
treatment (Gupta and Siminovitch I980)• Maximal expression of the
R
Oua phenotype is also achieved by approximately 48hr in L5178Y 
mouse lymphoma cells (Cole and Arlett 1976) and V79 Chinese hamster 
cells (Arlett 1977a and b), Mutation expression times ranging 48- 
52hr were therefore used in all subsequent experiments.
The apparent decline in peak mutation frequency observed at 
expression times of 63 and 72 hr (Table 4*2 and 4*3) has been re­
ported for CHO cells but only after an expression time of 100—120hr 
(Gupta and Siminovitch I980). However, in the mutation assay employ­
ed with CHO, cells were treated with mutagen and allowed to undergo 
mutation expression while continuously maintained in suspension cul­
ture, then plated into Oua-containing medium at the time of mutant 
selection in a manner akin to a re spreading protocol (4.6). This 
experimental procedure has the advantage that mechanisms which act 
to suppress the phenotypic expression and colonial out-growth of 
mutants after extended mutation expression times in situ do not op­
erate and so a plateau, rather than a peak, for the mutation frequen­
cy may be expected (Cole and Arlett 1976, Arlett 1977a and b). When
ROua V79 cells were induced and selected in an in situ protocol 
similar to that used in the present study, an early decline in mut­
ation frequency, after a peak level at about 48hr, was likewise ob­
served (Arlett 1977a and b) .
Cell crowding during mutagenesis can lead to impaired recovery
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of mutant colonies (Chu and Mailing 1968, Abbondandolo 1977) • The 
range of cell densities over which maximal mutant recovery was 
possible in the CHO—Kl/Oua^ system was therefore investigated 
(4*6,4) • Initially two Oua^ cell strains were isolated and propa­
gated, In a reconstruction experiment 100 cells from one of these 
strains (CHO-KlA Oua2) were then plated into 90mm T/C dishes seeded 
(24hr earlier) with between 1x10^ and 8x10^ wild-type (Oua^) cells. 
Percentage colonial recovery of Oua^ cells in Oua medium (added 24 
hr later) was subsequently determined. The results (Table 4*4)
Rshow that cell density had a moderate effect on the yield of Oua
R
mutants. The observed increase in plating efficiency of Oua cells 
with the size of the initial inoculum of wild-type cells (up to 
2x10^ cells/90mm dish) may reflect a feeder layer effect,whereby 
the large number of wild-type cells facilitate the colonial grov;th
Rof single Oua cells. The subsequent reduction in the number of
R  C C
Oua colonies, at initial inocula of 4x10 and 8x10 wild-type 
cells per dish, may be explained by molecular exchanges, or more 
likely-given the ion pumping activity of the Na'*/K'*'A?Tase enzyme 
affected in Oua^ mutations (4 *2)—ionic exchanges between cells dur­
ing the process of metabolic cooperation, rendering mutants pheno- 
typically normal. However, though metabolic cooperation has been
Rshown to operate in the Oua selective system in other cell types 
(Corsaro and Migeon 1977), CHO cells have been reported not to en­
gage in this process (Thompson et al. I98O, Kinsella I981) . Thus 
the observed reduction in mutant yield might, instead, be due to 
significant nutrient depletion of the culture medium prior to the
Raddition of Oua cells, or the inability of a proportion of these 
cells to attach to the crowded culture surface. As a consequence of 
the results of this investigation an initial inoculum of 2x10^ cells
18 8
per 90mm dish was used routinely in subsequent experiments.
An experiment,originally intended to determine both the eff-
p
ect of cell density on the colonial recovery of spontaneous Qua 
mutants from the wild-type CHO—EL population and the contribution
p
made by spontaneous mutants to the numbers of Qua colonies observ­
ed in the reconstruction experiment, revealed that in a total 6x10^ 
wild-type cells no Qua mutants were recoverable. Assuming the nor­
mal 80^ plating efficiency of CKO-KIA cells routinely achieved in
pother experiments, this means that recoverable Oua* cells occurred
7at a frequency of less than 2.1 mutants per 10 viable cells in the 
wild-type population. This finding is closely comparable with the 
results of Baker et al.(1974) who report that Oua cells occur at a
7frequency as low as 1 mutant per 10 viable cells in OHO populations.
pA low spontaneous frequency of mutation to Oua is likewise reported 
in V79 Chinese hamster (Arlett 1977a) and L5I78Y mouse lymphoma 
cells (Cole and Arlett 1976).
The above preliminary experiments established that optimal 
conditions for the expression and selection of the mutagen-induced
pOua phenotype of CHO—K1 were essentially as reported for the recov—
pery of Oua mutants from other established cell lines and that the
pfrequency of spontaneous Oua mutants in the wild-type CHO—K1 pop­
ulation was extremely low.
Having derived a protocol for the induction and selection of 
Oua^ CHO—K1 mutants (4.6.5), the effects of TPA at 1.6x10 concen­
tration on MÎTNG—elevated mutation frequencies were investigated. In 
an initial experiment cells were exposed to TPA throughout mutation 
expression and selection (4*7*l). The promoter caused no increase 
in control mutation frequency i.e. was non-mutagenic per se, as pre­
viously reported with the Oua system in V79 Chinese hamster cells
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(Lankas et al. 1977, Trosko et al. 1977) and had no effect on the 
toxicity of 2.72x10 l'tTH'ÎG (Table 4*5) • However, the number of 
mutant colonies and hence the mutation frequency, was higher foll­
owing EHHG + TPA treatment than following MHHG alone. Although 
statistical analysis of data showed the apparent increase in mut­
ation yield on TPA exposure not to be significant at the 55̂ level, 
further experiments were warranted to establish unequivocally 
whether or not the promoter could act to enhance I'HIHG mutagenesis.
In a series of experiments (4*7.2) TPA was presented to CHO—
K1 cells for different intervals following 3*40x10 HHHG treat­
ment, Unlike the original experiment, a medium change to end mut­
agen treatment was omitted. IHH-JG is known to have a very short 
half-life in mammalian cell culture medium at 37°C (jensen et al. 
1977). Furthermore, O'Neill et al. (1977) report that after 2hr 
at 37°C in Ham's FIO medium supplemented with 5̂ ' FBS, MNNG, at be­
tween 1,70x10"" and 6.8x10" M concentration, has no further muta­
genic effect on CHO-Kl cells. Thus the assumption that, under the 
almost identical conditions of the current experiments, MUtNG treat­
ment was self—limiting is well justified.
When cells were continuously exposed to the tumour promoter 
from 3hr after mutagen addition until the end of mutant selection 
it was found (see Table 4*6) that the mutation frequency was signif­
icant ly elevated above that observed following treatment with LHING 
alone. TPA actually increased the yield of mutants without affect­
ing the plating efficiency of HNNG-treated cells. This establishes 
that TPA enhancement of mutation frequency was not an artefact, due 
to a reduction in cell plating efficiency in survival plates which 
did not correspondingly occur in more densely populated mutant sel­
ection plates.
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Both Lankas et al. (1977) and Trosko et al. (1977) report 
that for V79 cells maximal TPA enhancement of induced mutation to
pOua occurs when cells are exposed to the promoter from towards the 
end of a 48hr period allowed for mutation expression (final 6hr) and 
throughout the mutant selection period. However, when a similar 
treatment regime was used with CHO—K1 cells TPA displayed no co- 
mutagenic activity (see Table 4*7)• In a third alternative treat­
ment regime cells were exposed to TPA for the duration of mutation 
expression only. In this case, although cells treated with MHNG + 
TPA displayed higher mutation frequencies than cells treated with 
MTIHG alone (see Table 4*8) , apparent increases in mutation frequency 
were not statistically significant. Thus, overall, the results of 
the series of experiments reported in 4*7*2 indicate that TPA can
pact to significantly enhance mutation to Oua in CHO—K1 cells induc­
ed by MNNG, but only when presented to cells immediately after mutar- 
gen treatment and continuously maintained in the culture medium 
throughout mutation expression and mutant selection.
A continual problem in the use of MNNG as the test mutagen 
was the low numbers of viable mutants produced in selection plates, 
which rendered statistical tests of significance (4*6.6) insensi­
tive to any enhancement of mutation frequency by TPA. Thus it may 
be that the small increases in mutation frequency observed following 
TPA exposure for the duration of mutation expression (see above), 
though statistically insignificant, represent a genuine enhancement 
of mutagenesis by the promoter.
The results of experiment 4*6.3 (Table 4*3) had shown EMS to
pbe a much more efficient inducer of viable Oua CHO—K1 mutants than 
MNNG. This finding was consistent with the results of Baker et al. 
(1974) showing that EMS is capable of inducing far more Oua^ mutants
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in CHO than MNNG. The study of the effect of TPA on mutation to
pOua was therefore extended by investigating its effect on EMS 
mutagenesis (4.8), both to determine the effect of the phorbol es­
ter on mutation induction by an agent other than MNNG and to try and 
obtain a more sensitive assay for any mutation—enhancing activity 
of this and other tumour promoters. Cells were treated with O.&nM 
EMS for l6hr (a virtually non-toxic dose) then, as in the MNNG ex­
periment in which the promoter displayed a positive co-mutagenic 
effect, treated with TPA for the remainder of mutation expression 
and the whole of mutant selection. M S —elevated mutation frequen­
cies,closely comparable with those in Table 4*3 following an iden­
tical exposure, were unaffected by TPA exposure (Table 4*9)• TPA 
also showed no mutagenic activity per se in this treatment regime.
Having determined the effect of TPA on mutagenesis induced by
p
two chemical mutagens, its influence on UV—induced Oua mutation was 
investigated (4*9)• Once again cells were continuously treated with 
promoter immediately after mutagen exposure until the end of mutant 
selection. A dose of 25 Jm" 254^ UV gave a moderate yield of mut­
ant colonies in selection plates and an average mutation frequency 
of 52.3 mutants/10  ̂survivors over three replicate experiments 
(Table 4*10) • In none of these experiments did TPA have an effect 
on UV-induced mutation frequency. Interestingly, however, the pro­
moter did cause a consistent reduction in single cell survival, as 
assessed by plating efficiency, which was accompanied by a corres­
ponding reduction in the numbers of mutant colonies in selection 
plates.
Overall, the results obtained with the Oua system suggest 
that MNNG induces one or more types of genetic change which are only 
expressed as Oua mutations when TPA is continuously present follow-
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ing mutagen exposure. These changes cannot he generated by M S  
or UV—light, since TPA does not act as a co-mutagen for either 
of these agents under closely comparable experimental conditions.
Investigations into the effect of TPA on spontaneous and EMS 
-induced mutation to TG^ in CHO—K1 (4*10) employed a respreading- 
type mutagenesis protocol based largely on the quantitative assay 
of TG^ mutation developed by O'Neill et al.(1977) with cells of the 
CHO—K1 subclone BH^ (4.IO.I). In an initial experiment the observ-
pation of O'Neill et al,that CHO-Kl TG mutation expression is max­
imal by approximately 7 days after M S  treatment was confirmed (see 
Table 4»H and Fig. 4*2). The decline in the peak mutation fre­
quency evident after 11 days mutation expression, suggesting that 
TG mutants are at some selective disadvantage compared with wild- 
type cells, had not however been observed with cells of the BH^ sub— 
clone. When developing TG colonies were tested for the ability to 
survive and grow in HAT medium after 5 days of mutant selection — 
a time interval sufficient for all wild-type CHO-Kl cells to be 
killed (O'Neill et al. 1977) - it was found that 17^ of TG^ vari­
ants retained sufficient HGPRT activity to survive (Table 4*12) be­
cause, presumably, they possessed a^leaky drug-resistant phenotype.
TPA exposure did not cause an elevation of the spontaneous 
mutation frequency in the CH0-K1/TG^ system i.e. was not mutagenic 
per se. However, when EMS-treated cells were subsequently exposed 
to the promoter, enhancement of induced mutation was observed at all 
expression times from day 5 - day 11, most notably on days 7 2nd 11.
Various modifications were made to the initial experiment in 
a succeeding investigation (4*10.3). In an attempt to reduce the 
high spontaneous mutation frequency evident in Table 4*11 CHO—KIA 
HAT1 cells, isolated and propagated in HAT medium, were used. With
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the aim of reducing the proportion of presumptive ̂ leaky'mut ants, 
the concentration of TG in selective medium was increased from 
10 J2M to 30 Because significant mutation induction is not
achieved in the CHO—K1/tG^ system until after approximately 7 
days expression, cells were only plated for mutant selection af­
ter 6, 8 and 11 days.
The results in Table 4*13 show that CHO-KIA HAT1 contains 
far fewer spontaneous TG mutants than the ordinary wild-type 
CHO—KIA cells used in the initial experiment. Nevertheless, the 
small increase in the control mutation frequency between day 6 and 
day 11 of expression suggests that if not checked, by growth in HAT 
medium, spontaneous mutants may slowly accumulate in this cell 
strain. Much lower EMS-induced mutation frequencies observed in 
CHO—KIA HAT1 cells may be explained by the more stringent mutant 
selection conditions imposed on these cells. However, the increase 
in TG concentration caused only a moderate reduction in the number 
of TG variants capable of growth in HAT medium (from 17*4^ to 
10.7^ for EI'IS treated cells, see Tables 4*12 and 4*14) • It would 
be expected that any reduction in mutation frequency as a result of 
increasing TG concentration would be a consequence of the elininac­
tion of such variants. Because this does not appear to be the case, 
the lower induced mutation frequencies may simply be attributable to 
differences between the cell populations used in the two experiments.
It was again found that while TPA did not increase the numbers 
of spontaneous mutants it enhanced both the yield of mutants and the 
mutation frequency following EtIS treatment. The co-fliutagenic effect 
of the promoter was statistically significant at all three mutation 
expression times. When means of the mutation frequencies at days 6,
8 and 11 were calculated, that for the EMS + TPA treatment mode was
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42^ higher than that for EMS alone. Interestingly, TPA concurr— 
ently increased the number of EMS-induced TG variants which could 
grow in HAT medium in this experiment (Table 4*14), though not 
sufficiently to account for its cobnutagenic activity.
Following a failure to detect a mutation-enhancing effect of 
TPA with some mutagens and mutation assay systems, it has been sugg­
esting that the coMuutagenicity of TPA in mammalian cells in vitro 
is an artefact due to the inhibition of metabolic cooperation (Lasne 
et al. 1980, Thompson et al. I98O and Kinsella I981). This suggest­
ion stems from the finding that at very low concentrations TPA and 
other tumour—promoting phorbol diesters are capable of enhancing 
the colonial recovery of TG V79 Chinese hamster cells cocultured 
together with high densities of wild-type, TG—sensitive (TG^ cells 
in selective medium (Yotti et al. 1979)• At the TG cell densities 
utilised these TG^ cells would normally be rendered phenotypically 
normal as a result of metabolic cooperation and therefore killed by 
TG. Metabolic cooperation is thought to be mediated by a special­
ised membrane structure, the gap junction, which is a likely ultra- 
structural pathway for the transfer of ions, metabolites and other 
small molecules between cells in contact (Gilula et al. 1972, Azar- 
nia et al. 1974)* Freeze fracture studies have demonstrated that 
TPA almost completely eliminates cellular gap junctions (Kinsella
1981).
Inhibition of metabolic cooperation is unlikely to be the rea­
son for the co-mutagenic effects of TPA observed in the current stu—
p
dy. With regard to the enhancement of MNNG—induced mutation to Oua 
by TPA two facts establish that this phenomenon is not involved:
(1) The results of the reconstruction experiment 
in 4*6.4 (Table 4*4) which show that the colonial
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Hrecovery of Oua cells was virtually complete 
under experimental conditions. Thus metabolic 
cooperation was not operating to suppress the
precovery of Oua mutants and consequently its 
inhibition cannot explain the increase in muta­
tion frequency.
(2) The mutagen specificity of the mutation—
penhancing activity of TPA found with the Oua 
system, which would not be expected if the tum­
our promoter had its effect by the inhibition 
of metabolic cooperation.
It is also unlikely that metabolic cooperation can account
p
for the enhancement of TG mutant yields and mutation frequencies 
observed following continuous TPA exposure of SMS-treated cells 
(Tables 4*11 and 4*13, Fig. 4*2) . It has been shown by recon­
struction-type experiments that when CHO-Kl cells are respread 
in TG—containing medium at less than 3*2x10^ cells cm  ̂ cell
p
density has no effect on the colony-forming ability of TG mutants 
within a wild-type population. Thus in the current experiments in 
which cells were respread for selection at a density of 2.4x10^ 
cells cm ^ (4*10.1), the possibility of metabolic ccoperation af­
fecting mutant recovery was assumed to be eliminated. Furthermore, 
in connection with the above, it has been reported that cells of 
CHO—Kl's parent, CHO, are incapable of metabolic cooperation 
(Thompson et al. I98O, Kinsella I981) . Although some data appar- 
enly contradict this conclusion (Abbondandolo 1977, O'Neill et al. 
1977), if true, this implies that CHO-Kl cells, likewise, do not 
engaged in this form of intercellular communication.
Two possible mechanisms have been suggested for the genuine
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enhancement of mutagenesis by TPA;
(1) inhibition of excision repair of damaged DNA; 
and
(2) induction of the expression of latent mutations.
Short single-stranded sections of DNA containing lethal or
mutagenic lesions can be excised by the action of endonuclease and 
exonuclease enzymes and then, in a process involving DNA polymer­
ase and ligase activities, be replaced with the correct sequence 
of nucleotides. Such a process is known as error-free excision 
repair and is detectable by the removal of thymine dimers from 
DNA or the occurrence of unscheduled DNA synthesis in synchronised 
cell populations (Auerbach 1976)•
TPA has been shown to inhibit the removal of UV light—induc­
ed thymine dimers from the DNA of irradiated HeLa cells and to aug­
ment the UV—killing of these same cells (Teebor et al. 1973)* It 
is also able to inhibit UV-induced unscheduled DNA synthesis in human 
amnion cells (Trosko et al. 1975) * Thus it may be that tumour pro­
moters act to enhance mutagenesis by inhibition of the excision re­
pair of mutational and/or premutational lesions in damaged DNA. An 
observation in the current study in agreement with this hypothesis 
was that, in CHO-Kl cells,TPA consistently enhanced the lethal effect 
of exposure to 25 Jm  ̂UV (see Table 4*10), as would be expected if 
the promoter inhibits DNA repair (Soper and Evans 1977» Trosko et al. 
1977)* However, the fact that TPA exposure following irradiation
pwith this dose of UV caused no enhancement of Oua mutation fre­
quency indicates that even if inhibition of DNA repair was responsi­
ble for enhanced UV lethality, it did not cause the promoter to ex­
hibit co*HTiutagenic activity.
The possibility that inhibition of excision repair or other DNA-
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repair processes is responsible for TPA enhancement of mutation
frequencies has been cast into doubt by the observation that TPA
R Ris able to elicit additional increases in both TG and Oua muta­
tion frequency in V79 cells up to 2—3 weeks after mutagen/carcino­
gen treatment (Trosko et al. 1977» Lankas et al. I98O) . DNA re­
pair replication in mammalian cells has, however, been reported 
to be essentially complete within a period of 24hr following the 
occurrence of DNA damage (Teebor et al. 1973)# Furthermore, it 
has been shown that TPA can act as an effective co-mutagen in a 
strain of S.typhimurium lacking the excision repair mechanism 
(Soper and Evans 1977) • The report that V79 cells do not perform 
much excision repair (Trosko et al. 1977) also argues against TPA 
acting by the inhibition of this DNA repair mechanism.
The more attractive, though less mechanistically specific, 
alternative hypothesis is that TPA owes its co-mutagenic activity 
to an ability to enhance the expression of latent somatic muta­
tions. This hypothesis envisages that not all mutagen—induced 
primary DNA lesions are expressed as mutations and that TPA and 
other tumour promoters act to activate these unexpressed mutations. 
It may be that these agents have their action by modulating (re­
pressing or derepressing) the expression of genes containing struc­
tural changes (Trosko et al. 1977» Chang et al. 1978). This hypoth­
esis is compatible with the characteristic capability of TPA to en­
hance mutation long after the occurrence of DNA damage and the op­
eration of DNA repair processes. Furthermore, TPA has been shown 
to induce changes in certain factors implicated in the regulation 
of gene activity in mouse epidermal cells. These include stimula­
tion of histone kinase activity (Raineri et al. 1973) and ornithine 
decarboxylase and resulting poly amine synthesis in vivo (O'Brien et
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al. 1975a-) and in vitro (Yuspa et al. 1976i).
In conclusion, the results of the current study establish
that TPA can act to enhance induced mutation to Oua^ and T(f̂  in
CHO—K1 as well as V79 cells. Differences between the mutation-
enhancing properties of the promoter in the two cell lines were
R / Rhowever evident with regard to mutation to Oua • In the V79/Oua 
system TPA is reported capable of enhancing mutation following 
MNNG, MAM and UV treatments (4*3) , being maximally effective when 
added just prior to and for the duration of the mutant selection 
period. Of the three mutagens tested in the CHO-Kl/Oua^ system, 
however, TPA was only capable of enhancing the mutagenic effect 
of MNNG and then only when present from immediately following 
mutagen treatment until the end of mutant selection.
Future experiments might usefully attempt to determine the 
type(s) of mutagenic event potentiated by TPA — an unfulfilled 
goal of the present study — and further, to establish whether this 




CYTOGENETIC EFFECTS OF A TUMOUR PROMOTER IN MAMMLIAN CELLS 
5»1 Tumour Promotion via Mitotic Recombination
Mitotic recombination (also termed mitotic or somatic crossing over) 
is a process, preceeding normal somatic cell division, whereby two 
non—sister chromatids of an homologous chromosome pair exchange 
longitudinal segments. The exchange, analogous to meiotic crossing 
over, is balanced, requires breakage and reunion events, and in­
volves an exchange of DNA duplexes rather than single strands (Mc­
Dermott 1975, Goodenough 1978)•
Kinsella and Radman (1978) have hypothesized that tumour- 
promoting compounds act to induce or enhance mitotic recombination. 
When followed by cell division this would make possible the express­
ion of recessive genetic or epigenetic chromosomal changes resulting 
from earlier exposure to an initiating carcinogen. In Fig. this 
mechanism for tumour promotion is illustrated. At the initiation 
step of two—stage carcinogenesis, treatment of a somatic cell (a) 
with a DNA—damaging agent causes a heritable mutation within a given 
gene. In the initiated cell (b) the mutant gene is recessive to the 
corresponding wild-type allele and therefore unexpressed. On nor­
mal DNA replication and cell division daughter cells (c) remain het­
erozygous at this locus. However, if prior to mitosis promoter-in­
duced mitotic recombination occurs between non—sister homologous 
chromatids (d) , a daughter cell (e) which is homozygous for the mut­
ant gene can arise. In such a cell, as a result of conversion from 
an heterozygous to an homozygous state (homozygosis) , the mutant gene 
is segreated from its wild-type allele and therefore achieves ex­














Fig.5.1. Tumour promotion via mitotic recombination.
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pressed and a growing tumour ultimately result. Though Kinsella 
and Radman acknowledg-i that segregation of recessive mutations due 
to promoter-induced mitotic recombination is likely to be a rare 
event, they expect its frequency to be enhanced to a biologically 
significant level when coupled with the strong proliferative effect 
of tumour promoters on cells in vivo (see 1*5)•
The obvious premise to the above hypothesis is that mitotic 
recombination, analogous to meiotic recombination, can occur in 
target mammalian cells. Though this genetic event is knoivn to take 
place in many types of lower eukaryotic cell (stern 1936, Pontecorvo 
and Kafer 1958, Holliday I964) direct evidence of its occurence in 
mammalian cells is lacking. This is due to the unavailability of 
appropriate selective mankers, required for its detection and the 
apparently low frequencies involved (Rosenstraus and Chasin 1978). 
However, a considerable volume of c;.-togonetic evidence suggests that 
mitotic recombination does occur occasionally in such cells (Craig- 
Holmes et al. 1975» Rosenstraus and Chasin 1978)• Strongest support 
has come from the observation of equal and symmetrical quadriradial 
configurations between homologous chromosomes in metaphase human 
cells (German I964, Chaganti et al. 1974)• Given that quadriradials 
are the result of chromatid exchange (Savage 1975» Evans and O'Rior— 
dan 1977) these configorations are precisely what would be expected 
in metaphase as a consequence of mitotic recombination earlier in 
the cell cycle.
Evidence of induction of mitotic recombination by tumour-pro­
moting compounds is required to support Kinsella and Radman's hypoth­
esis. In mammalian cells, in the absence of a system for the detec­
tion and quantification of the crucial genetic event, evidence is of 
necessity indirect. It has come from two sources. Firstly, Kinsella
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and co-workers (1978) reported that TPA (4x10 "̂I-l) stimulated the 
segregation of two recessive genetic traits, 6-thioguanine resis­
tance and ability to grow on agar, from doubly heterozygous inter­
specific cell hybrids. Increased segregation may well have occurred 
as a result of promoter—induced mitotic recombination. However, a 
number of equally plausible alternative mechanisms, including chrom­
osomal rearrangement or deletion (as a result of non—disjunction),
could not be excluded (Kinsella et al, 1978)• Of much greater im—
—7 —6portance was the observation that TPA at 1,6x10 and 1,6x10 M 
increased the frequency of sister chromatid exchange in established 
V79 Chinese hamster cells from a control level of 5*32 exchanges per 
cell to 7*88 and 12,91 exchanges/cell respectively (Kinsella and 
Radman 1978) .
Sister chromatid exchange (sCE), originally demonstrated by 
Taylor (1958), is a symmetrical exchange between sister chromatids 
at identical loci. Kodern techniques allow ready visualisation of 
this genetic exchange, with high resolution, in metaphase mammalian 
chromosomes (Latt 1973, Perry and Wolff 1974)• These techniques 
have revealed that SCE occurs at the time of DNA replication and 
involves an exchange of DNA duplexes (Evans 1977)• The normally 
low, stable, frequency of SCE is greatly increased in cells treated 
with very small doses of many DNA-damaging agents (Perry and Evans 
1975» Craig-Holmes et al, 1977)• This SCE induction is likely to 
be the result of a response on the part of the cell's replicating 
machinery to DNA lesions - possibly a repair response of a recombin- 
ational character (Perry and Evans 1975» Sasaki 1977) • Several 
classes of agents are capable of eliciting SCEs,suggesting that the 
lesions responsible are probably of many different types (Evans 1977)• 
Results of recent studies indicate a linear correlation between the
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induction of SCEs and mutations (Carrano et al. 1978, Davidson 
et al. 1980), though no conclusions can yet be drawn concerning 
the relationship of these two responses to DNA damage.
The report of SCE induction by TPA is unique because unlike 
all other SCE inducers TPA is incapable of damaging DNA (Boutwell 
1974, Poirier et al. 1975). Further, Kinsella and Radman found 
no evidence of ploidy effects, non—disjunction or structural chrom­
osomal aberrations at effective concentrations; and in V79 (bankas 
et al. 1977, Trosko et al. 1977) and other cell types (Lasne et al. 
1980, Thompson et al. I980) TPA has been reported non-mutagenic, 
unlike other SCE—inducers which cause mutations in parallel with 
SCEs (see above) •
In the absence of any detectable DNA damage,TPA SCE induction 
is taken by Kinsella and Radman as an indication of increased cell­
ular recombinogenic activity, brought about by promoter induction 
of enzymes involved in genetic recombination. A general increase 
in such activity might be expected to evoke not only an increase in 
SCE frequency, but also the stimulation of mitotic recombination.
The critical assumption, that SCE is closely related to mitotic re­
combination, is based largely on the likely similarity of the two 
events at the macromolecular level. SCE involves the exchange of 
DNA duplexes between sister chromatids at identical loci, whereas 
mitotic recombination involves the same exchange process but between 
non-sister homologous chromatids. It is possible therefore that both 
types of exchange are accomplished by a common enzymatic mechanism 
(Rosenstraus and Chasin 1978). The finding that increased frequen­
cies of quadriradial chromosomes, which as explained above are poss­
ible evidence of mitotic recombination, are observed in cells with 
high levels of SCE (Chaganti et al. 1974) lends support to the use
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of SCE frequency as a monitor of mitotic recombination.
Kinsella and Radman (1978) claim that Bloom’s syndrome pro­
vides circumstantial evidence for their overall model. Cells tak­
en from affected individuals show a very h i ^  spontaneous frequency 
of both SCE end quadriradial chromosomes (Chaganti et al. 1974)*
They propose that the clinical manifestations of this disorder - 
particularly predisposition to cancer - may be caused by a mutation 
resulting in a promotion—constitutive phenotype.
That elevation of SCE frequency by TPA is intimately involved 
in the mechanism of tumour promotion was supported by the finding 
that a non-promoting TPA analogue, MeTPA (see 1.2), had no effect 
on SCE in V79 cells (Kinsella and Radman 1978)• Thus for these 
compounds SCE inducing ability in V79 correlates with tumour—pro­
moting activity in mouse skin. Furthermore inhibitors of mouse skin 
tumour promotion; protease inhibitors antipain and leupeptin (Troll 
et al.1978) and the steroidal anti-inflammatory fluocinolone aceton- 
ide (Slaga et al. 1978t); also inhibit TPA induction of SCE (Kinsella 
and Radman 1978) .
Nagasawa and Little (1979) found that TPA (1.6x10 and 
1.6x10 M̂) increased not only the frequency of spontaneous SCE (by 
60-90 )̂ but also direct X—ray—induced SCEs (by approximately 30^) in 
established C3B/IOTI/2 mouse fibroblasts. Again incubation with the 
protease inhibitors antipain and leupeptin suppressed the effect of 
TPA. Interestingly, post-irradiation holding of cells in a non­
dividing state, termed 'recovery', increased the frequency of X-ray 
—induced SCE by an amount comparable with that brought about by TPA 
treatment. These recovery-induced SCEs could not be further enhan­
ced by promoter treatment and were suppressible by the protease in­
hibitors. This prompted the suggestion that the same recombinogenic
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enzymes as are proposed to be induced by TPA may also be induced 
by X-irradiation if cells are subsequently placed under suitable re­
covery conditions.
It was decided in the proposed study to determine whether TPA 
could induce SCEs in a third established cell line - CHO—Kl. In 
addition, because tumour promoters characteristically potentiate the 
action of initiating chemical carcinogens (l.l), it was also propos­
ed to determine the effect of TPA on SCE induction by two different 
mutagen/carcinogens, N-methyl-N^-nitro-N-nitroso guanidine (MIHIG) and 
mitomycin C (KC) (See 1.8), in CHO-Kl. Soon after this series of in­
vestigations was started, Loveday and Latt (1979) reported that TPA 
(5x10 - 5x10 M̂) did not increase SCE frequency in either V79 cells
or CHO cells (CHO—Kl's parental cell line). Moreover, they found 
— 7 —6that TPA (5x10 and 1.6x10 M) did not alter the induction of SCEs 
in CHO cells by MC during the first three replication cycles follow­
ing the addition of this agent. This contradiction of the earlier 
reports of Kinsella and Radman (1978) and Nagasawa and Little (1979) 
added to the need for the outlined series of investigations; the re­
sults of which, it was hoped, would help to establish the true eff­
ect of TPA on SCE frequency in mammalian cells and hence the likeli­
hood of tumour promotion occuring as a result of mitotic recombina­
tion.
A further investigation of the capability of tumour promoters 
to induce mitotic recombination used a different cytogenetic approach. 
Kinsella and Radman (1978), though they presented no data, reported 
that in V79 cells SCE induction by TPA was not accompanied by in­
creases in structural chromosomal changes (chromosomal aberrations).
It would be expected, if the tumour promoter does act by enhancing 
mitotic recombination, that the frequency of at least one type of
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chromosomal aberration, the symmetrical quadriradial, would in­
crease along with SCE frequency following TPA treatment of cells#
The influence of TPA on the spontaneous frequency of chromosomal 
aberration in CHO-Kl cells was therefore investigated#
Although the study of chromosomal aberrations was primarily 
concerned with possible TPA induction of quadriradial structures, 
all types of conventional structural aberration were scored, to 
determine if TPA, rather than specifically inducing mitotic recom­
bination, has a general disruptive effect on the organisation of 
genetic material at the chromosome level#
The types of chromosome damage which can be cytologically 
distinguished at metaphase can be divided into two main groups: 
chromât id-type and chromosome—type. Chromatid-type aberrations 
are induced by ionising radiations when oells are exposed in S or 
Gg stages of interphase, when the unit of breakage (and any reunion) 
is the chromatid. Chromosome-type damage is produced when cells are 
irradiated in G^ and the unit of breakage is the whole chromosome 
(i#e. both chromatids at the same locus). Many chemical mutagens 
and viruses cause only chromatid aberrations at the first division 
subsequent to treatment, even though the cells are exposed to the 
agent whilst in the G^ phase. These aberrations are a consequence 
of errors in replication that occur in the DNA synthesis, or S, 
phase following exposure. At subsequent divisions a proportion of 
chromatid aberrations give rise to chromosome—type aberrations — 
these being 'derived* from the former by duplication#
Many classes of both chromosome-type and chromât id-type aberr­
ations can be distinguished (Savage 1975)• However, for the purposes 
of the present study, each aberration was designated as one of the 
following:
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(1) Chromatid gap. A gap (or achromatic lesion) 
appears as a non-staining and constricted region 
in a chromatid arm, the apparently broken segnents 
of the chromatid being in alignment (Pig. 5*2a)•
(2) Chromatid break (or deletion)• A discontin­
uity in a chromatid arm such that the broken 
chromatid ends are not aligned (Fig 5»2b)•
(3) Chromatid minute. Single small fragment which 
appears as a dot (hence alternative term dot dele­
tion) . It arises from an interstitial deletion 
within a chromatid and usually appears in close 
association with the chromosome region from which 
it was lost (Fig 5.2c).
(4) Chromatid exchange. Any structure presumed 
to have resulted from an exchange of material be­
tween or within the chromatids of one or more 
chromosomes. Most importantly, it includes quad— 
riradials, which are cross-like configurations re­
sulting from a simple symmetrical exchange between 
one chromatid in each of two chromosomes (Fig.5.2d).
(5) Chromosome gap. A gap idential to the chromar- 
tid gap, but involving both chromatid arms at the 
same locus. It is alternatively termed an isolocus 
gap or a paired achromatic lesion (Fig.S.le)#
(6) Chromosome aberration. Any structural change 
which appears to affect both sister chromatids of 
a chromosome or chromosomes at the same locus. Two 












Pig 5*2 Classes of chromosomal aberration:
(a) Chromatid gap; (b) chromatid break; (c) chromatid minute;
(d) quadriradial; (e) chromosome gap and (f) two chromosome-
type aberrations i . centric ring with acentric fragnent ii. dicen­
tric chromosome with acentric fragnent.
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Chromosomal aberrations are found in many types of cancerous growths 
(Bloom 1972, McDermott 1975» Bempong 1979) and in at least one case 
there is an association of a specific chromosomal abnormality with 
a particular form of neoplastic growth — a deletion in the long arm 
of human chromosome 22 is usually found in leucocytes from individ­
uals with chronic myeloid leukaemia (McDermott 1975)* In addition, 
most chemical and physical agents shown capable of causing chromo­
somal aberrations in mammalian cells, either in vivo or in vitro, 
are also carcinogens (Auerbach 1976, Schmid 1976). Thus the ob­
servation of an induction of chromosomal aberrations by TPA in CHO- 
Kl would have important implications with respect to possible mech­
anisms of tumour promotion*
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5.2 Special Materials
5—Bromodeoxyuridine (BrdU) : Signa Chemical Co.Limited.
Solid and 5mÎI stock solution in PBS(a) (see 2.8.2) were stored 
protected from light at —20°C. Stock solution was added to 
complete medium prior to itsaddition to cultures. Hoechst 33258 
(2-(2-(4-hydroxyphenyl)—6-henzimidazolyl)-6-(l-methyl-4-piperazyl) 
-henzimidazole 3HCl): a gift from the Regional Cytogenetics Unit, 
Bristol, Received as a 5C^9^1  ̂ solution in deionised water, it 
was shored at 4°C protected from light. For use it was diluted 
with deionised water and placed in an opaque plastic, screw- 
capped Coplin jar.




To detect SCEs one must be able to distinguish between sister chrom­
atids, If cells are exposed to the thymidine analogue 5“t>romodeoxy- 
uridine (BrdU) over two rounds of DNA replication, due to the semi­
conservative nature of such replication metaphase chromosomes come 
to possess one chromatid unifilarly substituted with BrdU and its 
sister bifilarly substituted. Subsequent staining with the fluoro— 
chrome Hoechst 33258, which fluoresces more strongly when bound to 
chromatids unifilarly substituted with BrdU than when bound to bi— 
filarly substituted sisters (Latt 1973), allows chromatid different­
iation under the fluorescence microscope. Unfortunately the Hoechst 
dye demonstrates a high degree of photoinstability so that fluores­
cence fades rapidly (within one minute) and a photographic record 
has to be made of all cells to be fully examined. However, Perry 
and Wolff (1974) have described a method in which the use of Hoechst 
33258 is combined with Giemsa staining (fluorescent plus Giemsa or 
FPG technique) to make permanent cytological preparations. An add­
ed advantage of this technique is that the resultant 'harlequin 
chromosomes’ can be examined without recourse to fluorescence mic­
ro scopy.
5.3.1 Cell treatment procedure
This was designed so that when cells were harvested and processed 
for visualisation of SCEs virtually all metaphase cells were at 
their second mitosis following addition of BrdU, As exposures to 
environmental carcinogens and tumour promoters are likely to be chro­
nic exposures all test agents (TPA, MNNG and MC) were introduced in­
to the culture medium at the time of addition of BrdU and the medium 
was not changed until the cells were harvested.
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2x10^ CHO-KIA cells were inoculated into a 25cm^ T/C flask 
with 5^1 of modified Ham’s FIG medium lacking thymidine (MFlO(-dT), 
see 2.8,5) supplemented with 10^ foetal bovine serum (MFlO(-dT)X).
The culture was gassed with ^  CO^ in air and incubated for 20—24 
hr. The medium was then replaced with ^ 1  of MF10(—dT)X contain­
ing 20 jM  BrdU. Test compounds were added at the same time in 
20 ^1 volumes of vehicle. The culture was then reincubated for 
27hr, colchicine(1.25 jiM)being added, to accumulate metaphase cells, 
for the final 4hr. At harvest the whole cell population was removed 
by trypsinisation, treated with hypotonic KCl and fixed in 3:1 
methanol, acetic acid in the usual way (3.7*1)* Slides were spread 
by the air-drying technique (3.7*1) and stored in the dark until 
further processing.
During all experiments, to avoid effects due to the photo­
sensitivity of BrdU-substituted DNA (Kao and Puck 1$68, Evans 1977) 
cells were protected from short wavelength light until after fixa^ 
tion. Culture flasks were incubated wrapped in aluminium foil in 
li^t—tight boxes, and all manipulations were carried out under red 
light.
5.3.2 FPG technique
The method of Perry and Wolff (1974) with modifications employed by 
Kinsella et al. (1978) and Nagasawa and Little (1979) was used.
Slides were aged for at least 3 days then stained in Hoechst 33258 
(0.5 /igml  ̂ in deionised water) for 12min at room temperature. After 
rinsing in deionised water the chromosome preparations were mounted 
in water, coverslips being ringed with rubber cement to prevent evap­
oration and then exposed to a broad spectrum UV-li^t source for 
Ihr. This to allow the photochemical reaction to occur whereby
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chromatids come to fluoresce differentially. The coverslips were 
carefully removed and slides placed in 2 x SSC (2,9) at 60°C for 
2hr, before staining in 3^ Giemsa in Sorensen’s phosphate buffer 
at pH 6,8 (2,9) for 30 min. Finally, slides were rinsed in deion­
ised water, dried and preparations mounted in DPX,
5.3.3 Scoring of SCEs
In all experiments slides were coded following FPG staining and 
scored ’blind’. Each slide was scanned methodically in breadth­
wise sweeps under low power (x256) and every apparently unbroken 
metaphase cell encountered further examined under high power (xl600)• 
Only satisfactorily spread (intact, largely free of overlapping 
chromosomes), completely harlequin stained, quasi—diploid cells 
(17—23 centromeres) were analysed for SCEs, Cells showing chromo­
some/chromatid aberrations were not selected against. Each cell 
was sketched on an aberration scoring sheet and the SCEs in each 
chromosome noted, A SCE was only counted when it was clearly 
evident in both chromatids at the same point, Centromeric exchanges 
were not included because it was impossible to distinguish between 
a true exchange and a twisting of chromatids at this point, SCEs 
per metaphase were totalled. Results are expressed as the mean 
frequency of SCE — standard error (S,E,) per metaphase*
5,3.4. Testing the significance of differences between mean SCE 
frequencies,
A student’s t-test could not be used to test the significance of 
the difference between any two mean SCE frequencies because there 
was no basis for assuming the distribution of SCE/metaphase to be 
normal. Therefore tests of significance were based on the fact
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that when two sample sizes are large, regardless of the form of 
the population distributions, the random variable 'z, where 
:z = (x^ - x̂ ) - ( Pi - /ig)
"2
is approximately standard normal when
x^ = the mean of sample 1 Xg = the mean of sample 2
2 2 s^ = variance of *’ ” s^ = variance of ** ”
n^ = the size of ” ” n^ = the size of ” "
and and are the respective population means.
The tests were made as detailed by Hayslett (1974)• Tests made be­
tween samples of TPA—treated metaphase cells and of corresponding 
vehicle-treated metaphases were one-tailed, i.e. the alternative to 
the null hypothesis ( was where was the pop­
ulation mean for the vehicle—treated cells and the population 
mean for the TPA-treated cells. Tests of significance between other 
mean SCE frequencies were two-tailed, having the null hypothesis p ^
= p ^ and the alternative hypothesis otherwise
stated. If not specified tests were made at the 5^ significance 
level.
A one-tailed test v/as applied to data from TPA-treated 
and corresponding untreated cell populations because a 
possible increase in SCE frequency following promoter 
treatment v/as being specifically searched for. A two- 
tailed test of significance was applied to data from all 
other differently treated cultures because there v/as no 
prior indication of SCE enhancement or inhibition by any 
of the treatments concerned.
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5*4 Dose-Respouse Relationship for SCE Induction by MNHG 
An investigation was performed using this known mutagen to compare 
induced SCE yields obtained using the current assay system with 
those reported by other workers. Further, this served as a necess­
ary dose-ranging study to ascertain effective concentrations of 
MITNG for use in later experiments.
Certain details of the cell treatment procedure in this ex­
periment differed from the procedure described in 4x10^ CHO-
KIA cells at passage 38 in 5^1 MF10(-dT)2T were inoculated into 25cm^ 
flasks. After l8-20hr incubation the culture medium was discarded 
and replaced with of fresh MF10(—dT)ï containing 10 yM BrdU.
Test or control treatments were also introduced. After a furtfier 
30hr incubation colchicine was added and 2hr later cells were har­
vested by trypsinisation, fixed and spread on slides. Slides were 
stained by the FPG technique (5*3.2). For each treatment 10 harle­
quin stained metaphase cells — 5 on each of 2 slides — were scored 
for SCEs. The data obtained are presented in Table 5*1 • plates 
5.1 and 5*2 a cell from the vehicle control culture and a cell ex— 
posed to 1.4xlO” M KTING are shown respectively.
TABLE 5.1 Effect of MTNG at several concentrations on the control 
frequency of SCE in CHO—KlAcells cultured in the presence of 10 pM 
BrdU
Treatment Mean no. of SCEs/ metaphase — S.E.
Control, HgO 0.4^ 15.0 1 1.0
0
MNNG 3*4x10" M 17.3 -  1.7
6.8xlO"®M 27.3 -  1.7
1.4xlO"?M 35.9 -  3.6
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Plate 5.1. CHO-KIA cell cultured in the 
presence of lOyM BrdU and MNNG vehicle, 





Plate 5.2. CHO-KIA cell cultured in the 
presence of lOyM BrdU and treated with




A dose-response plot of the data in Table 5*1 (Fig. 5*3) shows
a very similar profile to the plot presented by Perry and Evans
(1975)1 who subjected cells of CHO-Kl’s parental cell line, CHO,
to MNNG treatments under very similar experimental conditions.
The concentration range over which MNNG produced the response
seen in Fig. 5*3 was also close to that reported by Perry and 
—8 6Evans (<^3x10 — 10 M). In addition, the control level of SCE
in Perry and Evans* study was 12.2 compared with I5.O here. Thus 
the observed SCE yields are in satisfactory agreement with those 
reported by other workers.
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5«5 Preliminary Investigation of the Effect of TPA on Control 
SCE Frequency
It was necessary to determine if TPA at 1,6x10 the concentra­
tion reported to he maximally effective at inducing SCEs in V79 
cells (Kinsella and Radman 1978) , has any effect on SCE frequency 
in CHO-Kl.
CHO—KIA cells at passage 32 were treated in an experimental 
procedure identical to that employed in 5*4« TPA used was from 
batch 1 (2.10.2). Following FPG processing 10 harlequin stained 
metaphase cells were analysed for SCEs on each of 2 slides per 
treatment. For the MNNG positive control the scoring of a single 
slide was considered sufficient to demonstrate a significant ele­
vation of SCE frequency. SCE yields following the different treat­
ments are given in Table 5«2,
TABLE 5.2 Effect of 1.6xlO"^M TPA 
SCE in CHO—KlAcells cultured in the
on the control frequency of 
presence of 10 pM BrdU
Treatment Mean no. of SCEs/ 
metaphase — S.E.
Control, untreated 12.2 ± 1.0
Control, DM SO 0.49% 15.2 i 1.1
Positive control, MNNG 3.4xlO"'^M 96.3 “ 6.8
TPA 1.6xlO"^M 13 * 8 — 0.8
As can be seen in Table 5*2 TPA at 1.6xlO"^M caused no increa­
se in SCE frequency in CHO—K1 cells. However, there is a notice­
able difference between the mean SCE frequencies of untreated and 
DMSO (TPA vehicle) controls.
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5.6 The Effect of IMSO on Control SCE Frequency
If DM SO were capable of modifying SCE frequency then the data from 
all experiments utilising DMSO as the vehicle for TPA would be inval­
idated. DM SO was always added to culture medium at 0.49%V/V con­
centration or less, therefore the effect of 0#4^V/V DMSO on SCE 
frequency in CHO-Kl was thoroughly investigated.
CHO-KIA cells at passage 32 were exposed to D̂ ÏSO for 27hr ex­
actly as in the definitive cell treatment procedure (5.3*1) and met­
aphases subsequently FPG stained (5.3.2) and scored for SCEs (5*3.3). 
Eight cells were scored on each of 4 (DMSO) or 5 (control) slides.
SCE yields are given in Table 5*3*
TABLE 5.3 Effect of 0.49%v/v DMSO on the control frequency of SCE 
in CHO—KlAcells cultured in the presence of 20 ^  BrdU.
Treatment Mean no. of SCEs/ metaphase — S.E.
Control, untreated 
DMSO 0 .49%
20.0 i 0.9 
18.2 i 0.8
Statistical analysis (5*3*4) of the data in Table 5*3 estab­
lished that there was no difference, at the 59% level of signifi­
cance, between the mean SCE frequencies observed in untreated and 
DMSO-treated cells. The non-aqueous solvent Dî̂ ISO was therefore 
considered suitable for use as the vehicle for TPA in subsequent 
experiments.
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5*7 Further Investigation of the Effect of TPA on Control SCE 
Frequency
In the preliminary investigation of the effect of TPA on control 
SCE frequency (5*5) the tumour promoter was only tested at a single 
concentration (1,6x10 M̂) • A further investigation was therefore 
undertaken which determined the response of SCE frequency to this 
and a ten-fold lower concentration of TPA. In addition the TPA 
employed was from a different hatch (hatch 2) to that used in the 
earlier study.
The cell treatment (cells CHO-KIA at passage 33), metaphase 
staining and SCE scoring procedures were as detailed in 5*3.1 - 
5*3*3* 30 harlequin stained metaphase cells were scored for SCEs
(6 on each of 5 slides) per treatment. The mean number of SCEs per 
cell following the different treatment are given in Table 5*4*
TABLE 5*4 Effect of TPA at two concentrations on the control fre­
quency of SCE in CHO-KIA cells cultured in the presence of 20 ̂  BrdU
Treatment Mean no. of SCEs/ metaphase — S.E.
Control, untreated 19*3 - 0.8
Control, DMSO 0.49% 17*3 - 0.8
Positive control,MlflTG 6.8x10 ^ 27*9 - 2.0
TPA 1.6xlO"?M 16.6 - 1.1
TPA 1.6xlO“^M 17*2 i 0.7
Statistical analysis of the data summarised in Table 5*4 reveals
that the mean SCE frequencies observed in cells treated with TPA at 
—7 —6both 1*6x10 and 1.6x10 M were not significantly different from 
either the untreated or M S O  control frequencies. These data are in
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agreement with those presentedin Table 5*2. The mean SCE frequen­
cies in Table 5*4 are not, however, directly comparable with those 
in Table 5*2, because both the TPA exposure time and the concentra­
tion of BrdU employed were different in the two studies. The latter 
distinction, with 20 BrdU used in this study and 10 yM in the 
earlier one, explains the consistently higher mean numbers of ex­
changes seen in this study for equivalent treatments - Davidson et 
al. (1980) having shown that BrdU itself induces SCEs in a dose- 
dependent manner.
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5*8 The Effect of TPA on the Induction of SCE hy MNNG
The possible enhancement of MNNG—induced SCEs in CHO—K1 by TPA at 
—7 —6both 1.6x10 and 1.6x10 M concentration was investigated. The 
mutagen concentration used throughout, 1.36x10" M MfMG, was ex­
pected (from Pig. 5.2) to evoke a moderate, though highly signif­
icant, increase in SCE frequency.
CHO-KIA cells at passage 33 were exposed to mutagen and 
promoter (TPA from batch l) and chromosome spreads prepared as in 
the definitive cell treatment procedure. Metaphases were then 
harlequin stained using the PPG technique and 8 cells scored for 
exchanges on each of 4 slides per treatment. Results are summar­
ised in Table 5*5*
TABLE 5*5 Effect of TPA at two concentrations on the elevated 
frequency of SCE observed in CHO-KlAcells treated with 1.36xlO"^M 
MNNG in the presence of 20 yiM BrdU
Treatment Mean no. of SCEs/ 
metaphase - S.E.
Vehicle Control 17.1 -  0 .7
(HgO 0 .49% + DMSO 0.49%)
MNNG + mSO 0.49% 50.6 ±  2 .8
MNNG + TPA 1.6xlO"\ 55.5 - 2.6
MNNG + TPA 1.6xlO"^M 44.6 - 2 .4
Statistical analysis of the input data to Table 5*5 reveals that 
neither of the mean SCE frequencies observed after MNNG treatment 
in the presence of the two concentrations of TPA were significantly 
higher (at the 59% level) than that following MMNG treatment alone.
It is, however, noteworthy that the difference between the mean SCE
—7 «.6frequencies following MNNG + 1.6x10 M TPA and MNNG + 1.6x10 M TPA
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was highly sigiificant (p <0.0l)
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5*9 The Possible Influence of Cell Harvesting Technique on the 
Observation of SCE Induction by TPA
In the experiments in which Kinsella and Radman observed induction 
of SCE by TPA, mitotic V79 cells were harvested by mitotic shake- 
off (see 3.7*1) at the end of BrdU and promoter exposure. In the 
current series of experiments whole cell populations were harvested 
by trypsinisation, prior to processing for SCE analysis. To ascer­
tain whether Kinsella and Radman’s observations were an artefact 
attributable to the shake—off procedure, an experiment was conducted 
which reinvestigated the effect of TPA on both control and MNNG— 
elevated SCE frequencies in CHO—K1 cells, whilst incorporating this 
harvesting technique.
CHO-KIA cells at passage 32 were exposed to different test and 
control treatments exactly as in 5*7 and 5*8 and mitotic cells, iso­
lated by shake—off, processed for SCE analysis in the usual way. TPA 
was from batch 2. Five cells were scored on each of 4 slides per 
treatment. The data obtained are given in Table 5*&*
TABLE 5*6 Effect of TPA on both the control and MNNG—elevated 
frequency of SCE in CHO-KlAcells when mitotic cells only were 
harvested by shake-off.
_ . , Mean no. of SCEs/
Treatment metaphase ± S.E.
Vehicle Control 14*6 i 1.3
(HgO 0.49% + DMSO 0.49%)
H^O + TPA 1.6xlO"^M 18.0 — 0.9
HgO + TPA 1.6xlO"^M 16.0 — 0.7
MNNG + DMSO 50.6 i 4*2
MNNG + TPA 1.6xlO"\ 52.1 i 2.8
MNNG + TPA 1.6xlO"^M 46.0 i 2.5
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Although the numbers of metaphases scored per treatment were too 
few ( > 30) to allow statistical analyses (see 5*3*4) the results 
in Table 5*6 show, once again, that TPA has no effect on SCE fre­
quency per se. Furthermore, they establish that cell harvesting 
by the shake-off technique, instead of by trypsinisation, does not 
make any appreciable difference to the mean SCE frequencies ob­
served following given treatments (compare results in Table 5*6 
with those in Tables 5*4 and 5*5)• Thus it appears unlikely that 
Kinsella and Radman’s results were a consequence of the use of 
this procedure.
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5.10 SCE Induction by Mitomycin C (MC)
It was intended to determine the effect of TPA on the induction of
SCEs by MC as well as MNNG. Therefore a concentration of MC had to
be found which would cause a moderate increase in exchange frequency
under the conditions of the definitive cell treatment procedure (5.3.
2.). Published data (Perry and Evans 1975» Loveday and Latt 1979)
—8suggested lO" M MC as an appropriate concentration and the mutagen 
was therefore tested at this dose level.
The experimental procedure was exactly as detailed in 5*3.1 — 
5*3*3* CHO-KIA cells were at passage 32 and MC was dissolved then 
further diluted in double distilled water immediately before addit­
ion to the test culture (see 2.10.1). Twenty cells (5 on each of 4 
slides) were scored from both test and control cultures. Results are 
presented in Table 5*7.
-8TABLE 5*7 Effect of MC at 10 M concentration on the control fre­
quency of SCE in CHO—Kl/cells cultured in the presence of 20 ^  BrdU
Treatment Mean no. of SCEs/
metaphase - S.E.
Control, HgO 0.49% 16.6 1 1.0
MC 10"®M 27*4 - 1*2
lO" M MC induced a moderate increase above vehicle control in the 
number of SCEs/metaphase, indicating that this concentration of mut­
agen was suitable for use in subsequent experiments with TPA.
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5.11 The Effect of TPA on the Induction of SCE by MC 
Following the finding that TPA has little or no influence on the 
yield of MNNG—induced SCEs, an investigation was undertaken to 
determine if TPA can modify the elevated frequency of SCE seen 
following treatment of CHO-Kl cells with a different chemical mut­
agen — MC. The MC concentration used in this investigation was 10
As in the MNNG experiments TPA was tested for SCE modulating activity
7 —6at 1.6x10*” and 1.6x10 M concentration.
CHO-KIA cells at passage 32 were exposed to mutagen with and 
without promoter (TPA from batch 2) and chromosome spreads prepared 
as in the definitive cell treatment procedure. Metaphases were then 
harlequin stained using the FPG technique and 8 cells scored for ex­
changes on each of 4 slides per treatment. The results of the exper­
iment are summarised in Table 5*8*
TABLE 5*8 Effect of TPA at two concentrations on the elevated fre­
quency of SCE observed in CHO—KIA cells treated with 10 ^  MC in the 
presence of 20 jiM BrdU
Treatment Mean no. of SCEs/ metaphase — S.E.
Vehicle control 17.8 i 0.6
(H^O 0.49% + DMSO 0.49%)
MC + DMSO 31.0 i 1.1
MC + TPA 1.6xlO"\ 27.9 - 1.0
c
MC + TPA 1.6x10 M 28.7 ± 1.1
The difference between the SCE frequency following MC treat- 
ment alone and MC treatment in the presence of 1.6x10 M TPA, though 
small, (see Table 5*8), was found to be significant at the 59% level 
when a two-tailed test of significance was made. At the higher con—
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—6centration of 1,6x10 M,TPA did not significantly affect the elevated 
frequency of SCE seen following MC treatment.
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5.12 The Effect of TPA on the Frequency of Spontaneous Chromo­
somal Aberrations
An investigation was undertaken to determine whether TPA causes 
chromosome breakage or any other microscopically discernible struc­
tural changes in the metaphase chromosomes of CHO—Kl cells. In 
particular this study attempted to establish if TPA has any effect 
on the incidence of quadriradial structures. If tumour promoters 
act by inducing mitotic recombination, as well as inducing SCEs, 
these agents would be expected to evoke non—sister chromatid ex­
changes, which are observed at metaphase as guadriradials (5.I)#
2x10^ CHO-KIA cells at passage 36 were inoculated with ^ 1  
of MFIOE into four 25cm^ t/C flasks. After a 24-28hr growth per­
iod the cultures were treated with either 1.6x10 M TPA; 1.6x10 M 
TPA; TPA vehicle — 19% V/V DMSO; or 2.4mM  ̂EMS. The cells were ex­
posed to these treatments for l6hr, then medium was replaced with 
^ 1  of fresh MFIOV and colchicine added (1.25 . Cells were re-
incubated for 4kr, to accumulate metaphases; then harvested by 
trypsinisation, swelled in hypotonic KCl and fixed in 3:1 methanol, 
acetic acid (3.7.1). Chromosome spreads were prepared on micro­
scope slides within an hour and later stained for 3—^in in a 59%
V/V solution of Giemsa (2.9), rinsed in neutral deionised water and 
dry mounted in DPX.
After staining and mounting, 4 slides from each of the differ­
ently treated cultures were coded and randomised before being exam­
ined ’blind' under transmitted light optics. Each slide was scanned 
methodically under low magnification (x256) for metaphase cells.
Once located, each metaphase cell was more closely examined under 
h i ^  magnification (xl600) . If the cell was quasi—diploid i.e. 
contained 17—23 centromeres and had not sustained any damage during
2 3 1
slide preparation, it was analysed for chromosome aberrations.
Bias towards the selection of well spread metaphase cells was 
countered by excluding only those cells so badly spread as to 
make scoring of chromosomal aberrations impossible. Twenty five 
cells were scored per slide, i.e. 100 cells per treatment# The 
chromosomal aberration yields following the four different treat­
ments which cells received are recorded in Table 5»9* The values 
refer to the percentage of metaphase cells showing the specific 
aberrations. In the final column of the table the percentage of 
cells, for a particular treatment, displaying any type of aberra­
tion is given. Because it is considered that chromatid and chrom­
osome gaps may not be true aberrations (Savage 1975» Nichols 1977) 
the percentage of cells with one or more abnormalities excluding 
these classes is also given in parentheses.
It is clearly evident from the results in Table 5*9 that the 
mutagen EMS, a known chromosome breaker (or clastogen) (Kao and 
Puck 1969) , induced a large number of chromosomal aberrations in 
CHO-Kl cells. The percentage of cells displaying aberrations foll­
owing 2.4mM EMS treatment was 6—fold higher than that observed foll­
owing vehicle control treatment and when gaps were excluded more 
than 10—fold higher.
The results obtained with TPA suggest that at 1.6x10 the 
phorbol ester has no effect on chromosome structure, except possibly 
to increase the incidence of chromatid gaps. However, following 
treatment at the higher concentration of TPA, 1.6xlO"^M, non-gap 
aberrations were observed in 5/% of cells, compared with 29% of cells 
from the vehicle control culture. Whether this difference was due 
to aberration induction by the phorbol ester or simply to biological 
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bers of aberrations/cells involved*
With regard to the incidence of guadriradials, none were ob­
served following treatment with either concentration of TPA, Thus 
it appears that TPA is not a potent inducer of symmetrical non- 
sister chromatid exchanges in mammalian cells#
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5.13 Discussion
It has been suggested that tumour promoters act by inducing or 
enhancing the frequency of mitotic recombinations in the cells 
of their target tissue, this action leading to the segregation 
and expression of recessive oncogenic mutations, induced by 
earlier treatment with an initiating carcinogen. Mitotic recom­
bination, if it occurs in mammalian cells, must involve an ex­
change between non-sister chromatids of homologous chromosomes, 
therefore the induction of sister chromatid exchange — a closely 
similar recombinational event — by the tumour promoter TPA has 
been cited as evidence in support of the stated hypothesis.
Initial reports regarding the effect of TPA on SCE in cul­
tured mammalian cells presented evidence of significant elevation 
of control exchange frequencies following treatment of V79 Chinese
hamster cells and C3H/1OTI/2 mouse cells at phorbol ester coneen—
7 —6trations of 1.6x10 and 1.6x10 M (5.I). The present study in­
vestigated the effect of TPA at these same concentrations on SCE 
frequency in a third cell line - CHO—Kl, Tumour promoters char­
acteristically potentiate the action of chemical carcinogens, 
therefore the influence of TPA on SCE induction by MNNG and MC 
was also determined.
To assay SCEs a cell treatment procedure was developed which 
involved exposing CHO-Kl cultures to the thymidine analogue BrdU 
over two DMA replication rounds (5.3.1). Test compounds were added 
for the duration of BrdU exposure and colchicine for the final 4hr 
prior to cell harvest, to accumulate metaphases. The semi—conser­
vative incorporation of BrdU into chromosomal DNA allowed the diff­
erential staining of sister chromatids by a modified FPG technique 
(5.3.2) and the visualisation of SCEs with high resolution (see
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Plate 5*ï)• Using a rigidly standardised scoring method (5*3.3) 
cells were subsequently analysed for SCEs. Results are expressed 
as the mean frequency of SCE per metaphase. Initial experiments 
(5.4 and 5.5) used BrdU at a concentration of 10 pM. However, sub­
sequent failure to obtain differential staining of sister chromatids 
in a few abortive experiments prompted an increase to the 20 pM BrdU 
used in the definitive cell treatment procedure (5.3.1). Following 
this change acceptable differential staining was achieved in vir­
tually all experiments.
In a preliminary study (5.4) the effect of KÎJNG on SCE in 
CHO—Kl cells was determined. It was found that the mutagen/carcin­
ogen induced exchanges in a dose—dependent manner, the lowest test 
concentration eliciting a marked elevation of control SCE frequency 
being 6.8xlO"^ (see Table 5.I). Thus, as reported by Perry and 
Evans (l975)î who treated cells of CHO—Kl’s parental cell line, CHO, 
under almost identical experimental conditions and over a closely 
comparable concentration range; MNNG was found to be a potent in­
ducer of SCEs in mammalian chromosomes. In another preliminary 
experiment (5*10), this time employing the definitive cell treatment 
procedure (5.3.1), the SCE-inducing ability of MC, another mutagen/ 
carcinogen reported to be a potent inducer of exchanges in CHO cells 
(Perry and Evans 1975, Loveday and Latt 1979), was determined. At 
10" ^  concentration this agent induced a marked increase (> 50f) 
above control SCE frequency (see Table 5.7). The results from these 
two experiments establish that the SCE assay procedure used here 
(5.3.1 - 5*3.3) was as sensitive to cellular mutagen/carcinogen ex­
posure as the assay systems used by other workers. It was therefore 
suitable for utilisation in the study of the effects of TPA on con­
trol and mutagen-elevated SCE frequency.
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In experiment 5*5, the response of the control CHO-Kl SCE fre­
quency (in the presence of 10 jM  BrdU) to l#6xlO"^M TPA was deter­
mined. This concentration of TPA is reported to be maximally effect­
ive for the induction of SCEs in V79 cells (Kinsella and Radman 1978)• 
The untreated control SCE frequency (12.2/metaphase) was identical to 
that reported for CHO cells cultured in the presence of the same con­
centration of BrdU (Perry and Evans 1975)* Cells from the positive
-7control culture, treated with 3*4x10 M IC'RJG, as expected, showed an 
elevated SCE frequency (see Table 5*2)* However, cells exposed to 
TPA showed no elevation of mean exchange frequency when compared with 
cells from untreated or DMSO-treated control cultures. A possible 
effect of MSO on SCE frequency was, however, observed. The numbers 
of cells scored per treatment were too small to permit meaningful 
statistical analysis of the significance of the difference between 
the mean SCE frequencies for untreated and DMSO controls, so a fuller 
study was necessary (5*6)* The results of that experiment (Table 5*3) 
and another in which both untreated and DMSO controls were included 
(5.7, results Table 5*4), unequivocally established that the TPA 
vehicle has no effect on SCE frequency in CHO—Kl cells.
In Experiment 5*7 the effect of TPA on control SCE frequency was
again determined at 1.6x10 ^M and additionally at the 10—fold lower
—7concentration of 1.6x10 M. TPA from a different sources to that used 
previously was utilised to ensure that batch differences were not 
responsible for the null response seen in the first experiment. Suff­
icient metaphase cells were scored to allow statistical analyses of 
the differences between mean SCE frequencies observed following the 
various test and control treatments (5*3*4) • The results in Table
5.4 clearly show that once again TPA had no effect on vehicle control 
SCE frequency. The slight reduction in SCEs/metaphase (compared with
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untreated control) seen with both concentrations of the ester was 
not significant at the 59% level.
The above findings of no SCE induction in CHO-Kl cells by TPA
were reinforced by the results of a further experiment (5.9) which
—T —*6again incorporated TPA treatments at 1.6x10 and 1.6x10 M concen­
tration. A modification was made to the SCE assay procedure in this 
case — instead of harvesting cells by trypsinisation at the end of 
BrdU exposure and promoter treatment, mitotic cells only were har­
vested by shake-off. The object of this modification was to deter­
mine if the increase in SCE frequency observed following TPA treat­
ment of V79 cells by Kinsella and Radman (1978) could possibly be an 
artefact of the latter harvesting procedure. The results of the ex­
periment (summarised in Table 5*6) are not only consistent with those 
in Table 5*4 with respect to the non—enhancement of control SCE fre­
quency by TPA, but also with respect to actual mean SCE frequencies 
obtained following identical treatments. Thus harvesting cells, 
whether by trypsinisation or mitotic shake—off, appears to give the 
same SCE yield following a particular treatment.
The effect of TPA on mutagen—elevated SCE frequency was exam­
ined with both mutagen and promoter added to cells for the duration 
of the BrdU exposure period. In the case of 1.36x10 M MNNG (5.8) 
no significant enhancement of SCE induction was observed at either of 
the two standard TPA test concentrations (see Table 5*5)* However,
n
it was found that the mean SCE frequencies following MNNG + 1.6x10 M 
TPA and MNNG + 1.6x10 ^M TPA were significantly different — the former 
being 11.1 SCEs/metaphase higher than the latter. This finding was 
reaffirmed by the results of the shake—off experiment mentioned above, 
which included MNNG treatments with and without TPA. Here again it 
was found that the lower concentration of TPA slightly-increased and
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the higher concentration slightly decreased, the MIJNG—elevated SCE 
frequency (see Table 5»6). Thus it appears that the tumour promoter 
may have some mild modulatory effect on MIJNG—elevated SCE frequency. 
Given that TPA has no influence on SCE frequency in CHO—K1 per se, 
this effect is likely to occur via an indirect mechanism. Possibly, 
at the different concentrations of phorbol ester, the accessibility 
of the DNA to MTNG or an ultimate DNA—damaging chemical species is 
oppositely affected - at the low concentration being increased and 
at the high concentration decreased. As TPA can act either to in­
duce or inhibit cell proliferation at different concentrations in 
other cell types (Wang et al. 1975» Fusenig and Samsel 1978), an alt­
ernative explanation is that opposing effects on MNNG—elevated SCE 
frequency in CHO—K1 are somehow connected with a differential effect 
of TPA on the rate of DNA synthesis at the two concentrations.
When TPA was tested for its effect on the elevation of SCE 
frequency by MC (5*ll), it was found that the promoter caused no 
significant enhancement of the response to the mutagen (see Table
mmTl5.8); indeed, in the presence of 1.6x10 M TPA, MC induced, on av­
erage, 3.1 fewer SCEs/metaphase than in the culture treated with MC 
+ DMSO. A two-tailed significance test applied to the relevant in­
put data revealed this difference between promoter—treated and veh­
icle-treated cells to be significant at the 'jfo level. As in the case 
of the marginal effect of TPA on MNNG induction of SCEs, this diff­
erence is easily attributable to cellular changes induced by the pro­
moter, which, though not directly related to exchange formation, can 
to a small extent influence SCE frequencies observed following muta­
gen treatment.
Since Kinsella and Radman*s original report of SCE induction by 
TPA in V79 cells, several groups of workers have investigated the
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effects of the tumour promoter on the frequency of this chromosomal 
change in cells of this and other established cell lines. As det­
ailed in 9.1, Nagasawa and Little (1979) observed that TPA increased 
both the control frequency of SCE observed in the presence of 10 
BrdU and the frequency of X-ray induced SCEs in C3H/IOTI/2 mouse 
fibroblasts. Gentil et al. (I980) have expanded the study of TPA's 
effect on SCE frequency in V79 cells. They report that, at between
<7 ^
3.3x10"* and 1.3x10*” M concentration, TPA caused an increase of app­
roximately 50̂  over the level of spontaneous SCE formation observed 
in the presence of I5 BrdU. In addition, in UV-irradiated cells, 
TPA, when present after mutagen exposure, strongly enhanced UV— 
induced SCE formation; more SCEs being induced than the expected sum 
of SCEs formed by the separate treatments. The protease inhibitor 
and anti-promoter antipain (Troll et al. 1978) completely inhibited 
TPA induced SCEs but did not affect UV—induced SCEs. When UV—irrad­
iated cells were treated with both TPA and antipain the promoter en­
hancement of SCE induction was only partially inhibited, suggesting 
that TPA was responsible for two independent effects, both leading 
to SCE formation.
The results of the present study, which show that TPA does not 
significantly enhance either control or mutagen elevated SCE frequen­
cies in CHO—K1 cells, though in disagreement :ith the findings out­
lined above, are consistent with observations by several other groups 
who have attempted to confirm that TPA increases SCE formation in 
vitro. Love day and Latt (1979) a,nd Thompson et al. (1980) both re­
port that TPA, over a wide concentration range, does not increase SCE 
frequency in either CHO or V79 cells. Neither does the phorbol ester 
appear to influence the induction of SCEs in CHO cells by MC (Loveday 
and Latt 1979)• In another set of investigations with V79 cells.
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Pujiwara et al. (1980) failed to demonstrate that TPA (l.6xlO"^M) 
significantly alters either baseline or UV—elevated SCE frequencies 
— in direct contradiction of the results of Gentil et al. discussed 
above. As part of this same study, the effect of continuous expos­
ure to TPA on the frequency of delayed SCEs, observable 6—7 days 
after mutagen treatment, was also determined. Again the promoter 
had no effect.
Importantly, although TPA and 4 other unrelated chemicals, with 
widely different skin tumour-promoting potencies, all increased con­
trol SCE frequency when recently tested in V79 cells, the increase 
was closely similar and very small for all 5 compounds (Connell and 
Duncan I98I). This lack of distinction between potent and weak pro­
moters in the ability to induce SCEs does not support the concept of 
the induction of SCEs being mechanistically related to tumour pro­
motion.
Reasons for the discrepancies between the results of very sim­
ilar studies into the effects of TPA on SCE frequency in cultured 
mammalian cells, though unknown, can be conjectured. The conflicting 
reports regarding the phorbol ester's effect in V79 cells may be a 
consequence of the fact that different clones of these cells have been 
used in all the various studies conducted to date. It may be that TPA 
enhances SCE formation in certain clones of these aneuploid established 
cells while not in others. If this is the case, the question immedi­
ately arises as to which is the true result with respect to TPA's eff­
ect in normal cells in vivo. Alternatively, the use of the shake-off 
cell harvesting procedure by Kinsella and Radman may have been respon­
sible for an ante factual observation of TPA induction of SCEs in V79 
cells, as suggested by Thompson et al. (1980) . However, results with 
CHO-Kl cells in the present study (Table 5*6) and the fact that Gentil
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et al. (1980) observed elevated SCE frequencies in TPA—treated V79 
cells harvested by trypsinisation suggest that this is not the case. 
Results obtained with CHO—K1 cells (Tables 5*2, 5*4 - 5.6, 5*8) and 
with cells of the parental CHO cell line (Loveday and Latt 1979» 
Thompson et al. I980) are consistently negative. Positive results 
with C3H/IOTI/2 mouse fibroblasts (Nagasawa and Little 1979) are as 
yet unrefuted. In these latter cases it may be that conflicting 
findings are due to the tissue or species difference in the origin 
of the two cell lines.
There is now an urgent need to determine the probable effect of 
skin tumour—promoting compounds on SCE in their target cells in vivo 
- the epidermal stem cells (Boutwell 1974)• CHO, CHO—Kl, V79 and 
C3H/1OTI/2 are all established cell lines whose cells possess abnor­
mal (aneuploid) chromosome complements (Kao and Puck I968, Nagasawa 
and Little 1979» Pujiwara et al. I960) . This task should therefore 
be immediately approached by determining the effect of TPA on SCE 
frequency in cells of primary diploid lines, whose characteristics 
closely approximate those of cells in vivo (Paul 1975)•
Techniques have been developed which permit newborn mouse 
epidermis to be cultured in vitro (Yuspa et al. 1976a, Pusenig and 
Samsel 1978). A future study might usefully determine the effect of 
TPA on SCE frequency in the cells of such primary cultures. Ultim­
ately, the effect of TPA on SCE in stem cells of adult mouse epiderm­
is, treated with the promoter in vivo, will have to be established.
As well as the controversy regarding the possible induction of 
SCEs in mammalian cells by TPA, several other facts detract from the 
hypothesis that tumour promotion is a consequence of mitotic recom­
bination. In experiment 5*12 the ability of TPA to induce structur­
al chromosomal aberrations was tested, to determine:
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(1) if the tumour promoter can induce metaphase 
quadriradial chromosome structures which, thou^ 
rare, are the most unequivocal cytological indi­
cators of mitotic recombination available (German 
1964, Chaganti et al. 1974); and
(2) if the tumour promoter has any general dis­
ruptive effect on chromosome structure, as do many 
primary carcinogens.
The results of the experiment (Table 5*9) suggest that in CHO-Kl 
cells TPA does not induce quadriradial structures. However, a 
larger study is indicated to show that this is definitely the case, 
because it is possible that even when their frequency is markedly 
elevated, no increase in quadriradials will be detectable in as few 
cells as the 100 scored per treatment in the current experiment.
The results in Table 5«9 also show that the phorbol ester had no 
observable disruptive effect on chromosome structure, in agreement 
with the findings of Kinsella and Radman (1978).
Kinsella et al. (1978) have cited their finding that TPA 
stimulates the segregation of two recessive genetic traits from 
doubly heterozygous interspecific cell hybrids as possible evidence 
of the induction of mitotic recombination by the tumour promoter.
This finding has now been contradicted. Using a fluctuation test 
it has been shown that TPA (6.4x10"’̂ M) does not affect the mutation 
rate in CHO cells at the autosomal aprt locus (Thompson et al. I980) . 
This locus is functionally heterozygous (+/—) and if TPA possesses 
recombinogenic activity it would be expected that the rate of change 
to the homozygous (-/—) state (which confers resistance to the anti- 
metabolite azaadenine) would be increased. It may be argued, from 
SCE results, that CHO is merely a cell type in which TPA is ineffect—
24 3
ive as a recombinogen. However, even if this is the case, the 
original results of Kinsella et al.are seemingly invalidated as 
evidence of TPA induction of mitotic recombination by the finding 
that spontaneous or induced segregation of markers in cell hybrids 
does not involve this genetic event (Posenstraus and Chasin 1978)• 
Furthermore, Kunz et al. (I980) report that, for a short series of 
skin tumour promoters, there is no consistent correlation between 
tumour—promoting activity and the ability to induce mitotic recom­
bination in yeast Saccharomyces cerevisiae.
Thus the results of the present study are consistent with 
those obtained by several other groups which question whether TPA 
induces SCE in mammalian cells in vitro and hence whether tumour 
promotion is the result of mitotic recombination, causing the ex­
pression of recessive oncogenic mutations in carcinogen-initiated 
cells. A final objection to the mitotic recombination model of 
tumour promotion is that it does not allow for an important char­
acteristic of tumour promotion, namely the reversibility of this 
stage of chemical carcinogenesis (Boutwell 1964, 1974)*
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CHAPTER 6
LYMPHOCYTE STIMULATION IN VITRO BY TUMOUR PROMOTERS
lymphocytes are non-phagocytic, actively amoeboid white blood cells 
found in the blood and lymphatic system of all vertebrates (Aber­
crombie et al. 1973). They are relatively small cells (6-8 pm 
diameter in man) usually spherical, showing a thin rim of aigranu- 
lar cytoplasm around a densely packed nucleus (see Plate 6.1). Der­
ived from primitive lymphoid cells, whose source is the bone marrow, 
fully differentiated lymphocytes are of two types:
(1) T-lymphocytes which mature under the influence of 
the thymus gland and subsequently mediate cellular 
immunity and
(2) B-lymphocytes which mature in the bone marrow (in 
mammals) to become antibody—forming cells responsible 
for humoral immunity.
Cells of both these populations are long-lived and normally non- 
dividing. However, on stimulation by antigens both T- and B- 
cells proliferate and undergo changes in morphology known collect­
ively as blast—transformation. Such a response is also obtained 
when lymphocytes from genetically dissimilar (allogeneic) individ­
uals are cultured together in vitro, a phenomenon called the mixed 
lymphocyte reaction (MLR)• Comparable changes can be induced by 
compounds termed lymphocyte mitogens. Such agents, usually plant 
lectins, act at the lymphocyte cell surface to elicit morphologic 
blast—transformation and mitosis. Unlike antigens, to which only 
small specific cell fractions can respond, mitogens are polyclonal 
activators capable of stimulating large portions of the lymphocyte 
populations (Roitt I980).
The potent tumour promoter l?-0-tetradecanoylphorbol—13—
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acetate (TPA) is a mitogen for lymphocytes from several animal 
species. As well as possessing direct mitogenic activity TPA 
can also enhance lymphocyte stimulation by other mitogens, that 
is, it can act as a comitogen. Much attention has been paid to 
TPA’s effects on lymphocytes because in studies of cell stimu­
lation these cells offer certain technical advantages over oth­
er cell types — they have a low basal level of DNA synthesis, 
are readily available (normally forming 20—40^ of the white 
blood cell count in human blood) and can be maintained and grown 
in suspension.
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6c1 Effects of Phorbol Esters on Non-Human lymphocytes 
When assessed using stimulation of DNA synthesis as a monitor,
TPA has been shown to be strongly mitogenic for rat thymus lym­
phocytes (Whitfield et al. 1973) and for several types of primate 
peripheral blood lymphocytes (Abb et al. 1979)* A weak mitogenic 
effect has also been demonstrated for mouse spleen (Suss and Schu­
ster 1974) and thymus lymphocytes (Rosenstrich and Mizel 1979) and 
for bovine lymph node lymphocytes (Mastro and Mueller 1974) •
TPA most commonly exhibits comitogenic activity when en­
hancing mitogenesis induced by the plant lectins phyto haemagglu­
tinin (pe a) and concanavalin A (ConA). A moderate effect of TPA 
was demonstrated in mouse spleen cells treated with ConA (Suss 
and Schuster 1974) • In bovine lymphocyte populations a much great­
er comitogenic effect was observed (Mastro and Mueller 1974)» TPA 
was found to act synergistically with both PHA and ConA to stimu­
late DNA synthesis, affecting cells that would not otherwise res­
pond to the lectins. In contrast to its comitogenic effect on 
bovine lymphocytes stimulated with lectins, TPA inhibits the induc­
tion of DNA synthesis in cultures of these cells undergoing the mix­
ed lymphocyte reaction (Mastro and Mueller 1978). TPA was shown not 
to affect cells already undergoing DNA replication, suggesting that 
it probably acts at some early step necessary for the triggering of 
cell replication.
TPA has a unique effect on purified guinea pig T-lymphocytes 
(Rosenstrich and Mizel 1979)• These cells cannot be stimulated by 
lectins unless macrophages or macrophage-derived solult factors are 
present. Although TPA by itself was found to be non-mitogenic for 
these cells, at extremely low concentrations ( 1.6x10 ^^) it en­
abled them to respond to PHA or ConA. TPA appeared to replace
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macrophages as the source of a putative second signal required to 
induce T-cell proliferation in vitro.
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6.2 Effects of Phorbol Esters on Human lymphocytes 
Estensen and co-workers (1974) first observed TPA-induced morph­
ologic blast-transformation and proliferation of human peripheral 
blood lymphocytes (PBL) . Cultures treated for 72hr with 1.6x10 
TPA showed a high proportion of blast lymphocytes (lymphoblasts) 
and some mitotic cells. The lymphoblasts were larger than normal 
lymphocytes. They had a more basophilic cytoplasm, which was often 
vacuolated and contained pale staining nuclei usually showing one 
or more nucleoli. These TPA-induced blast cells resembled those 
induced by PHA, but could be distinguished from them by their 
smaller size and more extensive vacuo1ation.
Using both transmission and scanning electron microscopy 
Skinnider (1979) performed an ultrastructural study of TPA-induced 
blast-transformation. Human PBL treated with TPA ( 1.6x10 M) for 
72hr showed nuclear dedifferentiation, increases in cytoplasm and 
polyribosomes and occasional annulate lamellae. The changes were 
generally similar to those found in PHA—stimulated lymphocytes, ex­
cept for the finding of annulate lamellae. These are cell organ­
elles of unknown function found mainly in malignant and embryonal 
cells (Ghadially 1975)• Their presence may indicate that TPA pro­
duces a more fundamental dedifferentiation of lymphocytes than PHA.
Estensen et al. (1974) determined a dose—response relation­
ship for TPA mitogenesis by measuring ^H-thymidine uptake into new­
ly synthesised DNA of stimulated lymphocytes. They showed that TPA 
was mitogenic at concentrations ranging from about 1.6x10 ^ to
1.6xlO*"^M, the highest concentration tested. Comparing the rela^ 
tive mitogenic efficiencies of TPA and PHA, Touraine et al. (1977) 
reported that maximum lymphocyte stimulation by TPA (at 1.6x10 M) 
averaged 80̂  ̂of the response to an optimal dose of PHA. Considéra-
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ble variability in the relative responses to TPA and PHA was however 
noted between lymphocytes from different donors. When lymphocytes 
were treated with TPA and PHA simultaneously the resultant ^H—thy­
midine incorporation was approximately equivalent to the sum of the 
uptakes observed in response to each agent alone. On the basis of 
these observations, Touraine et al. proposed that separate TPA— 
responsive and PHA—responsive fractions exist within the human PBL 
population. Further investigations indicated that the TPA—respon­
sive subpopulation resides almost completely within the T—lympho­
cytes, Its cells appear to have a high affinity for sheep red blood 
cells (SRBC) and to be distinct from those responding to PHA and 
ConA. The size of the TPA-responsive subpopulation has been est­
imated to approximate 20^ of the whole PBL population, about one 
quarter of the T—cells, a subpopulation only slightly smaller than 
that responsive to PHA (Estensen et al. 1978).
An interesting distinction between the TPA and PHA responses 
also reported by Touraine et al. (1977) was their differential sen­
sitivity to glucocorticosteroid inhibition. The TPA response was 
found to be sensitive to 2-3 logs lower concentration of hydro­
cortisone than the PHA response. It was not ascertained whether TPA 
was sensitizing the responding cells to hydrocortisone or acting on 
a sterioid sensitive subpopulation. Nevertheless, these workers were 
prompted to suggest that the TPA responsive subpopulation is more 
likely to correspond with T—cells helping antibody production 
(helper T-cells), than T-cells responding in the mixed lymphocyte 
reaction (allogeneic responders), since the activities of these 
two T-cell subsets show analogous differential sensitivity to ster­
oids (Segal, Cohen and Feldman 1972). Similar differential sensi­
tivity of the TPA and PHA responses to dexamethasone inhibition has
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also been reported (Gordon and Nouri I981). The suggestion that 
cells stimulated by TPA are not allogeneic responders was supported 
by the finding that the MLR was unaffected by bromodeoxyuridine in­
corporation and subsequent light ablation of the TPA-responsive sub­
population. The data imply that cells responsive to TPA and to allo­
geneic cells in the MLR come from non-overlapping subpopulations. 
However, the results of Edwards et al. (I981) suggest that signifi­
cant interaction between the MLR and phorbol ester action must occur 
at some level. They reported that TPA and certain closely related 
deoxyphorbol esters have strong comitogenic effects on the MLR. The 
observed enhancement of lymphocyte stimulation was not simply the 
result of summation of the ester and MLR responses, since the com­
pounds exhibited their comitogenic activities at concentrations 
well below those required to induce mitogenic responses. These 
workers suggest that either different mechanisms are involved in 
mitogenicity and comitogenicity or, more likely, that two signals 
are required to trigger mitogenicity, only one of which is required 
for comitogenicity. A theory consistent with findings in guinea pig 
T-l^mphocytes, where stimulation in vitro has been shown to require 
two distinct stimulatory signals (Rosenstrich and Mizel 1979)•
In contrast to the evidence of TPA selectivity for T—lympho­
cytes reported by Touraine et al. (1977)» Abb et al. (1979) have 
reported that TPA causes a non-selective activation of human PBL.
They showed that both T- and B-cell enriched lymphocyte populations 
responded to stimulation by TPA. Identification of induced lymph­
oblasts, following TPA treatment of an unfractionated population, 
provided additional evidence for non-selectivity of action. Sixty- 
seven percent of TPA-induced lymphoblasts bound a T-cell marker and 
^ a B—cell marker, indicating that TPA is a potent mitogen for both
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T— and B—lymphocytes. The conflicting reports concerning TPA sel­
ectivity may reflect differences in the spectrum of responses to 
TPA between lymphocyte populations from different donors. Alter­
natively, subtle differences in the fractionated lymphocyte sub- 
populations treated may have had profound effects on the mitogen­
ic responses observed in the two studies.
Recently Abb and Deinhardt (1980) have shown that TPA induces 
the production of lymphocyte—activating factors (LAP) by human PBL. 
Production of LAP was shown to be independent of macrophages and 
therefore must occur within the lymphocytes themselves. Thus pro­
duction of LAP by a lymphocyte subset may mediate TPA's mitogenic 
(and possibly comitogenic) action. The cells producing LAP are 
likely to be T-cells because many biologically active soluble factors 
similar to LAP (termed lymphokines) are known to be released from 
within the T-cell population (Roitt I980). Therefore, though B- as 
well as T-cells probably respond to TPA, it is likely that the phor— 
bol ester elicits a mitogenic response by first acting on a T—cell 
sub-po pulat ion.
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6.3 The Possible Use of lymphocytes to Test for Tumour-Promoting 
Activity
The probable targets for initiator and promoter action in two—stage 
mouse skin carcinogenesis are the epidermal cells, since these are 
the cells from which skin tumours develop (Boutwell 1974)* Mouse 
epidermal cells show increased macromolecular synthesis and sub­
sequent cell proliferation following TPA exposure, both in vivo 
(Baird et al. 1971) and in vitro (Pus enig and Samsel 1978). Such 
tumour promoter-induced epidermal cell proliferation has been shown 
to have an essential role in the promotion step of mouse skin tumour 
formation (Boutwell I964) • It has also been found that for a series 
of phorbol esters the ability to stimulate DNA synthesis in epiderm­
al cells correlates well with promoting potency (Baird et al. 1971, 
ïisçpa et al. 1976 b).
The mitogenic response of human and other lymphocytes to TPA 
treatment in vitro is analogous to the proliferative response shown 
by mouse epidermal cells following exposure to TPA or other tumour- 
promoting phorbol esters. Furthermore the pattern of morphological 
and ultrastructural changes induced in epidermal cells following 
application of TPA to mouse skin (Raick 1973a)shows similarities to 
the changes that have since been observed in TPA—stimulated human 
lymphocytes (Skinnider 1979)• In both cases TPA modifies the cells, 
returning them to a less differentiated state; epidermal cells ac­
quire characteristics resembling those of such cells in embryonic 
skin and lymphocytes undergo blast—transformation.
Rohrschneider and Boutwell (1973) reported that early stimu­
lation of phospholipid metabolism, particularly synthesis of phos­
phatidylcholine, occurs in mouse skin following application of TPA. 
This stimulation was recognised as an important early event in tumour
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promotion, since it could only be induced by the tumour—promoting 
phorbol ester and not by non-promoting hyperplastic agents. Simil­
arly TPA has been shown to cause rapid increases in ^H-choline incor­
poration into phospholipids of bovine lymphocytes (Wertz and Mueller 
1978). Allied to the other similarities of the mouse epidermal cell 
and lymphocyte respcnses to TPA, this is a compelling indication of 
a relationship between the lymphocyte-mitogenic and tumour-promoting 
actions of phorbol esters. Support for the existence of such a 
relationship was provided by the work of Estensen et al. (19?8) in­
vestigating the effects of TPA, three TPA analogues of mild biolog­
ical activity and the parent alcohol phorbol on ^5-thymidine uptake 
into the DNA of human PBL. Phorbol which has no mouse skin tumour- 
promoting activity (Hecker 1978) failed to stimulate DNA precursor 
uptake at any of the test concentrations. All the other compounds 
stimulated uptake in a dose—dependent manner. TPA, the most potent 
tumour promoter, was also the most potent lymphocyte mitogen. The 
three TPA analogues, all weak promoters, though mitogenic were only 
effective at much higher concentrations than TPA. Thus for this 
group of compounds correspondence of lymphocyte-stimulating activ­
ity with tumour-promot ing activity was evident. Lymphocyte stimula­
tion in vitro therefore warranted investigation to determine if it 
could provide a useful system for identifying and studying tumour 
promoters.
The aim of the proposed study was to determine if the above 
correspondence of lymphocyte-stimulating and tumour-promoting activ­
ities extended to other pherbol derivatives not tested by Estensen et 
al. By investigating a larger series of compounds, with a better 
spread of tumour-promoting potencies, than these workers, it was 
hoped to establish whether, in addition to an overlap of the two
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activities, there is a correlation between the level of lymphocyte- 
stimulating activity exhibited by a compound and its tumour-promot­
ing potency. If this was found to be so, then a lymphocyte stimu- 
ation assay system could possibly be adopted as a partially quanti­
tative prescreening test for the tumour-promoting potential of envir­
onmental chemicals. To have value as a prescreening test such an 
assay system would, however, have to be capable of detecting tumour 
promoters of classes other than phorbol derivatives. Therefore it 
was proposed that phe nobarb it one, a promoter of rat liver tumours 
(Peraino et al. 1971, Peraino et al. 1978), should also be tested 
for its effect on human lymphocytes#
Phorbol and its derivatives are from the diterpene class of 
compounds (see 1.2). To conclude the study, it was planned to as­
certain if a non—phorbol diterpene, possessing extremely high bio­
logical activity, could stimulate lymphocytes.
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6.4 Culture Media
During the initial (macroculture) experiments lymphocytes were 
cultured in modified PIO medium supplemented with ICÇb serum 
(MPIOI, see 2.8) . In the preliminary experiment attempting to 
confirm that TPA stimulates cellular ^-thymidine uptake, the 
same medium minus the thymidine component (MFlO(-dT)Z) was used.
Throu^out the microculture experiments lymphocytes were 
cultured in a modified RFMI I64O medium supplemented with 10%& 
foetal bovine serum (PBS). RFMI I64O was originally designed 
for growing leukaemic cells (Moore et al. I967), it is now pop­
ular as a general purpose medium and is widely used for the cul­
ture of lymphocytes. A modification of this medium containing 
both HEPES buffer (20mM) and sodium bicarbonate (ll.9mM) was used. 
Such a medium with a dual pH buffer system, has been reported to 
give better and more reproducible results in lymphocyte stimula­
tion experiments than media containing either buffer alone 
(Sanderson et al. 1974)*
Single strength RFMI I64O (Dutch modification) obtained in 
500ml quantities was sub-divided into 100ml volumes and stored at 
4^C. Before use the following supplements were added per 100ml of 
medium ; 1.^1 of 200mM L-glutamine solution; 1ml of penicillin 
(5,000 lUml**̂ ) and streptomycin (5,000 solution; and
11.4ml of PBS, giving 10^ serum in the complete medium. The pre­
pared culture medium (designated RFMH) was stored at 4^C and used 
within one week. Medium and all supplements,except PBS (Sera Lab 
Limited, Crawley), were obtained from Plow Laboratories Limited, 
Irvine, Scotland.
Sera probably contain inconsistent titres of factors weakly 
mitogenic to lymphocytes. These may well affect the control level
of lymphoèyte thymidine uptake and possibly, via a comito— 
genic action, the level of induced uptake in response to mito­
gen treatment. Therefore the batch number of the PBS used in 
each experiment is recorded.
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6*5 Special Materials 
Blood specimen tubes:
10ml volume, coated with preservative—free lithium heparin 
(Walter Sarstedt (UK) Limited, Leicester)•
Screw—capped test tubes:
Round bottomed, glass, l6 x 120mm (Plow Laboratories Limited, 
Irvine)•
Picoll-Isopaque:
Histopaque — 1077, an aqueous solution containing 5*7g/l00ml 
Picoll and 9g/l00ml sodium diatrizoate (Sigma Chemical Co.Ltd# 
Poole) • The filter sterilised solution, in 100ml bottles with 
rubber septum closures, was stored protected from light at 4°C. 
Phytohaemagglutinin (PHA) :
Vials of sterilised, freeze-dried,reagent grade material 
(Wellcome Reagents Limited, Beckenham) stored at 4^C. Vials 
were reconstituted with 5ml of sterilised distilled water, 
stored at 4^C and used within one month.
Microtitre plates:
96 U—well type of bacterial grade with lids (Sterilin Limited, 
Teddington, Middx)•
(Methyl-^H) thymidine:
Specific activity 5 Ci/mmol, in aqueous solution, radioactive
-1 —1concentration 1 mCiml and thymidine concentration 0.2 mmol 1
(Radiochemical Centre Limited, Amersham)• For routine use a 
1 in 40 dilution of stock in PBS(a) (see 2.8,2) was prepared 
and used within seven days.
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Scintillation counting vials:




1,4-di-2-( 5-phenyloxazolyl)-benzene (POPOP) 0.05g 
toluene to 1 litre.





All glass surfaces coming into contact with hlood samples or separ­
ated lymphocytes were coated with silicone, to prevent the adherence 
and consequent loss of cells.
Test tubes and bijou bottles were washed out twice with sili­
cone solution (Repelcote; Hopkin and Williams Ltd., London) then 
thoroughly rinsed in two changes of fresh single distilled water 
and a large volume of DD H^O (2.8.1) . After a minimum 30min in the 
final rinse the coated tubes and bottles were dried at l60°C and 
then sterilised in a hot air oven at l60°C for Ihr.
Graduated and Pasteur pipettes were coated by twice drawing 
up silicone solution into them. They were rinsed out with freshly 
distilled water then immersed in a large volume of DD H^O for a min­
imum 30min. The siliconed pipettes were dried and sterilised at 
160°C for Ihr.
6.6.2 Taking and handling blood samples
Good microbiological practice was employed in the handling of all 
blood samples. To minimise variation due to inter—individual diff­
erences in responsiveness to the test compounds, blood from one 
healthy male donor aged 38 years was used throughout the study.
10—15ml samples of venous blood were taken and transferred into 
10ml screw—capped specimen tubes. It proved impracticable to sep­
arate and treat the lymphocytes immediately after the collection of 
blood and so a standard protocol was adopted, in which blood was 
stored overnight at room temperature prior to processing.
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6.7 lymphocyte Separation
To avoid microbial contamination good aseptic technique was employed 
throughout the isolation, treatment and culturing of lymphocytes.
The lymphocyte isolation procedure was basically that of Boyum 
(1968). Its principle is that when diluted blood is layered on top 
of Picoll-Isopaque (an iso-osmotic solution of density 1.077g ml  ̂
but low viscosity) a biphasic discontinuous density gradient is 
created. During low speed centrifugation erythrocytes and granulo­
cytes are aggregated by Picoll and rapidly sediment, wheras mono­
nuclear cells, predominantly lymphocytes, remain at the interface 
between the Picoll-Isopaque and supernatant plasma.
lymphocyte separation and processing were carried out at room 
temperature. All solutions contacting the lymphocytes were pre— 
warmed to 20°C. The blood sample was thoroughly mixed and 2ml 
added and mixed with an equal volume of PBS in a screw-capped test 
tube. 3m 1 of Picoll-Isopaque was placed in another tube and the 
diluted blood layered onto it, ensuring that the two phases did not 
mix. The tube was centrifuged at 400g (l600rpm) for 35min in an 
accurately calibrated MSB-Minor centrifuge (see 2.1).
Pol lowing centrifugation the upper plasma layer was with­
drawn by Pasteur pipette without disturbing the opaque lymphocyte 
interphase. Using a fresh Pasteur pipette the interphase layer was 
carefully transferred to a clean tube, avoiding contamination with 
plasma or granulocyte—containing Picoll-Isopaque. 5ml of PBS was 
added to the isolated lymphocytes which were suspended by gentle 
pipetting and then pelleted by centrifugation at l?Og (l,000rpm) 
for 5min. The washed cells were suspended in 5ml of culture medium, 
pelleted as before and re—suspended in about 0.5ml of the super­
natant medium. Routinely lymphocytes were separated from six 2ml
volumes of blood, washed, resuspended in culture medium and then 
bulked. The bulk suspension was thorou^ly mixed and a total cell 
count performed using a haemocytometer (2.1) . The suspension was 
adjusted to 10^ cells ml*"̂  by the addition of culture medium.
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6.8 Measurement of ^H-Thymidine Uptake by Lymphocyte Micro- 
Cultures
A lymphocyte suspension containing 10^ cells ml  ̂ in culture med­
ium was thoroughly mixed by pipette and then subdivided into 0.6 - 
1.5ml volumes in 5ml bijou bottles. To these were added the test 
compounds. 0.1 - 0.2ml volumes of the treated cell suspensions 
were then dispensed into the wells of a microtitre plate. The 
microtitre plate was sealed in its polythene sleeve and incubated 
for 72hr at 37*5°C in a humidified 5^ 00^ in air atmosphere (ach­
ieved as in 2.4) » ^H-thymidine, 1 pCiml was added to each well
for the final 24hr of incubation.
The microcultures were harvested onto filter discs using a 
semi-automatic multiple microculture harvester (llacon disc cutter; 
Ilacon Limited, Tonbridge, Kent). This apparatus harvests one 
12—well row of a microtitre plate at a time. The contents of the 
wells are automatically aspirated and delivered onto filter discs 
supported on a vacuum manifold. Wash solutions added to the wells 
via a reservoir immediately carry over onto the filters. In the 
standard procedure, cells were collected on filter discs cut from 
Whatman glass fibre filter paper (GP/C grade) (Whatman Limited, 
London) . Each row of wells and corresponding filters was then 
washed successively with 45̂ 11 distilled water, 15ml 5^ W/v trich­
loroacetic acid (TCA) and 15ml methanol (TCA and methanol, AnalaR 
grade, BDH Limited, Poole). The washed filter discs were placed in 
empty glass counting vials and left open overni^t at 37°Co
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6*9 Liquid Scintillation Counting
The samples were counted supported on the dried filter discs. $ml 
of scintillation fluid was added to each vial. The capped vials 
were allowed to equilibrate at room temperature for a minimum 
30min then counted in a RackBeta 1215 liquid scintillation count­
er (LKB—Wellac, Turku, Finland) • Each sample was counted for 
tritium until 10,000 counts had been made or a maximum 10min 
counting period elapsed.
A comparative measure of ^H-thymidine uptake into the acid 
insoluble cellular fraction was. required. Quench correction, to 
determine the absolute number of tritium decays per minute (dpm) 
was therefore unnecessary. The raw counts per minute (cpm) of 
labelled precursor in each sample, corrected for background (20cpm), 
served as the measure of uptake.
Cpm of incorporated ^H-thymidine from a minimum 5 replicate 
microcultures were obtained for each concentration of test com­
pound. Data are presented as the arithmetic mean cpm of ^I^thy— 
midine i the standard error of the mean (s.E.M.) . Any suspect, 
discrepant count arising in a group of replicate sample counts 
was excluded from these calculations if it fulfilled Chauvenet's 
criterion for data rejection (Yutaka and Maudsley 1974)#
Though no quench correction was undertaken, an external 
standard channels ratio (ESCR) was determined for each sample.
This was found to be extremely consistent within experiments, as 
one would expect for series of identically and concurrently pre­
pared samples. Abnormally quenched counts would have been identi­
fiable by ESCR’s significantly lower than the mean ratio for a par­




Initially it was necessary to confirm the reported morphologic 
response of human lymphocytes to TPA (Bstensen et al 1974)• It 
was also intended to ascertain if lymphocyte stimulation could he 
quantified by determining the proportion of blast—transformed 
cells in a mitogen treated population.
lymphocytes were separated from 8ml of fresh blood, washed 
and then resuspended at 10^ cells ml**̂  in MFIOX supplemented 
with serum from batch 1 (see 2.8.6)• 1ml macrocultures, prepared 
from the bulk suspension, in bijou bottles were dosed with 
1.6x10’**̂ M TPA ( batch 1 ) and with 10 p i PHA, as a positive con­
trol. Negative control cultures, untreated and treated with 
DMSO (the vehicle for phorbol esters) were included. After treat­
ment additions cultures were gassed with 9^ CO^ in air and incub­
ated at 37*5°C.
0,1 — 0.2ml samples were taken from each culture at 24$ 48 
and 72hr post—treatment and transferred to small V—bottomed tubes. 
Cultures were gassed after each sample had been withdrawn and re- 
incubated. The cells were sedimented by centrifugation (5min at 
l,500rpro in MSB-Minor) and the supernatant medium removed. Pellet­
ed cells were spread on a microscope slide, air-dried, stained by 
Leishman's method (Duddington I960) and then dry mounted in DPX 
(BDH Limited, Poole).
The stained preparations were microscopically examined with 
transmitted li^t under low (x 256) and high power (x640 and 
xl600). Photomicrographs of untreated and treated lymphocytes are 
shown in Plates 6.1 and 6.2
The cells of untreated and M S O —treated cultures maintained
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Plate 6.1. Untreated human peripheral blood lympho­
cytes after 72 hr in culture. Magnification x 1350.
Plate 6.2. Human peripheral blood lymphocytes
-724 hr after addition of 1.6 x 10 M TPA to culture 
medium. Magnification x 1350.
2 6 6
the typical appearance of small untransformed lymphocytes (Plate 
6,1) throughout the 72hr incubation period, A few degenerated 
pycnotic cells and contaminating monocytes were found in these 
and the mitogen-treated populations at all times, Pycnotic cells 
increased and monocytes decreased with time in culture.
The plant lectin PHA induced the expected responses. At 
24hr many of the lymphocytes already showed changes associated 
with blast-transformation. Considerable agglutination of lymph­
ocytes was also evident; large cell clumps, some containing hun­
dreds of cells, were observed. The extent of this lymphocyte 
agglutination was similar in all subsequent samples.
By 48hr a large portion of the cell population had under­
gone full blast-transformation. The resultant lymphoblast cells 
were much larger than normal lymphocytes, with increases in both 
cytoplasmic and nuclear volume. Their cytoplasm was more baso­
philic and often vacuolated, while the enlarged nuclei were paler 
staining, more granular, and usually contained one or more meta- 
chromatic nucleoli, A few mitotic cells were observed in this 
sample. The 72hr preparation had much the same appearance as the 
48hr, except that the degree of cytoplasmic vacuolation in blast 
cells was increased and mitotic cells were more numerous.
The changes induced by TPA closely resembled those in the 
PHA-treated culture i,e, considerable agglutination and classical 
blast-transformation of lymphocytes. However, two differences were 
noted. Firstly, the degree of cytoplasmic vacuolation in induced 
lymphoblasts was less than in the PHA-treated cultures. Secondly, 
mitotic cells were first observed in the 72hr sample rather than 
in the 48hr sample and even then they were only found infrequently. 
These distinctions possibly reflect a difference in the time course
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of lymphocyte transformation hy PHA and TPA, the latter inducing 
certain of the characteristic morphological changes at later times# 
When attempting to determine the proportion of induced lymph­
oblasts in PHA and TPA-treated populations a number of difficulties 
were encountered. Firstly, the considerable lymphocyte agglut­
ination in the cultures meant that this parameter could only be 
determined for the discernable, non-clumping cells, which may not 
have been representative of the whole population. Certain cells 
only partially fulfilled the criteria for classification as lymph­
oblasts, thus there was a subjective element in cell scoring. Ob­
servations suggesting that the time course of transformation might 
vary for different mitogens also meant it was not sufficient to 
determine the proportion of lymphoblasts at one time post-treat­
ment. It was therefore concluded that this approach to quantify­
ing lymphocyte stimulation was laborious and any results obtained 
equivocal and that it was unsatisfactory for use in an assay sys­
tem.
2 6 8
6.11 TPA-Induced ^ —thymidine Uptake
In an attempt to develop a reliable procedure for assessing TPA— 
induced lymphocyte stimulation an experiment was conducted to 
confirm the observation of Bstensen et al. (1974) that blast- 
transformation of human lymphocytes is accompanied by increased 
incorporation of ^-thymidine into cellular DNA.
lymphocytes were separated from 8ml of fresh blood, washed 
and then resuspended at 10^ cells ml  ̂in MP10(—dT)l supplemented 
with serum from batch 1. 1.5ml macrocultures in 5^1 bijou bottles
were dosed with either 1.6x10 TPA ( batch 1 ) or 1*^1 PHA.
A control culture was treated with DM SO. All cultures were gass­
ed with jfo COg in air and incubated at 37#5^C. After 48hr 
thymidine was added to each culture to give 1 jdCiml 24hr later 
the cultures were harvested by filtration under negative pressure 
onto 2,4cm diameter GP/c filter discs (Whatman Limited, London). 
The entrained cells were washed successively with 15ml of dis­
tilled water, 15ml of 5^ TCA and 15ml of methanol. The filters 
were partially dried under vacuum, transferred to open counting 
vials and dried at 37^C. 15ml of scintillation fluid was added 
to each vial, the vials were capped, allowed to equilibrate and 
then counted. The counts obtained are recorded in Table 6.1. 
TABLE 6.1
Uptake of ^-thymidine by TPA- and PHA-treated human lymphocytes
Treatment Cpm of incorporated 
H-thjmidine
DMSO, o.Tÿ v/v 14,463
TPA 1.6xlO~^M 385,760
PHA 10 /ll/ml 393,980
It can be seen from Table 6.1 that treatment of lymphocytes with 
either TPA or PHA results in increases of the order of 2^fold over
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control in the uptake of ^ —thymidine into acid—insoluble material* 
Since morphological changes characteristic of blast-transformation 
had been observed in similarly treated lymphocytes (see previous 
experiment, 6.10) the data confirmed the findings of Bstensen et 
al. (1974) and suggested that measurement of ^H-thymidine uptake 
could be used to assay lymphocyte stimulation.
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6.12 Range of TPA Concentrations Stimulating lymphocytes 
Preliminary experiments were conducted to obtain an outline of the 
concentration response profile for TPA induction of thymidine 
uptake.
Freshly separated lymphocytes dosed with varying concentra­
tions of TPA were dispensed into microtitre wells in O.l^ml volumes 
(1.5x10^ cells/well) and incubated. ^H-thymidine incorporation 
into cellular DNA was determined as in the standard microculture 
assay (6.8 and 6.9)$ with one modification - filter discs were 
counted in 5̂ 1̂ of scintillation fluid in plastic minivials (LKB— 
Wellac, Turku, Finland). TPA was from batch 3 and the cul­
ture medium(RFMIX) was supplemented with serum from batch 1.
The data obtained in two separate experiments (l and II) 
are recorded in Table 6.2.
TABLE 6.2
Stimulation of ^-thymidine uptake into lymphooyte microcultures 
by a range of TPA concentrations
Treatment Replicatemicrocultures
^ Kean cpm of 
^-thymidine — S.E.M.
DM SO I f 10 1,319 - 75
TPA 1.6xl0"^I 10 161426 " 662
I
1.6x10“ 'm 12 23,013 - 1005
1.6xlO“^M 12 20,703 - 723
DMSO If 7 597 -  100
TPA 8xlO"®M 8 20,456 - 959
II 7
8x10“ 'm 7 17,344 ~ 626
8xl0"^M 7 5,228 1 880
It was found that plastic min—vials swelled on prolonged contact 
with the scintillation fluid and sample counts were consequently 
increasingly quenched. This was the cause of differently cfuenched
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counts in I and II, which as a result could not he pooled to pro­
duce a single dose—response plot. Nevertheless it can he seen in
Table 6.2 that lymphocyte stimulation increased with TPA concen-
—8 —6trat ion to a broad peak between about 8x10 M and 1.6x10 M, it
-6then declined markedly, TPA at 8x10 M eliciting a response far 
below the maximum. In all subsequent experiments glass counting 
vials were used.
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6.13 Effect of Storage on the Response of lymphocytes to TPA 
and PHA
Experimental work would be greatly facilitated if separated lymph­
ocytes could be stored and used whenever desired. It was there­
fore determined whether lymphocytes retain their responsiveness 
to TPA and PHA following short-term holding at 4^C.
6ml of lymphocytes; separated, washed and resuspended at 
10^ cells ml“  ̂in RFMIÎ, were placed in a screw-capped test tube. 
The tube, purged with 9̂  CO^ in air and sealed with gas-tight tape, 
was placed in a 4^C refrigerator. After 3 days the lymphocytes 
were thoroughly suspended by prolonged Pasteur pipetting and dis­
pensed in 0.2ml volumes into microtitre wells (2x10^ cell/well) .
In this experiement only, treatments in 2 ^1 volumes were added 
directly to the microoultures. The lymphocytes were incubated 
and ^H—thymidine uptake measured in the usual way (6.8 and 6.9) . 
TPA was from batch 3 and RPMH was supplemented with serum 
from batch 1.
The data obtained are given in Table 6.3.
TABLE 6.3
Stimulation of ^ —thymidine uptake into lymphocyte microcultures 
by TPA and PHA after short-term stora^ of cells.
Treatment Replicate raicrecultures
Mean cpm of 
H-thymidine - S.E.M.
DMSO, I f 6 44 i 8
PHA, lO^l/ml 6 3,789 - 1,464
TPA, 1.6xlO“®M 6 88 i 28
TPA, 1.6xlO“?M 6 83 i 39
It was found (see Table 6.3) that after storage in complete culture 
medium for 3 days at 4°C, lymphocytes became refractory to TPA 
treatment. They also lost much of their responsiveness to PHA, a
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muoh higher mean cpm (at least xlO) would be expected from the 
data obtained with lymphocytes exposed to 10 p l /w l PHA immediate­
ly after separation (see Table 6.1).
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6.14 Determination of the lymphocyte—Stimulating Activities of 
a Series of Phorhol Derivatives
These experiments were designed to fulfill a main aim of the 
study - to ascertain whether lymphocyte mitogenic activity corr­
elates with tumour-promoting potency for phorbol and its deriva­
tives. The compounds tested were TPA, phorbol—12,13—didecanoate 
(PDD), phorbol—12,13-4ibenzoate (PDB), phorbol—12,13—dibutyrate 
(PDBu) , phorbol—12,13-diacetate (PDA) , 4̂ -0-<nethyl—12-0—tetradec— 
anoylphorbo1-13—acetate (MeTPA), 4<^—pLorbol—12,13-didecanoate 
PDD) and the parent alcohol phorbol (P) •
Lymphocytes dosed with varying concentrations of test com­
pound (added in 5 ̂ 1 DMSO per ml of cell suspension) were dis­
pensed into microtitre wells in 0.1ml volumes (ixlO^ cells/well) 
and incubated, ^ —thymidine incorporation into cellular DNA was
measured as in the standard microculture assay procedure. Within
-9each experiment TPA was included as a positive control at 2.5x10 K 
and 10 concentrât ions eliciting a moderate though significant 
response and a maximum response respectively. In all cases culture 
medium was supplemented with serum from batch 2. TPA throughout 
was from batch 3 (for sources and handling of TPA and all 
other phorbol derivatives see section 2.10.2).
The results obtained with phorbol and its derivatives are 
presented in Tables 6.4 to 6.9• Dose—response plots derived from 
certain of these data are given in Figures 6.1 and 6.2.
2 7 5
TABLE 6.4
Effect of a range of TPA concentrations on ^H-thymidine uptake 
into lymphocyte microcultureb
Treatment Replicatemicrocultures
, Mean cpm of 
■^-thymidine - S.E.M.
DMSO control 8 296 105
TPA 1.6il0“^^M 7 138 10
1.6xlO“^M 8 2,363 + 241
1.6xlO“^l 8 6,844 + 344
1.6x10“?% 8 7,000 + 356
8xl0“?M 8 6,724 + 344
1.6xlO“^M 6 3,953 280
8xlO“^M 7 3,832 + 302
TABLE 6.5
Effect of a range of PDD concentrations on ^H—thymidine uptake
into lymphocyte microcultures
_ Replicate Mean cpm of
rea men microcultures H—thymidine — S.E.M,
control 6 169 - 26
2.5xlO“^M 6 4,077 - 213
10“?M 6 - 396
2.5x10“^% 6 319 - 45
10“\ 6 1,906 i 82
5xl0“^I 6 3,508 - 142
10“?H 6 4,346 - 140
7.5xlO“?M 9 7,087 - 418
1.5x10“^ 9 7,298 i 563
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TABLE 6.6





Mean cpm of 
^-thymidine — S.E.M.
DMSO control 6 834 -  57
TPA 2.5xlO"^M 6 4,676 —  464
10"?M 7 10,913 -  265
PDB 2.5xlO"^M 7 3 0 0 - 8 2
10"^ 6 592 - 50
5xlO"\ 6 4,430 -  204
10“?M 7 8,061 i  382
10"^M 7 3,771 i  474
1.75x10“^ 7 131 -  46
TABLE 6.7
Effect of a range of PDBu concentrations on H—thjnnidine uptake
into lymphocyte microoultures
Treatment Replicatemiorocultures
, Mean opra of 
H-thymidine - S.E.M.
IMSO control 6 808 i  74
TPA 2.5x10“^» 5 2,849 -  347
10“?M 6 5,527 -  235
PDBu 10“^ 6 2,177 -  202
10“?M 6 5,372 -  263
5xlO“?M 6 8,338 1 671
10“*M 6 7,503 - 304
lO"^ 6 4,835 -  271
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TABLE 6.8
Effect of a range of MeTPA and P concentrations on ^-thymidine 
uptake into lymphocyte microoultures
Treatment Replicatemicrooultures
- Mean cpm of 
^-thymidine - S.E.M.
DMSO control 6 429 - 21
TPA 2.5xlO"^M 6 3,023 - 226
10“?M 6 4,765 - 261
MeTPA 10“?M 6 264 - 18
10*^M 6 871 - 71
10“^M 5 2,526 - 118
P 10“?M 6 356 - 17
10“^M 6 331 - 37
10“^ 6 380 i 22
TABLE 6.9
Effect of a range of 4ol—PDD and PDA concentrations on
thymidine uptake into lymphooyte microoultures
Treatment Replicatemicrooultures
- Mean cpm of 
■%-thymidine - S.E.M.
jWîSO control 8 184 t  8
TPA 2.5xlO“^M 8 2,822 i 66
10“?M 5 4,866 i 288
401-PDD 10*?M 8 586 1 46
10" ^ 9 470 i 47
10“^ 9 49 — 3
PDA 10“?M 9 270 i 16
10"^M 9 2,%1 i  99
10“^ 9 3,931 -  230
N.B. The somewhat reduced response of TPA positive controls seen 
in Tables 6.7 to 6*9, as compared with Tables 6.4 to 6.6, was
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probably due to reduced efficacy of the TPA stock solution avail­
able for these experiments.
A comparative measure of lymphocyte—stimulating (mitogenic) 
activity was required for the tested compounds. In the case of 
TPA, PDD, PDB and PDBu,for which dose—response plots were con­
structed (Pigs. 6.1 and 6.2), two parameters were used to define 
activity:
(1) The lowest significantly mitogenic concentration 
(ED^ ) ; determined by interpolating the upper 955̂  con­
fidence limit of control ^H-thymidine uptake onto the 
response plot#
(2) The concentration eliciting 50̂ ' of the maximal 
induced response (ED^) .
ED„ values could not be determined for PDA, MeTPA, 4®^-PDD or P. 
However, the lowest test concentration eliciting a significant 
response (greater than the upper 95^ confidence limit of control) 
was taken as the ED^ value.
These values along with the relative skin tumour—promot ing 
potencies of the compounds are given in Table 6.10. Unfortunately 
no satisfactory absolute measure of promoter potency is available. 
The semi—quantitative estimates given have been arrived at follow­
ing assessment of results from many studies within the mouse skin 
system for two—stage tumour formation. Also included is another, 
more general, measure of biological activity, the dose of each 
compound producing inflammation in 50?- of animals (irritant dose 
50 ID^^) in Becker's mouse ear irritancy test (Hecker I968).
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TABLE 6.10
The relative lymphocyte-mitogenic activities of the tested phorbol 
derivatives together with their previously reported potencies as









TPA + + + + 0.016 (2) 0.25 3.1
PDD + + + 0.010 (2) 2.5 60
PDB + + 0.24 (3) 12 50
PDBu + 0.067 (4) 4.4 56
PDA 2.0 (3) lo" -
MeTPA 2.3 (2) 10^ -
P +/—* 100 (3) Inactive -
401-PDD - 100 (2) Inactive -
References (Ref)
1. Diamond et al. I98O 
2 • Hecker 1978
3. Schairer I966
4. Thielmann & Hecker I969
* Only exhibit tumour—promoting activity in skin—tumour—sensitive 
(STS) mice#
The ED^ for PDBu was obtained from the most likely extrapolation
of the incomplete dose—response profile to the upper confidence
limit of control (dotted line in fig. 6.2). The mean cpms for 
—7 —64^-PDD at 10“ and 10 M (see Table 6.9) were both significant ly 
higher than control. Nevertheless this diester was classed inactive; 
the lymphocyte stimulation observed was comparatively low and 
assumed to be the result of contamination with other, active, esters 
remaining from 4*^‘-PDD's partial synthesis (Thielmann and Hecker
1969).
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The results summarised in Table 6,10 indicate that for 
derivatives of phorbol, ability to stimulate human lymphocytes 
corresponds with ability to promote mouse skin tumours. Further­
more, for those compounds showing a positive effect, mitogenic 
activity (as reflected by ED^ values) appears in general to paral­
lel tumour-promoting potency.
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6.15 An Investigation to Determine if Phenob art itone Possesses 
lymphocyte-stimulating Activity
Phorbol and its derivatives are classed as diterpenes (see 1.2). 
It was of interest to determine if the correspondence of lympho­
cyte mitogenicity with tumour—promoting ability demonstrated for 
these compounds extended to a non—diterpene tumour promoter.
Phenobarbitone (sodium salt; Evans Limited, Speke, Mersey­
side) was dissolved in DD H^O (200mgml 0.79%) and filter ster­
ilised. This stock solution was serially diluted in the same sol­
vent and added to lymphocyte suspensions at 5 )il per ml. The ex­
perimental procedure was exactly as detailed for the proceeding 
investigation of phorbols, except that a PHA positive control was 
included at one effective concentration (lO ^l/ml). Medium was 
supplemented with serum from batch 2.
The data obtained with a range of phenobarbitone concentra^ 
tionsbetween 3.9x10“^  and 3#9xlO“^M are given in Table 6.11. 
TABLE 6.11
Effect of a range of sodium phenobarbitone concentrations on 
^H-thymidine uptake into lymphocyte microcultures
Treatment Replicatemicrocultures
 ̂ Mean cpm of 
H-thymidine - S.E.M.
Solvent control 9 454 -  41
PHA 10 ;il/ml 6 11,622 - 1080
Sodium phenobarbitone
3.9x10“^ 8 418 i  50
3.9xlO“?M 5 415 -  31
3.9xlO“^M 8 496 ±  47
3.9x10"^ 9 517 -  57
3.9x10" ^ 9 369 i  32
3.9xlO“^M 9 73 -  17
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Over a wide range of concentrations — from the suh-raicromolar 
levels at which phorhol derivatives are active, up to 3*9x10 
where ^H-thymidine uptake was suppressed below control, presuma- 
bly due to non-specific toxicity — this compound showed no mito— 
genic effect.
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6.16 An Investigation to Determine if Resiniferatoxin Possesses 
Lymphocyte-Stimulating Activity
Resiniferatoxin, a daphnane (see 1.2), is the most irritant diter—
pene ester found so far, it exhibits an IDq^ between 10  ̂— 10 ^y j
nmol/ear in a mouse ear irritancy test (Hecker 1978) . Though 
tumour promotion by resiniferatoxin is as yet unreported the close 
association of irritancy with promoting activity (Hecker 1968, 1978) 
suggested it was worthwhile determining the effect of this compound 
in the lymphoc^rte system. For phorbol diterpene esters mitogenic 
activity seems to correlate well with irritancy (see Table 6.10). 
Thus, should resiniferatoxin also be mitogenic it might reasonably 
be expected to be highly potent. It was therefore tested over a 
wide range of low concentrations from 10 to 10 ?M.
The experimental procedure was identical to that employed in 
the investigation of phorbols. Culture medium was supplemented with 
serum from batch 1. The data obtained are given in Table 6.12.
TABLE 6.12
Effect of a range of resiniferatoxin concentrations on ^H-thymidine 






DMSO control 9 158 + 11
PHA 10 ;il/ml 7 10,042 + 928
Resiniferatoxin
10”^^M 9 193 + 17
10“^^M 9 210 18
10“% 9 210 + 19
2.5x10“% 8 225 + 27
io“% 9 114 + 14
10“?M 9 113 + 8
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As can be seen in Table 6.12, resiniferatoxin was unable to stimu­
late human lymphocytes at any of the tested concentrations.
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•6,17 Discussion
It has been shown that normal, non—proliferating lymphocytes, from 
several animal species, can be stimulated to undergo blast—trans­
formation with increased DNA synthesis and cell division, following 
treatment with the tumour—promoting phorbol diester TPA (Estensen 
et al. 1974, Mastro and Mueller 1974, Abb et al. 1979). Further­
more, there is an indication, from results with TPA, a short series 
of other phorbol derivatives and phorbol itself, that lymphocyte- 
stimulating activity (or lymphocyte-mitogenicity) correlates with 
tumour—promoting activity (Estensen et al. 1978)• The aim of the 
present study was to further investigate this possible correla^ 
tion and hence to determine whether an assay of lymphocyte- 
mitogenicity might serve as a valid prescreening test for tumour- 
promoting environmental chemicals.
Initially a density gradient centrifugation technique was 
established for the separation of human peripheral lymphocytes 
from venous blood (6.7). The lymphocytes, once separated and 
washed, were suspended at 10^ cells ml  ̂in a modified RPMI I64O 
medium supplemented with 10^ FBS and then incubated in a 9^ CO^ 
in air atmosphere at 37*5°C. It was confirmed (6.IO) that the 
majority of cells had the typical appearance of blood lymphocytes 
- small, spherical cells, with a dense nucleus surrounded by a thin 
rim of cytoplasm — and that they maintained their appearance for at 
least 72hr in culture (see Plate 6.I). Thus it was concluded that 
undamaged, normal lymphocytes could be isolated and that the chosen 
culture conditions had no deleterious effect on the cells#
When lymphocytes were dosed with either TPA or the plant 
lectin mitogen PHA, prior to incubation, a large proportion of cells 
subsequently underwent typical morphologic blast-transformation,
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readily observable in cytological preparations (6.IO)• Those cells 
affected were greatly increased in size; had an enlarged, vacuolated 
and more basophilic cytoplasm and contained nuclei showing one or 
more nucleoli (see Plate 6.2)• Some of these lymphoblast cells pro­
ceeded to mitosis in both the TPA- and PHA—treated cultures. The 
changes seen in the differently treated cultures did show two notic— 
able differences. Firstly, mitotic cells arose later and less fre­
quently in the TPA—treated culture than the PHA culture. Secondly, 
the degree of cytoplasmic vacuolation in TPA—induced lymphoblasts 
was less, at all corresponding times, than in PHA lymphoblasts.
These distinctions possibly reflect a difference in the time course 
of lymphocyte transformation by TPA and PHA, the former inducing 
certain of the characteristic morphological changes at later times. 
Nonetheless, the observation of classical blast—transformation 
following TPA treatment of human lymphocytes confirmed the original 
report of Estensen et al. (1974) regarding the response of such cells 
to the tumour—promoting phorbol ester. When an attempt was made to 
assess lymphocyte stimulation by determining the proportion of in­
duced lymphoblasts in cytological preparations, this was found to be 
laborious and unreliable. Therefore a better means of assaying lym­
phocyte stimulation was sought.
It was demonstrated that blast—transformation of lymphocytes 
is accompanied by increased uptake of ^H-thymidine into acid- 
insoluble cellular material (6.II) i.e., increased DNA synthesis.
This observation agreed with the findings of Estensen et al. (l974) 
and indicated that measurement of ^H—thymidine uptake could be used 
as a reliable monitor of lymphocyte stimulation. Consequently a 
lymphocyte microculture assay system was developed (6.8) and used 
to obtain an outline of the dose—response profile for TPA induction
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of cellular ^H-thymidine uptake (6.12). The range over which TPA
—8 —6elicited a maximum response (8x10 — 1,6x10 M) agreed well with
the data of Estensen et al, (1974) and Touraine et al, (1977)• How­
ever, the observation of a very marked reduction of lymphocyte DNA 
synthesis at a higher concentration ( 8 x 10"”^M) was not reported by 
these workers, the highest concentration tested in each of their 
studies being 1,6x10 ^M.
Lymphocytes became refractory to TPA at concentrations 
previously shown to be mitogenic, after storage at for 3 days 
(6.13) . Reduced lymphocyte responsiveness with time in vitro has 
previously been reported (Mastro and Mueller 1974, Estensen et al, 
1978). A possible reason for the present observation is greatly 
reduced cell viability, an explanation which might be confirmed by 
dye—exclusion viability determinations (Paul 1975) on identically 
processed lymphocytes. Such determinations were not made in this 
study, but would be necessary in future work, since both Mastro 
and Mueller and Estensen et al. presented evidence suggesting 
changes in the number and/or properties of cellular binding sites 
with a relatively high affinity for TPA as an alternative explana­
tion for reduced lymphocyte responsiveness. Whatever its cause, 
this phenomenon readily explains the lower ^H—thymidine uptake per 
cell in all experiments subsequent to 6.13, in which overnight 
storage of cells prior to treatment was unavoidable*
In the main body of the study the mitogenic activities of 7 
phorbol derivatives of varying promoting potency and their parent 
alcohol, phorbol, were determined (6.I4)• The demonstration of a 
rank order correlation of lymphocyte-mitogenicity with tumour- 
promoting potency within such a series of promoting and weak— or 
non—promoting TPA analogues would favour a relationship between
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these two biological activities. Pull dose—response plots were 
constructed for the four phorbol diesters TPA, PDD, PDB and PDBu 
because they exhibit high activities in other biological systems 
(see tumour—promoting potencies and irritancy (iDy^) values in 
Table 6.IO) and of the test compounds were, therefore, the most 
likely to induce measurable lymphocyte stimulation. The remaining 
compounds - PDA, MeTPA, 4o(-PDD and phorbol — were each tested at 
three different concentrations to obtain an estimate of the dose 
threshold for any proliferative response they might evoke.
The dose—response profiles for TPA, PDB and PDBu (see Pigs.
6.1 and 6.2) all show a rise to a similar level of maximal stimu­
lation, followed by a decline at higher dose levels. This type of 
dose—response profile, with concentrations significantly below or 
above the optimum showing reduced or no stimulation, is described 
as unimodal and is characteristic of the response of lymphocytes 
to mitogens (Wang et al. 1975). Reduced lymphocyte stimulation at 
high concentrations may be the result of non-specific toxicity. 
However, there are alternatives. Physical phenomena, reducing the 
concentration of single freely dispersed phorbol ester molecules 
in the culture medium cannot be excluded, for example, these hydro­
philic/lipophilic molecules may aggregate to form micelles (Edelman 
and Wang 1978). Furthermore, Wang et al. (l975) have suggested that 
the inhibitory portion of the typical mitogen dose—response curve is 
not due to toxicity, but to a disruptive action of high doses of 
mitogen on a hypothesised structure — the cell surface modulating 
assembly (CMSA). The CSMA is thought to mediate cell surface 
receptor-cytoplasmic communication (Wang et al. 1975)#
Its disruption mi^t lead to the blocking of stimulatory signals 
to the cell's replicating machinery from surface receptors binding
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mitogen. Thus, as in the case of loss of responsiveness of lympho­
cytes on storage, the possibility of reduced cell viability account­
ing for inhibition of lymphocyte stimulation at high TPA, PDB and 
PDBu concentrations requires confirmation by dye exclusion methods.
The dose—response profile for PDD (see Pig 6.2) is atypical,
although it reaches a maximum comparable with that achieved by
TPA, PDB and PDBu it shows no subsequent decline. PDD is known
—8to have a much lower aqueous solubility than TPA (5x10 M and 
2xlO’”̂ M respectively at 25°C, Jacobson et al. 1975)* It seems 
likely, therefore, that under the conditions of the present ex­
periment the solubility limit of this ester was exceeded at, or 
soon after reaching, maximum stimulation, further addition of PDD 
having no effect.
Although TPA, PDD, PDB and PDBu all evoked a similar maxi­
mal response (again see Pigs 6.1 and 6,2), their potencies varied 
markedly. Potency refers to the absolute concentration of drug 
necessary to attain an appropriate end-point (Blumberg I98I). In 
this system two end-points were selected: (l) occurrence of stat­
istically significant stimulation above control and (2) half- 
maximal response. The concentrations at these end-points were 
determined by interpolation and are referred to as ED^ and ED^ 
values respectively.
TPA was mitogenic at nanomolar levels, its EDj^ was 3.1nM 
(see Table 6.IO) , in good agreement with the value of 5̂ 'I calcu­
lated from the results of Abb et al. (1979)» There are however a 
wide range of other ED„ values for TPA available in the literature: 
Estensen et al (1974) 23nM; Wang et al. (1975) lOnM; Estensen et 
al (1978) 0.8nM and Edwards et al. (198I) have reported an E D ^  
of 26nM. This variation is perhaps not surprising,as at the nano—
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molar concentrations involved differences in medium components 
(particularly serum) and even the material of the culture vessel 
itself might significantly alter both the concentration of TPA at 
its site of action and the ability of cells to respond.
Dose—response data, allowing calculation of ED^ and ED„ values, 
have not previously been reported for lymphocyte stimulation by PDD,
PDB and PDBu, Results in Tables, 6.5, 6.6 and 6.7 (plotted in Fig 6.2) 
reveal that these three phorbol esters are all capable of eliciting 
a maximal level of lymphocyte stimulation comparable with that seen 
following treatment with an optimally effective concentration of TPA 
(see Fig 6.I). However, all three are markedly less potent mitogens 
than TPA, ED^ and ED values being, in all cases, at least 10-fold 
higher than for TPA (see Table 6.IO). It can also be seen in Fig
6.2 that the dose-response plots for these agents, though not super­
imposable, overlie each other. This fact is reflected by the close­
ness of their ED^ and ED„ values (Table 6.IO) . ED^^ values couldyo jU
not be determined for the less active phorbol derivatives — PDA,
MeTPA, 40C—PDD or phorbol itself, but for these compounds the ED^ 
was approximated by the lowest test concentration evoking a response 
significantly above control.
In Table 6.10 it can be seen that for the series of phorbol 
esters tested, the capacity to stimulate human lymphocytes corres­
ponds with tumour-promoting ability in mouse skin. However, rank 
order comparison does not reveal a perfect correlation between 
lymphocyte mitogenicity, as measured by ED/̂  values, and tumour- 
promoting potency. Most notably PDBu, which is a weak promoter, 
was found to be a powerful mitogen. Its ED^ (4*4î 'î) is close to 
that for PDD (2.5nM) and somewhat lower than that for PDB (l2nM), 
both markedly better promoters. Similarly, certain closely related
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12—deoxyphorbol derivatives with short chain substituents are non­
promoting, yet exhibit strong mitogenic activity (Edwards et al#
1981)• These findings suggest that molecular structure activity 
relationships in the lymphocyte mitogenesis and mouse skin tumour 
promotion systems are different and that the two systems are possibly 
not closely related.
Many phorbol esters are potent irritants and produce severe 
inflammatory responses when applied to mouse skin, in addition to 
or instead of promoting tumoiors (Hecker 1971» Schmidt and Evans 
1980, Edwards et al. I98I). It has been shown that PDBu is much 
more potent as a skin irritant than as a tumour promoter (Thielmann 
and Hecker I969) and this suggests that lymphocytemiitogenicity may 
be better correlated with irritancy than tumour-promoting activity. 
Comparison of ID^ and ED^ values in Table 6.10 strongly supports 
this view and the fact that the mitogenic, though non-promoting, 
12-deoxyphorbols mentioned above are potent irritants (Schmidt and 
Evans I980) is also in agreement.
In the light of the apparent correlation of lymphocyte-mito- 
genicity with irritancy for the series of phorbol diterpene esters, 
it was decided to test resiniferatoxin, the most potent irritant of 
the diterpene ester class (Hecker 1978) in the human l^miphocyte 
system (6.16). The observed lack of lymphocyte-stimulating activ­
ity over a wide concentration range (Table 6.12) was not altogether 
surprising. Though resiniferatoxin is a highly potent irritant, its 
effect is short-lived and different in nature to the persistent in­
flammatory response typically evoked by TPA and other diterpene 
esters (Evans and Schmidt 1979» Schmidt and Evans I98O). Evans and 
Schmidt (1979) have therefore suggested that the acute response to 
resiniferatoxin is the result of an agonist—receptor interaction.
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whereas the effect of TPA and other irritant diterpenes is due main­
ly to less specific biological activity. Such a fundamental differ­
ence in the mechanism of action of resiniferatoxin; further supported 
by the fact that this compound does not fit in with normal structure— 
activity relations for diterpene esters (Evans and Soper 1978, Hecker 
1978); probably explains its lack of mitogenic activity.
A sound working hypothesis, based on the above findings, is 
that potency of lymphocyte stimulation in vitro by phorbol esters 
correlates with non-specific biological activity (as reflected by
values) and that because high biological activity is a necess­
ary property of mouse skin tumour promoters (I.5) all skin tumour- 
promoting phorbol esters exhibit mitogenic activity.
The necessity of high biological activity for skin t'omour— 
promoting activity is now universally accepted (Boutwell 1974,
Diamond et al. I98O, Blumberg I98I). However the relationship of 
the two is uncertain. With respect to the phorbol esters, Blumberg 
(1981) has outlined two alternative hypotheses. Firstly, biological 
activity in the mouse ear irritancy test and many other in vitro 
systems (which might now be expanded to include the lymphocyte stimu­
lation system) may truly reflect the intrinsic skin tumour—promoting 
potency of a given phorbol ester. However, in longer term mouse skin 
tumour promotion experiments, other factors e.g. absorption, dégrad­
ât ion and excretion of the compound can mask its intrinsic activity.
PDB provides a classic example of this. PDB was originally classed 
as a poor tumour promoter, following the finding that it only weakly 
enhances tumour formation when applied to initiated mouse skin twice 
a week (Hecker I968 ); however, it was subsequently shown to be a good 
promoter when applied more frequently (four times a week) (Baird and 
Boutwell 1971)• The original result and misclassification are pre—
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siamed to have been due to the chemical instability of this phorbol 
diester (Blumberg I981) . It may be that an analogous complicating 
factor will explain the observed low promoting potency of PDBu, which 
one would expect to be much higher from its significant irritant and 
mitogenic activities (Table 6.IO)• The alternative hypothesis is 
that promotion occurs upon interaction at a unique cellular target 
and that high biological activity is only required to provide a 
proliferative stimulus so that 'promoted' tumour cells can express 
their neoplastic phenotype. The unique promoter action and distinct 
proliferative stimulus of this latter hypothesis correspond very 
well with the conversion and propagation sub—steps of skin tumour 
promotion identified by Boutwell (1964) (see l.l).
In an attempt to obtain firmer evidence, for or against, an 
overlap of mechanisms involved in mitogenesis and tumour promotion, 
a non—diterpene ester-type tumour promoter was tested in the lympho­
cyte system (6.I5). Phenobarbitone is an established promoter of 
rat liver tumours within a system of two—stage tumourigenesis which, 
though it differs in certain characteristics, is analogous to that 
in mouse skin (see l.l) . Like phorbol esters, phenobarbitone in­
duces hyperplasia, hypertrophy and a complex of biochemical changes 
(including increased DNA synthesis) in its target organ (Peraino et 
al. 1971). These changes are not a regenerative response to drug- 
induced hepato—toxicity and have been identified as being vital to 
the compound's action as a tumour promoter, in much the same way that 
proliferative stimulation of epidermal cells is necessary for pro­
motion in mouse skin (Peraino et al. 1978) . Such similarities, 
though they do not necessarily suggest a common mode of action for 
all classes of tumour—promoting agents, do indicate some common act­
ivities - which might extend to mitogenic activity in human lympho-
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cytes. If found to be so, this would suggest that the changes in­
duced in lymphocytes by these agents are relevant to tumour promotion 
and that lymphocyte stimulation can serve as an end-point in a pro­
moter screening test. However, at none of the concentrations tested 
did phenobarbitone exhibit mitogenic activity (Table 6,ll)• This 
failure to detect a known tumour promoter would preclude the use of 
a lymphocyte stimulation assay as a prescreening test for tumour- 
promoting environmental chemicals.
One might conclude, because phenobarbitone*s tumour—promoting 
ability is not accompanied by mitogenic activity in human lympho­
cyte cultures, that lymphocyte mitogenesis is totally unconnected 
with tumour promotion and just a coincidental effect of tumour- 
promoting phorbols. Indeed, only of mouse skin tumour—promoting 
phorbol esters, since phorbol itself, though a non-promoter in 
mouse skin, is a promoter of mouse lung and liver tumours and 
murine leukaemia (see Table l.l) but not a lymphocyte mitogen 
(Table 6.10). Alternatively, the mechanism of skin tumour pro­
motion by phorbol esters may be totally dissimilar from the mech­
anisms of tumour promotion by phenobarbitone and phorbol in their 
respective target organs or only correspond where changes assoc­
iated with mitogenesis are not involved. One of the latter ex­
planations seems possible, at least from findings with phenobarb— 
itone, because the character of promotion by this agent is some­
what different from that by phorbol esters. Although phenobarb­
itone enhances tumour incidence in initiated rat liver it does not 
shorten the lag period to appearance of tumours (Peraino et al.
1971) as do phorbol esters in mouse skin (Boutwell 1964)• Further­
more, the tumour—enhancing effects of phenobarbitone, unlike those 
of phorbol esters, are apparently irreversible after cessation of
2 9 7
promoter treatment (Peraino et al. 1978).
It may be, as suggested by Blumberg (I98I), that the mech­
anism of action of skin tumour-promoting phorbol esters is unique. 
This proposition is based largely on the high promoting potencies 
of these compounds and their wide range of biological activities 
(see Chapter 1), both of which are unrivalled. If this is so, the 
studies reported here, though they indicate that lymphocyte stimu­
lation is not related to tumour promotion in general, do not exclude 
the possibility that the mitogenicity of phorbol esters is related 
to their skin tumour-promoting ability. Assuming there is some 
commonality in the actions of phorbol esters as skin tumour pro­
moters and lymphocyte mitogens, it is worthwhile considering the 
effects of these agents on lymphocytes for possible insights into 
the mechanism of tumour promotion.
Phorbol esters contain highly lipophilic fatty acid moieties, 
suggesting that they will associate more readily with the membranous 
fractions of cells than with the more aqueous cytosolic compartment 
(Van Duuren I969)• It has been observed on electron microscope 
autoradiographs that ^H-TPA appears to bind preferentially to 
membranous elements within lymphocytes (Wenner et al. 1978). Rapid 
hyperpolarization of the membrane potential (Tsien et al. I982), 
early changes in phospholipid metabolism (Wertz and Mueller 1978) 
and cell agglutination (see 6.10 and Skinnider 1979) all follow 
lymphocyte exposure to TPA and strongly suggest directly induced 
changes in the plasma membrane following binding of TPA. The fact 
that other lymphocyte activators - antigens, allogeneic cells in 
the mixed lymphocyte response and plant lectin mitogens — bind to 
the cell surface (Roitt I980) reinforces the probability of a phor— 
bol ester target on or in the cell surface membrane*
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The very low concentrations at which TPA is active, not only 
as a lymphocyte mitogen, hut also in many other systems (see Chapter 
l) , suggest that TPA acts sls a surrogate at a cell membrane receptor 
site for an endogenous hormone-like substance (Estensen et al. 1978). 
Attempts have been made to identify a phorbol ester receptor in sev­
eral cell types. Sando et al. (I98I) have recently presented exper­
imental evidence of a specific saturable cellular binding component 
which may mediate phorbol ester effects in normal human peripheral 
blood lymphocytes. ^H-PDBu was used to identify this binding site 
and it was found that other unlabelled phorbol esters competed for 
it in approximate order to their skin tumour-promoting potency. 
Scatchard analysis of data indicated a median number of 2x10^ 
binding sites per cell. Subcellular fractionation to localise the 
phorbol ester binding component was not carried out, though from 
the above discussion, one would expect it to reside on or in the 
cell membrane.
Whatever its cellular target, the activities of TPA seem to 
be ultimately mediated by Ca^* ion-dependent processes. Inter­
action of TPA with Câ "*’ was first observed in the rat thymus 
lymphocyte system (Whitfield 1973). High concentrations of Ca^*
('^ 1.5n}l) stimulated these cells; in the presence of TPA (8lnl/l) 
the dose-response curve for stimulation by Câ '*’ was shifted to 
lower ion concentrations. Consistent with these findings Wang et 
al. (1975) found that TPA caused a synergistic enhancement of 
stimulation of human lymphocytes by the Câ **" ionophore A23187, 
which enhances Ca^* ion transport. Recently Tsien et al. (1982) 
have presented evidence which strongly suggests that elevated 
intracellular Ca^* concentration ( [Câ *̂  ̂) precipitates lympho­
cyte proliferation and that TPA is mitogenic because it stimu-
2 9 9
lates relevant Câ **’—dependent cellular processes. TPA appears to
act directly on these processes to increase their sensitivity to
2+ 2+Ca ions. Analogous stimulation of Ca —dependent processes in
other cell types may explain many actions of TPA, including tumour 
promotion. There is already evidence from at least one study that 
calcium—induced release from growth control is an obligatory pre­
liminary stage of tumour promotion (McGaughey and Jensen I980).
In conclusion, the lyraphocyte-mitogenicity of phorbol esters 
seems to correlate with their aggregate activity in a number of 
biological systems, as best reflected by ID^ values. High bio-jU
logical activity, though insufficient in itself, is a prerequis­
ite for skin tumour-promoting activity. Therefore for phorbol 
derivatives and possibly other diterpenes, significant lympho- 
cyte-mito genic ity is indicative of skin tumour-promoting poten­
tial. However, the inability of the lymphocyte system to detect 
the known rat liver tumour promoter, phenobarbitone or the mouse 
lung and liver tumour and leukaemogenesis promoter, phorbol, pre­




In multi-step carcinogenesis tumour promoters, though non-carcino— 
genic per se, act to complete a process initiated by carcinogens 
and produce increases in tumour frequency and decreases in the lag 
time for tumour appearance. The present study investigated the 
effects of the mouse skin tumour promoter TPA on gene mutation, 
sister chromatid exchange (sCE) and structural chromosomal aberra­
tions in the cells of a single established rodent cell line, CHO—Kl; 
with the aim of both obtaining insights into the mechanism of tumour 
promotion and identifying a basis for a short term screening test
for tumour—promoting agents amongst environmental chemicals. In
/
addition, with respect to the latter goal, the relative abilities 
of TPA, several TPA analogues and a non-diterpene ester-type tumour 
promoter to stimulate human peripheral blood lymphocytes (PBL) were 
determined, to ascertain if a tumour promoter screening test with 
immediate relevance to man could utilise this cell type.
CHO—Kl was selected for use in these investigations because it 
is a well characterized cell line, with a small quasi—diploid chromo­
some complement amenable to karyotype analysis and scoring of SCBs 
and chromosomal aberrations. Furthermore, conditions for the select­
ion of variants resulting from mutation at several different gene 
loci have been defined for this cell type. Cells were certified as 
CHO-Kl on the basis of their epithelioid morphology (Plate 3.1); the 
need to supplement medium with 2x10 ^ mol 1  ̂L—pro line (3*2.2) ; a 
mean generation time of 12hr in exponential growth phase (3*5); aad. 
most importantly, on the basis of their chromosomal constitution.
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The cells had a modal chromosome number of 20, as reported for 
CHO-Kl cells by Kao and Puck (1968) (Pig. 3.2) and exhibited 
chromosomal G—band sequences recognisable in the normal female 
Chinese hamster cell karyotype (Plate 3*4)• To minimise unwanted 
genetic heterogeneity and consequent non-uniformity of phenotype, 
a clonal population, CHO—KIA, was isolated and propagated for use 
in all investigational experiments (3«4) • This clonal population 
contained a higher proportion of cells with 20 chromosomes than 
the original population, establishing that cloning had had the de­
sired effect of reducing heterogeneity (Pig. 3*2.b).
Survival responses of CHO—KIA cells following SMS treatments
of both monolayer cultures (3*8.1) and single, plated, cells
(3.8.2), as assessed by values, were closely comparable with
earlier reports regarding the lethal effects of this agent on CHO-
Kl or CHO cells. When monolayer CHO—KIA cultures were treated with
MNNG, cells showed survival responses to the mutagen comparable with
those previously reported, at corresponding doses, for cells of a
different CHO-Kl subclone (3*8.3, Table 3*3)* Interestingly, it was
found that single CHO-KlA cells and presumably other CHO-Kl cells,
are far more sensitive to M M G  than single CHO cells (3*8.3, Fig*3*5) *
Conversely, the results in Fig* 3*6 suggest that for UV radiation
the situation is the reverse; CHO-KlA cells plated at high density
require exposure to four times the dose of 254^^ UV-li^t before
showing kill equivalent to that reported for CHO cells, under almost
identical experimental conditions, by Thompson et al. (I98O). Ex-
—7 ~6posure to TPA for 24hr at both 1.6xlO" and 1.6x10 M concentration 
was non-toxic to CHO—KIA cells, but at 1.6x10*"^ TPA, survival was 
reduced to 2^ of control (Table 3*5)* An incidental observation.
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that at both the lower concentrations TPA caused cells to become 
more fibroblastic in appearance, is in agreement with similar 
observations with CHO (Thompson et al. I980) and other cell types 
(Driedger and Blumberg 1977) • This may be a membrane associated 
phenomenon or, alternatively, a result of altered gene expression.
If cancer cells arise from normal cells as a consequence of 
somatic mutations (Boveri I929) then TPA and other tumour promot­
ers may exert their characteristic biological action by increasing 
the mutagenic consequences of exposure to initiating carcinogens. 
There is evidence from in vitro bacterial and mammalian cell sys­
tems that TPA and other skin tumour promoters have such a co—mutar- 
genic effect (4*3) • The influence of TPA on mutation to both Qua?pand TG in CHO-Kl cells was therefore investigated.
pAn in situ Qua mutation assay system was optimised with res­
pect to mutation expression time for the Oua^ phenotype, cell den­
sity in mutant selection plates and drug concentration for mutantp
selection (4.6)# Conditions for the colonial recovery of Qua CHO—
p
Kl cells were essentially as reported for the recovery of Oua mut­
ants from other established rodent cell lines and the spontaneous 
mutation frequency in the wild-type CHO-Kl population at <2.1 mut- 
ants/io'^ viable cells was very low (4.6.4 and 4«H) • 2MS was found
pto be a far more efficient inducer of viable Oua CHO-Kl mutants 
than LHING (Tables 4*2 and 4*3) » consistent with a similar observa^ 
tion with CHO cells (Baker et al. 1974) *
In the fully developed mutation assay system (4*6.5) 1*6x10 
TPA, though apparently non—mutagenic per se, was able to signifi—
p
cantly enhance mutation to Oua induced by I#TNG, though only when 
presented to cells immediately following mutagen treatment and main—
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tained in the cell culture medium throughout mutation expression 
and selection (Table 4*6) • However, in the same promoter treat­
ment regime, TPA was incapable of enhancing mutation following 
either EMS (Table 4*9) or UV treatments (Table 4*10)* In the 
case of UV, TPA consistently enhanced the killing action of the 
mutagen, which may indicate that it can inhibit DNA repair mech­
anisms capable of ameliorating otherwise lethal damage (Soper and 
Evans 1977, Trosko et al. 1977)* A mechanism for the co-^utagenic 
action of TPA, seen here with MTNG and in various other systems 
(4*3), based on the inhibition of excision repair or other DNA 
repair mechanisms is however contradicted by the ability of TPA 
to enhance mutation when presented to cells long after the comple­
tion of such processes on damaged DNA (Trosko et al. 1977, Lankas 
et al. 1980). Furthermore, it appears that the inhibition of DNA 
repair by TPA reported by some workers (Teebor et al. 1973, Trosko 
et al. 1975) reflects a non-specific cellular response, since the 
tumour promoter has been found to inhibit replicative DNA synthesis 
as effectively as repair synthesis (Poirier et al. 1975, Trosko et 
al. 1977)* p
Mutation to TG was assayed using a protocol for the quantité^ 
tive recovery of HGPRT /TG^ CHO-Kl mutants developed and fully val- 
idated by O'Neill et al. (1977)* The ET'lS-induced TG phenotype was 
found to require 6—7 days to achieve full expression, (Table 4*11, 
Fig. 4*2) as reported by O'Neill et al. A subsequent decline in 
mutation frequency and a h i ^  control mutation frequency were eff­
ectively countered by using cells isolated and propagated in HAT 
medium and more stringent selection conditions for the TG^ phenotype 
(4.10.3, results Table 4*13)•
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As in the CHO—Kl/Oua system, TPA per se was apparently non— 
mutagenic when tested for the ability to induce TG mutants (Tables 
4*11 and 4*13) * However, because Trosko and Chang (1976) have re­
ported that TPA is capable of inducing a significant increase in 
the frequency of TG mutants in unmutagenized V79 Chinese hamster 
cell populations, the non-mutagenicity of the compound requires 
confirmation in a more extensive future investigation, possibly us­
ing a modified Luria-DeIbruck fluctuation test (Luria and Delbruck 
1943) as employed by Lasne et al. (1980)• Although there are no re- 
ports of TPA being capable of inducing Oua mutations, such an exper­
iment is also recfuired to unequivocally confirm that this is the case 
in CHO-Kl.
In contrast to its lack of co-mutagenic activity with M S  in 
the CHO-Kl/Oua^ system, TPA significantly enhanced both the yield 
and frequency of TG mutants following treatment with this mutagen. 
Although the promoter could also enhance the recovery of 'leaky mut­
ants, this effect was insufficient to account for its co-mutagenic 
activity (Table 4*14)*
It has been hypothesised that TPA and other tumour promoters 
have their co-mutagenic action by causing stable, heritable, pheno­
typic changes which are not the result of true genetic mutations - 
so called epigenetic mutations (Trosko and Chang 1976, Trosko et al.
1977) * There is evidence of such non—structural mutations in cer­
tain rat and mouse cells, in which repressed HGPRT genes are re—ex­
pressed on hybridization with human and chick cells respectively 
(Trosko and Chang 1976) * In support of the stated hypothesis, TPA, 
which does not cause DNA damage (Poirier et al. 1975) has been re­
ported to increase the yield of HGPRT"/tG^ variants in V79 popular-
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tions (Trosko and Chang 1976). This result has not, however, been 
repeated in V79 (Trosko et al. 1977, Kinsella I981), CHO (Thompson 
et al. 1980) or CHO—Kl cells (present study. Tables 4*11 and 4*13)* 
Nevertheless, since TPA has been repeatedly shown to enhance mutar- 
genesis by SMS or UV in this and other studies (Trosko et al. 1977, 
Fujiwara et al. I98O, Thompson et al. I980), it may be that TPA is 
only capable of modulating the expression of genes bearing certain 
mutagen-induced structural changes. Future experiments might inves­
tigate whether TPA is capable of inducing epigenetic mutations, by 
determining if it can act either to cause the re—expression of re­
pressed HGPRT genes in the aforementioned rat and mouse cells or, 
conversely, to inhibit or reverse the re-expression of these same 
genes in human-rat and mouse—chick cell hybrids. TPA would have to 
be presented to both untreated and mutagen—treated cells and cell 
hybrids, in case, as seems likely from the results discussed above, 
the cells require prior mutagen exposure for the promoter to have 
its effect.
In a variation of the cobnut agen theory for the action of tum­
our promoters, Kinsella and Radman (1978) suggest that such agents 
act by increasing the frequency of mitotic recombination in the 
cells of their target tissue, thereby causing the segregation and 
expression of oncogenic mutations resulting from prior exposure to 
an initiating carcinogen. The experiments reported in Chapter 5 
investigated whether TPA is capable of increasing either the control 
or mutagen—elevated frequency of SCE in CHO-Kl cells; such exchanges 
being possible cytological indicators of mitotic recombination (Char- 
ganti et al. 1974, Kinsella and Radman 1978, Rosenstraus and Chasin
1978). SCEs were visualised by growing cells for two DNA replica^
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tion rounds in the presence of BrdU and staining chromosome prepar­
ations by a modified PPG technique (5*3)• Preliminary experiments 
with MNNG (5*4) and MC (5*10) gave results closely comparable with 
those of other workers with CHO and established that the developed 
SCE assay procedure was suitable for use in the study of the effects
of TPA on SCE levels.
7 —6At both 1.6x10 and 1.6x10 M concentration, TPA had no influ­
ence on the control SCE frequency observed in the presence of 20 
BrdU (Table 5*4)• The harvesting of mitotic cells only, by the shake- 
off technique (5*9)» made no difference to this result (see Table
5.6), SCE frequencies observed in identically treated populations 
being closely comparable with those in cells harvested by trypsinis- 
ation.
TPA had no statistically significant enhancing effect on the 
mean number of SCEs in cells treated with MNNG (Table 5*5)* Again, 
the use of the shake—off technique did not alter this finding (Table
5.6) . The two sets of data did, however, suggest that TPA is capable
of modulating MNNG-^levated SCE frequency to a small degree - in both
—7 —6cases 1.6x10*” M TPA caused a slight increase and 1.6xlO” M TPA a
slight decrease in exchange frequency. This observation may be att­
ributable to cellular changes induced by TPA not directly related to 
SCE formation. It may be, for example, that at the higher concentra­
tion, the promoter transiently inhibits CHO-Kl cell replication and 
allows more time for pre—replication repair of mutagen—induced DNA 
lesions capable of triggering SCE formation, the lower concentration 
having the opposite effect. Moreover, given the reported replication 
fork specificity of MNNG (I.8.I), a reduced rate of DNA replication 
would also probably result in less damage being initially sustained
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by the DNA.
Consistent with the results with MNNG was the finding that TPA 
did not cause a significant enhancement of the elevated SCE fre­
quency observed following mitomycin C (MC) treatment (Table 5*8)c A 
small, though statistically significant, reduction of MC—elevated 
SCE frequency by 1.6x10 M TPA might, once again, have been the re­
sult of an indirect effect of the promoter.
The results of the present study add to a considerable number 
of conflicting reports regarding the effect of TPA on SCE frequency 
in mammalian cells. Increases in SCE frequency following TPA ex­
posure of untreated or mutagenized cells have been reported by Kin— 
sella et al. (l9?8), Kinsella and Radman (1978) and Gentil et al. 
(1981) using V79 cells; and by Nagasawa and Little (1979) using 
C3H/IOTI/2 mouse fibroblasts. Conversely, Loveday and Latt (1979) 
using V79 and CHO cells; Fujiwara et al. (I980) using V79 cells; and 
Thompson et al. (I980) using CHO cells, all report that TPA has no 
effect on either base-line or mutagen—elevated SCE frequency. Given 
these conflicting reports, it is desirable that future studies as­
certain the effect of the mouse skin tumour promoter on SCE frequen­
cy in adult mouse epidermal cells, either in vitro or preferably in 
vivo. Until such time as techniques have been developed to allow 
these experiments, an immediately achievable aim is to establish the 
effect of TPA on SCE frequency in cells of primary skin fibroblast 
lines, which, unlike all the above aneuploid established cell types, 
are diploid and closely approximate cells in vivo (Paul 1975)•
As well as the controversy regarding the induction of SCEs in 
mammalian cells by TPA, an investigation of the effects of the pro­
moter on the frequency of structural chromosomal aberrations in CHO—
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Kl also detracted from the hypothesis that tumour promotion is a 
consequence of mitotic recombination (5.12)• Metaphase quadrira- 
dial structures are likely evidence of mitotic recombination earl­
ier in the cell cycle (5.I)• None were observed in cells from 
either of two TPA-treated cultures (Table 5*9)• However, a very 
much larger study is required to unequivocally establish that TPA 
does not induce quadriradials. Since these structures are normally 
only very rarely encountered (German I964) it is possible that a 
significant increase in their frequency is not detectable in as few 
cells as the 100 scored per treatment in the current study. In this 
experiment it was also found that TPA has no general disruptive eff­
ect on CHO—Kl chromosome structure. The effect of TPA on mutagen- 
elevated chromosomal aberration frequencies was not investigated. Gi­
ven that tumour promoters characteristically enhance the effects of 
carcinogens, this is a worthwhile objective of future experiments.
The results of Estensen et al. (1978), with TPA, a short ser­
ies of other phorbol derivatives and phorbol itself, indicate that 
the potency of a human peripheral blood lymphocyte (PBL) stimulating 
activity of these compounds correlates well-with their tumour—pro­
moting activity. Allied to similarities between the responses of 
mouse epidermal cells and lymphocytes to TPA (6.3) this suggested 
the use of an assay of lymphocyte stimulation as a short term screen­
ing test for tumour—promoting agents. Initially it was confirmed 
that human PBL treated with TPA underwent blast transformation very 
similar to that observed following exposure to the plant lectin mit­
ogen PHA (6.10). The only apparent distinctions were the later app­
earance of mitotic cells and less extensive cytoplasmic vacuolation 
following TPA treatment, possibly reflecting a longer time course
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for transformation compared with PHA, An assay involving the liquid 
scintillation counting of ^H-thymidine incorporated into acid insol­
uble cellular material (6,7 — 6,9) was then developed to monitor lym­
phocyte stimulation, following the finding that cytological methods 
were not satisfactory for this purpose.
The results in Table 6.10 show that for phorbol, TPA and six 
other phorbol esters, the capacity to stimulate human PBL corres­
ponds with tumour-promoting ability in mouse skin. However, rank 
order comparison docs not reveal a perfect correlation between tijm— 
our promoting potency and lymphocyte mitogenicity - assessed by the 
lowest concentration of test agent eliciting a significant response 
(SDa value). Most notably PDBu, which is a weak promoter, is a pot­
ent mitogen. Instead, promoting potency appears to be better correl­
ated with irritancy (as given by ID^ values), a more general monitor 
of biological activity. Discrepancies between structure activity re­
lationships for such non-specific biological activity and promoting 
potency, within the series of phorbol derivatives, may be due to fac­
tors which mask the intrinsic activity of certain phorbols in long 
term mouse skin tumour promotion experiments or, alternatively, to 
the fact that promotion occurs upon interaction at a unique celluler 
target.
The finding that phorbol, a known promoter of mouse lung and liv­
er tumours and murine leukaemia and the non-diterpene ester-type rat 
liver tumour promoter, phenobarbitone are both unable to stimulate 
human PBL precludes the use of a lymphocyte stimulation assay as a 
widely applicable screening test for environmental tumour promoters. 
However, a relationship between the mechanism of lymphocyte stimula­
tion by phorbol esters and their skin tumour-promoting action is not
3 1 0
excluded by current data. Indeed, there is evidence to suggest 
that both actions may somehow be mediated by Ca^*—dependent pro­
cesses (McGaughey and Jensen I98O, Tsien I982)• A worthwhile ex­
tension to the present set of experiments would be to determine the 
response of human PBL to a non-diterpene ester—type mouse skin tum­
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